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ABSTRACT 
PGC-1α is a transcriptional co-activator well established as a potent regulator of 
oxidative metabolism in skeletal muscle. This co-activator mediates metabolic adaptation to 
exercise by orchestrating mitochondrial biogenesis. PGC-1α is also integral for the maintenance 
of muscle mass and function during atrophic conditions.  
Autophagy is a highly conserved proteolytic pathway responsible for the degradation of 
dysfunctional organelles and protein aggregates through the lysosomal machinery. Autophagy is 
upregulated during metabolic distress and is essential for cell survival. While PGC-1α has been 
extensively studied in the context of skeletal muscle adaptations, its role in autophagy has not 
been dissected. To this end, the purpose of this dissertation was to examine the interplay between 
PGC-1α and autophagy in skeletal muscle in the spectrum of muscle contractile states. 
 We first assessed the role of PGC-1α in the regulation of autophagy and mitophagy 
during chronic muscle disuse in the form of denervation. To do this we denervated wildtype 
(WT), PGC-1α knockout (KO) as well as PGC-1α overexpressing (Tg) animals. We found that 
autophagy and mitophagy flux were compromised in KO animals both basally, and in response 
to denervation, resulting in a myopathic phenotype. In the Tg animals we uncovered enhanced 
levels of certain autophagy and lysosomal markers, but surprisingly noticed reduced targeting of 
mitochondria for degradation. Overall we concluded that PGC-1α is important for the fine-tuning 
of autophagy in skeletal muscle based on cellular metabolic state, but that it is not required for 
this process.  
Next we evaluated the role of PGC-1α in mitochondrial turnover following an acute bout 
of exhaustive exercise. We found that in the absence of PGC-1α, exercise-induced mitochondrial 
turnover was compromised, as evident by reduced expression of mitochondrial genes and 
diminished autophagy/mitophagy induction, as well as flux. 
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Collectively, our data demonstrate that PGC-1α is instrumental in maintaining 
mitochondrial health in skeletal muscle through enhancing organelle turnover. Moreover, PGC-
1α can fine-tune autophagy/mitophagy in a manner that is specific to cellular metabolic state.  
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CHAPTER 1: 
Introduction 
Skeletal muscle is the largest of all human organs, and aside from its undisputed role in 
locomotion, it is also central to whole body metabolism and glucose homeostasis. Muscle 
possesses a unique ability to adapt to alterations in contractile activity and metabolic cues. This 
plasticity is responsible for many of the beneficial adaptations induced by exercise, and the 
metabolic derailments which accompany sedentary behaviour. Mitochondria, the cellular power 
plants, are at the fulcrum of cellular bioenergetics. These organelles are also major signaling 
hubs making day to day decisions that can influence cellular fate. Mitochondrial loss during 
muscle disuse contributes to atrophy, while enhanced organelle density and vigor with exercise 
are beneficial to cellular metabolism, muscle mass and overall health.  
PGC-1α is a transcriptional regulator most renowned for its ability to drive the expression 
of oxidative genes in a variety of tissues and cells. The level of this co-activator rises and falls 
with mitochondrial content, and enhancing the expression of this protein is sufficient to block 
organelle loss as well as the decline in muscle mass under various atrophic conditions, such as 
diabetes, chronic heart failure, disuse, denervation and aging. PGC-1α is also responsible for 
mediating exercise-induced adaptations and has insulin sensitizing benefits. 
Autophagy is a cellular quality control mechanism responsible for the recycling of toxic 
organelles and protein aggregates. Autopagy induction is cytoprotective during conditions of 
metabolic stress, but either deficient or hyperactive autophagy is detrimental to cellular health. 
Lack of autophagy exacerbates loss of muscle mass under atrophic conditions, resulting in the 
accumulation of aberrant organelles, and prohibits the glucose sensitizing benefits of exercise. 
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Overactive autophagy is equally detrimental, as it results in a net catabolic effect. Thus, tight 
control over autophagy regulation is imperative for the maintenance of muscle mass. 
Although both PGC-1α and autophagy appear vital for mitochondrial homeostasis and 
muscle health, the interplay between them in the spectrum of muscle contractility has not been 
investigated as of yet. Elucidating the role of PGC-1α in autophagy regulation, and establishing 
how these two entities may communicate to influence mitochondrial turnover and skeletal 
muscle vitality is critical for expanding our understanding of muscle plasticity. With today’s 
aging demographics and growing obesity epidemic, it is more important than ever to uncover the 
mechanisms responsible for the preservation of muscle health. The ability to target and 
manipulate the energy resources of skeletal muscle can have widespread implication for well-
being and disease prevention, which is of great importance to public health. 
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CHAPTER 2: 
Review of Literature 
2.1 Mitochondria 
2.1.1 Introduction 
Once two organisms apart, now mitochondria are an integral part of the eukaryotic cell 
and represent the most efficient and cost effective energy producing mechanism, albeit with 
some toxic by products. Mitochondria are self-contained double-membrane organelles and are 
often regarded as the cellular “power plants”. These organelles are believed to have provided the 
evolving eurokayotic cell with a significant advantage, giving rise to the complex variety of 
biological organisms that exist today. Mitochondria have entrenched themselves so far into 
cellular biology that they are now considered to contribute much more than just the energy 
needed for survival. Indeed, mitochondria have been recognized to play an integral role in 
cellular signaling, and are involved in cellular maintenance, growth, calcium signaling and 
storage, metabolite synthesis as well as life and death decisions (65). Therefore, a tight control 
over mitochondrial density, quality, and distribution is critical for cellular homeostasis. The 
consequences of aberrant mitochondria are dire, and have been implicated in a plethora of 
malignant conditions including cancer, neurodegenerative diseases, cardiovascular diseases, 
diabetes, as well as aging (301).  Alterations in mitochondrial content in skeletal muscle in 
response to changes in muscle milieu are believed to, at least in part, be responsible for the 
unique metabolic plasticity of muscle (82). This makes the processes of mitochondrial regulation 
an important field of study with great pleiotropic therapeutic potential in a large number of 
conditions.  
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2.1.2 Mitochondrial Biogenesis 
Hints of the independent origin of mitochondria are evident from their peculiar nature. 
For instance, in contrast to other organelles, mitochondria are not formed “de novo” but rather 
originate only through the division of existing organelles, a process known as fission. 
Mitochondria also contain their own DNA, hosted in a circular plasmid within the mitochondrial 
matrix, very much like bacterial DNA. As further proof of their prior autonomous state these 
organelles possess their very own transcriptional and translational machinery. In the 1970s, all of 
these “coincidental” findings found their way into the now well accepted, theory of 
endosymbiosis postulated by Dr. Lynn Margulis (73). However, mitochondria do not contain 
anywhere near the amount of DNA needed to encode all ~1500 mitochondria-specific proteins. 
Only 13 proteins, 22tRNAs, and two rRNAs are actually transcribed within mitochondria (34). It 
is conceivable that throughout evolution the transcription of a growing number of mitochondrial 
proteins migrated into the nucleus. This is possibly due to the delicate nature of fairly 
unprotected mitochondrial DNA (mtDNA) and its close proximity to the electron transport chain 
(ETC), a major site of production of damaging reactive oxygen species (ROS) (305). 
Mitochondrial DNA is rendered fairly defenceless against the damaging effects of ROS due to its 
lack of protective histones, and fairly scarce DNA repair and proof-reading mechanisms. The 
vast majority of proteins required for mitochondrial function are, therefore, blueprinted by 
nuclear genes encoding for mitochondrial proteins (NUGEMPs) (252). Once transcribed in the 
nucleus these proteins are then translated in the cytosol and must be imported into mitochondria, 
and processed before being incorporated into their respective roles. Many of these NUGEMPs 
are destined for the ETC with the vital task of oxidative phosphorylation, while others may assist 
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with mitochondrial DNA replication and maintenance (i.e mitochondrial transcription factor A; 
Tfam) (70). Thus, mitochondrial biogenesis is a complex process that requires intricate 
cooperation of two separate genomes. Nuclear control of mitochondrial protein expression is 
achieved by the activation of several transcription factors, in response to diverse stimuli. 
Alterations in nutrient availability, hormones, growth factors and even temperature fluctuations 
can activate this process. Among the transcription factors involved in contributing to 
mitochondrial mass are the nuclear respiratory factors (NRF1 and NRF2) (315), the peroxisome 
proliferator activator receptor family (PPARα, PPARβ, PPARγ) (296) and estrogen-related 
receptors (ERR-α, ERR-β, ERR-γ) (53). But perhaps the most infamous factor involved in 
mitochondrial network growth and expansion is the transcriptional co-activator PPARγ 
coactivator-1α (PGC-1α). This transcriptional regulator was first described as a coactivator of the 
adipocyte-enriched nuclear receptor, PPARγ, in brown adipose tissue and skeletal muscle (211). 
PGC-1α was documented to drive the adaptive thermogenic response to cold exposure, by 
boosting mitochondrial machinery (211).  It has since been demonstrated to robustly upregulate 
many aspects of mitochondrial content under various metabolic stresses by facilitating the 
activity of numerous transcription factors (98, 296, 315). It has also been recognized to mediate 
many of the benefits attributed to regular exercise (82). 
2.1.2.1 PGC-1α  
Since its discovery, PGC-lα has been studied extensively. Time and again it was 
demonstrated to orchestrate mitochondrial biogenesis under a variety of metabolic changes. As a 
transcriptional co-activator PGC-1α does not in itself bind DNA, nor does it possess any 
enzymatic activity. PGC-1α functions by binding to transcription factors on the promoters of 
mitochondrial genes within the nucleus and recruiting various histone acetyl transferases (HATs) 
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such as CREB binding protein (CBP)/p300 and SRC-1, thus allowing for chromatin remodelling. 
This greatly increases the access of the transcriptional machinery to DNA (174, 210). 
Furthermore, the coactivator can eliminate transcriptional repressors such as HDACs, and 
associate with RNA polymerase II, all with the ultimate goal of facilitating gene transcription 
(174). PGC-1α interacts with transcription factors NRF-1 and NRF-2 to upregulate the 
expression of genes involved in the electron transport chain (ETC), mitochondrial import 
machinery and transcription factors of mitochondrial DNA (mtDNA) (70). PGC-1α also 
enhances the activity of the hormonally-regulated ERRα, which drives the transcription of genes 
involved in many aspects of mitochondrial biology including fuel utilization, oxidative 
phosphorylation, and mitochondrial shaping machinery (53, 255). Finally, PGC-1α has been 
implicated in mammalian target of rapamycin (mTOR) kinase-mediated regulation of 
mitochondrial biogenesis. In this scenario mTOR forms a complex with transcriptional repressor 
YingYang1 (YY1) and PGC-1α on the promoters of several mitochondrial genes (50). Thus, 
PGC-lα coordinately regulates various transcription factors to facilitate the many facets involved 
in mitochondrial biogenesis.  
Given its central role in cellular energy management, it is not surprising that PGC-lα can 
be regulated both transcriptionally and post-translationally to allow for both short- and long-term 
potentiation of metabolic machinery. Both aspects of modulation are highly responsive to 
energetic status, temperature, nutrient availability, hormonal stimuli and more (82, 155). 
Changes in cellular milieu result in alterations in ROS, NAD+, AMP and Ca2+ levels, which 
launch signaling cascades resulting in the activation of metabolically-sensitive factors that 
converge on the PGC-1α promoter. Various transcription factors are implicated in this process, 
including cAMP responsive element binding protein (CREB) (88, 314), calcium-regulated 
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transcription factor 2 (ATF2) (6), p38 mitogen-activated protein kinase (MAPK), (6, 252), and 
Forkhead transcription factor (FKHR) (51), to name just a few. The activation of the energy 
sensor AMP-activated protein kinase (AMPK) genetically or pharmacologically though AICAR 
treatment results in the induction of both PGC-lα transcription, and activity (101, 102, 276) (Fig. 
1). The coactivator also regulates its own levels in an autoregulatory loop (8, 81).  Post-
translational modifications of PGC-lα protein constitute an additional major regulatory axis as 
they affect protein stability, activity and subcellular localization. In skeletal muscle, PGC-1α 
activity can be enhanced by p38 MAPK-mediated phosphorylation, while phosphorylation by 
Akt results in an unstable protein that is less active (6, 51, 147, 272). Additional post-
translational modifications of PGC-lα include acetylation, methylation and SUMOylation (the 
addition small ubiquitin-like modifier) (32). The AMPK-activated NAD+-dependent histone 
deacetylase, silent information regulator 1 (SIRT1), can deacetylate the coactivator on its many 
lysine residues (8, 35, 185) which enhances the activity of the protein.  In contrast, the 
acetylation of PGC-lα by general control of amino acid synthesis 5 (GCN5) acetyltransferase 
renders that protein inactive (143). PGC-lα is also a target of the transcriptional coactivator 
PRMT1. This protein enhances the function of PGC-lα by methylating its arginine residues 
(285). PGC-lα activity can also be antagonized by transcriptional corepressors which co-exist 
within the nucleus. Nuclear receptor interacting protein 140 (RIP140) and the nuclear receptor 
corepressor 1 (NCoR1) bind to PGC-1α, preventing its transcriptional activities (79, 205).  
Therefore, changes in tissue metabolic status regulate PGC-1α activity which, in turn, strongly 
modulates cellular metabolism, resulting in a metabolic feed-forward loop. 
 The overexpression of PGC-lα results not only in the upregulation of NUGEMPs and 
mitochondrial content, but also has more profound physiological consequences. Actually, 
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overexpression of PGC-1α has been documented to enhance endurance capacity, delay fatigue 
and improve whole body oxygen uptake (33, 150). A natural increase in the activator post-
exercise supports its role in exercise-induced metabolic adaptations (10). Consistent with this, 
gain-of-function experiments documented improved metabolic profile through increased muscle 
glucose uptake and reduced glycolysis (2, 149, 150). In addition, forced expression of PGC-1α 
specifically in muscle was protective against various atrophic insults including the sarcopenia of 
aging (243, 307). Indeed, muscle mass was spared in PGC-1α overexpressing mice following 
denervation. This effect was mediated by PGC-1α suppression of FoxO3-induced atrophic 
program (243). Moreover, pharmacological activation of PGC-1α with bezafibrate was 
protective against metabolic disturbances caused by ETC deficiencies (306). Conversely, PGC-
lα-deficient animals confirm the essential role of PGC-lα in mitochondrial biogenesis (142, 151, 
323) as deficits in the coactivator result in poor mitochondrial content and dysfunctional 
organelles (4, 53). Furthermore, lack of PGC-lα results in increased oxidative stress and 
predisposes mitochondria to apoptotic cell death (4). Collectively, the manipulation of PGC-lα 
expression and activity revealed a dynamic role for the coactivator that appears to be centered 
around, but not limited to, the regulation of mitochondrial biogenesis.  
2.1.3 Mitochondrial quality control and homeostasis 
As a by-product of oxidative phosphorylation, mitochondria produce reactive oxygen 
species. These are composed of free radicals and unstable molecules derived from oxygen that 
can be toxic to cellular components. The rate of ROS production is estimated to be 1-5% of all 
oxygen consumed, but may increase beyond that under conditions of stress (24).  In small 
amounts, ROS can act as signal transducers to activate mitochondrial biogenesis and enhance 
antioxidant defence mechanisms. However, high levels of ROS that surpass cellular antioxidant 
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capabilities can result in oxidative stress. This may lead to dangerous modifications to 
membranes, proteins, and lipids within the mitochondrion itself as well as spillover into 
neighbouring organelles. In order to minimize ROS production and to ensure optimal energy 
generation, mitochondria require robust and fool proof quality control mechanisms. Several 
mechanisms have been proposed to assist with this purpose. In concert, these processes ensure 
proper mitochondrial function basally, as well as increased mitochondrial efficiency during times 
of enhanced metabolic demands. These quality control mechanisms include: mitochondrial AAA 
Lon proteases (136, 163), mitochondria-derived vesicles (MDVs) (165, 271), mitochondrial 
unfolded protein response (mtUPR) (204), and mitophagy (288, 318). If these fail to restore 
mitochondrial function, apoptotic cell death might ensue, in order to avoid the spread of toxic 
waste to neighbouring cells. 
2.1.3.1 Degradation of specific mitochondrial proteins and cargo 
In accordance with their prior independence, mitochondria possess their own proteolytic 
system responsible for the safe removal of damaged or dysfunctional proteins. This process 
functions within the mitochondrial matrix as well as degrades proteins that fail to be imported 
and remain on the outer mitochondrial membrane (13, 163, 204). Left unattended these oxidized 
or misfolded proteins can aggregate and lead to organelle toxicity. The mitochondrial Lon 
protease is responsible for the specific degradation of these proteins and is highly inducible 
during increased mitochondrial stress (136, 186). Another recently discovered mitochondrial 
quality control mechanism involves mitochondrial-derived vesicles that engulf only select 
mitochondrial proteins and deliver them to lysosomes or peroxisomes for degradation (165, 271). 
Moreover the existence of lysosome-like organella within mitochondria have also been proposed 
to assist with the degradation of select mitochondrial proteins within the matrix (170). These 
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pathways collectively act as guardians of mitochondrial protein integrity under steady state 
conditions and can be further upregulated by metabolic and oxidative stressors. If these 
mechanisms fail to absolve mitochondria of damaged proteins and injury continues to snowball, 
the whole organelle can be targeted for degradation by selective autohpagy in order to ensure 
cellular survival in light of pending apoptotic death. 
2.1.3.2 Mitochondrial Dynamics in quality control 
Despite the long lasting dogma about the stationary nature and bean-like shape of 
mitochondria, in reality, these organelles are dynamic and constantly undergo cycles of fission 
and fusion. Moreover, the size and shape of the organelle greatly varies from punctate fragments, 
to long, branched, tubular networks. Rapid alterations in mitochondrial shape and trafficking are 
advantageous during sudden changes in local energy needs. Fission and fusion of mitochondria 
not only control organelle morphology and distribution, but also contribute to mitochondrial 
protein repair and mtDNA continuity along the network (21, 41). Mitochondrial dynamics are 
regulated by unique fission and fusion machinery composed of members of the dynamin-like 
GTPase family. The Dynamin-related protein 1 (DRP1) mediates mitochondrial fission by 
forming a multimeric ring-like structure around the mitochondrial outer membrane. This results 
in the division of the mitochondria into two daughter organelles. Mitochondrial fusion of inner 
and outer membranes occurs separately, where the fusion of mitochondrial outer membrane is 
mediated by the Mitofusins 1 and 2 (MFN1 and MFN2), while optic atrophy 1 (OPA1) mediates 
inner membrane fusion. Mitochondrial fission and fusion aid in quality control by allowing the 
complementation and exchange of mitochondrial contents and of mtDNA throughout the 
network. Interestingly, Twig et al proposed that fission is not a randomly occurring event, but is 
rather a targeted assymetrical division of the organelle resulting in daughter mitochondria with 
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uneven membrane potentials (293). This provides a major quality control benefit, as only the 
daughter mitochondrion that maintains a membrane potential will persist and be allowed to 
rejoin the healthy network. The depolarized daughter mitochondrion, on the other hand, will be 
segregated from the reticulum and targeted for degradation, unless it is able to restore its 
membrane potential (293). This allows for the selective maintenance of preferentially healthy 
and fully functional mitochondria. Interestingly, wholesale organelle removal requires fission as 
loss DRP1 or Fis1 or alternatively, overexpression of OPA1, prevents mitochondrial division and 
their subsequent autophagic degradation (140, 262). It has also been noted that during starvation, 
mitochondria elongate to survive and those that fail to join the network are eliminated (71). 
Therefore, organelle dynamics play a pivotal role not only in mitochondrial shaping and 
distribution but also in quality assurance, by selectively isolating damaged or nascent 
mitochondria for elimination. 
2.1.4 Mitochondrial degradation: Mitophagy  
Wholesale removal of mitochondria occurs through a selective process of autophagy 
termed mitophagy. During mitophagy, the organelle is engulfed within a double membrane 
vesicle known as the autophagosome, and it is subsequently delivered to the lysosome for 
proteolytic degradation. Mitophagy is ever-ongoing at low levels, and accounts for routine 
mitochondrial turnover which occurs approximately every 7-14 days, but may be accelerated 
during energetic imbalance or oxidative stress (168). Mitophagy also participates in the pruning 
of healthy mitochondria during various physiological processes such as erythrocyte maturation 
and the elimination of paternal mitochondria during oocyte fertilization (187, 218, 242, 249). 
Interestingly, the stimulation of mitochondrial oxidative phosphorylation has also been 
demonstrated to enhance mitophagy thorough the small GTPase Rheb (167). This acts as a pre-
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emptive mechanism to facilitate mitochondrial renewal in response to enhanced metabolic 
demands.  
During irreversible mitochondrial damage, when all other quality control mechanisms 
have failed to restore proper mitochondrial function, mitophagy is triggered (Fig. 1). During 
canonical mitophagy, mitochondrial membrane potential is lost which allows the stabilization of 
PINK1 (PTEN-induced putative kinase protein 1) on the mitochondrial outer membrane. PINK1 
serves as a docking station for the arrival of the cytosolic E3 ubiquitin ligase parkin to damaged 
mitochondria. PINK1 was documented to regulated parkin action by phosphorylation (130, 179, 
297). Together, PINK1 and parkin ensure the effective segregation of dysfunctional 
mitochondria into quarantine from the healthy network. To keep mitochondria stationary, PINK1 
phosphorylates Miro, a component of the motor adaptor complex. Miro is responsible for 
anchoring the motor protein kinesin to the mitochondrial surface and facilitating mitochondrial 
movement along microtubule tracks. Miro phosphorylation predisposes it for degradation in a 
parkin-dependent manner (303) thus, keeping mitochondria at a standstill. Moreover, parkin also 
mediates the ubiquitination and degradation of factors belonging to the mitochondrial fusion task 
force, MFN1 and MFN2. This ensures the isolation of the damaged organelle. Parkin has also 
been documented to ubiqitinate a variety of other outer mitochondrial membrane proteins such as 
the voltage dependent anion channels (VDACs), translocases of the outer membrane (TOMs) as 
well as many others (245). The presence of ubiquitinated proteins on the mitochondrial outer 
membrane, act as signals for the arrival of adaptor proteins such as NBR1 and p62/SQSTM1 
which contain both ubiquitin and LC3 interacting domains (68, 125). These proteins then act as 
middlemen to facilitate the formation of a double membrane around the targeted organelle. 
However, some new evidence suggests that p62 may not be required for mitochondrial 
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degradation by autophagy (178, 318). Alternative pathways that facilitate recognition of 
dysfunctional mitochondria by autophagosomes involve the mitochondrial BH3-only receptors 
BNIP3 and BNIP3-like (BNIP3L/NIX). These transmembrane proteins act as direct receptors for 
LC3 independently of PINK1/Parkin (83, 159, 187, 220). It is evident then, that mitophagy-
specific mechanisms are beginning to emerge that separate mitochondrial degradation from non-
specific bulk autophagy. 
2.1.4.1 The PINK1/Parkin pathway 
PINK1 and Parkin were first discovered for their role in parkinsonism, where mutations 
in either one of these factors result in early-onset of the disease (127, 295). Under steady state 
conditions, PINK1 is imported into the mitochondria and is rapidly cleaved by mitochondrial 
proteases such as presenilin-associated rhomboid-like (PARL) (111). This is followed by a rapid 
degradation of the protein. When the mitochondrial membrane potential is compromised, PINK1 
can no longer be imported and it accumulates on the outer membrane. This recruits Parkin to the 
organelle. Parkin has been documented to ubiquitinate many proteins on the mitochondrial outer 
membrane including VDAC, the mitochondrial Rho GTPases, as well as components of 
mitochondrial translocase complex (TOMs) (179, 245). The presence of ubiquitinated proteins 
on the outer mitochondrial membrane engages the autophagic machinery to aid in the removal of 
the tagged organelle. However, Parkin can also promote the elimination of mitochondria without 
affecting protein ubiquitination, by directly associating with AMBRA1(97). AMBRA1, in turn, 
triggers mitophagy by interacting with the Beclin1-PI3K complex involved in autophagosome 
formation (63). These studies connect the mechanisms responsible for selective cargo 
recognition and targeting, with those responsible for the activation of core autophagic machinery 
(Fig. 1). Moreover, the cytoplasmic SMAD-specific E3 ubiquitin protein ligase 1(SMURF1) has 
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also been recently recognized by a genome-wide siRNA screen, and was deemed required for 
Parkin-dependent mitophagy (194). The exact role and mechanism of action of SMURF1 in 
mitophagy remains to be further elucidated. Interestingly, additional E3 ubiquitin ligases are 
beginning to emerge, suggesting some redundancy and overlap in this vital process. The 
mitochondrial ubiquitin protein ligase 1 (Mul1) has been recently documented to poly-
ubiquitinate the Parkin target, MFN2. In skeletal muscle, Mul1 mediated FoxO3-dependent 
mitophagy during muscle atrophy (156). 
In addition to the now fairly well documented role of Parkin in mitophagy, it has also 
been implicated in mitochondrial biogenesis. Parkin was found to target the trascriptional 
repressor PARIS (ZNF746) for proteasomal degradation. Uninhibited, PARIS represses PGC-1α 
transcriptional activity. Parkin-dependent elimination of PARIS results in the release of PGC-1α 
and an increase in mitochondrial biogenesis. Parkin has also been documented to ubiquitinate the 
proapototic factor Bax, thus playing a cytoprotective role. Therefore, the PINK1/Parkin pathway 
is emerging as a turn-key mechanism for the efficient turnover of mitochondria and cell death 
evasion.  
2.1.4.2 BNIP3 and BNIP3L/NIX-mediated mitophagy  
Bcl-2/adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3) and BNIP3-like 
protein X (BNIP3L/NIX) are BH3-only proteins, originally described to participate in 
mitochondrially-induced apoptosis (40). These factors have since been recognized to play a role 
in selective mitochondrial autophagy. These proteins possess an LC3 interacting region (LIR) 
and act as receptors displayed on the mitochondrial outer membrane, to attract the 
autophagosomal isolation membrane. NIX is vital in mediating vigorous mitochondrial 
elimination during erythrocyte maturation (187, 242). Moreover, BNIP3 has been documented to 
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trigger mitochondrial fission by recruiting DRP1 to the mitochondria, which can then activate 
canonical Parkin-dependent mitophagy (140). BNIP3 and BNIP3L/NIX also promote autophagy 
under hypoxic conditions by competing for Bcl-2 binding with Beclin1. This results in the 
liberation of Beclin1 from its Bcl-2-mediated captivity, allowing for the initiation of 
autophagosome formation (16, 103, 201).  The expression of BNIP3 and NIX during hypoxia has 
been attributed to the hypoxia-inducible factor 1 (HIF-1α), the master regulator of hypoxia-
inducible genes (16). During hypoxia superfluous mitochondria can generate excess ROS thus 
further exacerbating oxygen deficits; the elimination of these organelles is therefore vital. 
Indeed, additional hypoxia-inducible mitophagy mediators are beginning to emerge. For 
instance, FUNDC1 was recently identified as an outer mitochondrial membrane protein, 
involved in mitochondrial clearance in response to hypoxic conditions (153). FUNDC1 acts in a 
similar fashion to NIX and BNIP3 in promoting mitophagy by interacting with LC3, as it too is 
endowed with an LIR. FUNDC1 expression was proposed to also be regulated by HIF-1α which 
forms the basis for an attractive model where NIX, BNIP3, and FUNDC1 may function in 
concert to eliminate mitochondria during hypoxic stress (146, 153). 
The study of mitophagy, although still in its infancy, has already demonstrated the vital 
role of this process not only as a pillar of mitochondrial quality control, but also as an important 
mediator of programmed developmental elimination of mitochondria. Persistence of damaged or 
superfluous organelles due to deficiencies in mitophagy results in developmental defects and 
debilitating conditions such as Parkinsons Disease, cardiovascular disease, muscular dystrophies 
and countless others.  
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2.1.5 Co-ordination between mitochondrial biogenesis and degradation 
Evidence for the coordinated regulation of mitochondrial sysnthesis and degradation are 
now beginning to emerge. Cooperation between these two opposing processes allows the fine- 
tuning of mitochondrial quantity and quality in response to cellular metabolic needs. During 
nutrient deprivation, the activation of cellular energy sensors such as AMPK and SIRT1 results 
in the mobilization of autophagic machinery. AMPK initiates autophagic signaling by activating 
ULK1, while SIRT1 deacetylates several essential autophagy components, including Atg5, Atg7, 
and Atg8 (also known as LC3) (55, 138). These cellular energy indicators are also well 
recognized to promote mitochondrial biogenesis through PGC-1α. Interestingly, cells lacking the 
acetyl transferase GCN5 experience an upregulation in both autophagy and mitochondrial 
biogenesis though a concomitant increase in the expression of the autophagy-lysosome master 
regulator TFEB, and the mitochondrial biogenesis co-ordinator PGC-1α (257). Moreover, TFEB 
and PGC-1α were also found to regulate the expression of one another in various cell types (259, 
291), further hinting at the co-ordinated regulation of mitochondrial synthesis and degradation. 
PGC-1α overexpression, itself, was also documented to upregulate the expression of several 
autophagic proteins as well as enhance lysosomal biogenesis (280) (Fig. 1). The role of the co-
activator in mitophagy specifically, however, has not been investigated as of yet. Moreover, 
protein kinase D1 (PKD) is activated during oxidative stress (300) and can directly 
phosphorylate VSP34, which is involved in autophagosome formation (57). Furthermore, PKD 
can also sense ROS levels and induce the nuclear factor kappa-light-chain-enhancer of activated 
B cell (NF-κB) to promote the expression of antioxidants and mitochondrial biogenesis through 
the transcriptional regulation of PGC-1β (14). As previously mentioned, Parkin also participates 
in both mitochondrial elimination and regeneration by regulating the transcriptional repressor 
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PARIS. In addition, Parkin can also promote mitochondrial biogenesis by enhancing mtDNA 
replication through interaction with Tfam (135). In summary, a great deal of coordination 
between mitophagy and mitochondrial biogenesis must occur in order to maintain mitochondrial 
content and vitality. A disturbance in either one of these processes will result in the loss of 
homeostasis and in impending energetic stress, which form the underlying causes of diverse 
pathologies. Moreover, concomitant decreases in mitochondrial biogenesis and autophagy flux 
have been documented with aging (154, 155, 189), resulting in an overall decrease in 
mitochondrial turnover, and therefore diminished function. This can certainly account for the 
progressive accumulation of dysfunctional and nascent mitochondria during aging (39). 
Furthermore, these dysfunctional mitochondria are strongly correlated with age-associated loss 
of muscle mass (sarcopenia), increased incidence of neurodegenerative disorders, as well as 
increased risk of cardiomyopathies and metabolic diseases (161, 195, 286). Thus, targeting the 
mitochondrial turnover circuit represents a viable and enticing option for the treatment of a 
plethora of pathologies. 
2.1.6 Conclusions 
Mitochondrial content hangs in the balance between organelle synthesis and degradation. While 
organelle synthesis occurs through mitochondrial biogenesis, a process that has been extensively 
studied, the selective degradation of wholesale mitochondria has only recently begun to be 
described. A selective form of autophagy known as mitophagy mediates last resort mitochondrial 
quality assurance and the removal of nascent or superfluous mitochondria. Mitochondrial 
distribution is likely to occur through mechanisms of mitochondrial dynamics such as fission, 
fusion and mitochondrial movement. All of these processes must work in unison in order to 
maintain proper mitochondrial health and cellular homeostasis. 
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2.2 Autophagy-lysosome System 
2.2.1 Introduction 
The term Autophagy literally means to self (auto) eat (phagy) in Greek. As suggested by 
its name, this is a process of self cannibalism, where cellular components are degraded by the 
lysosome. Autophagy is conserved on the evolutionary scale, which hints at the importance of 
this mechanism for cellular survival. However, the concept of self cannibalism is rather 
unsettling, and seems counter-intuitive to the main purpose of biological entities, which by and 
large is to survive. Why did then evolution favor this mechanism? Interestingly, autophagy 
appears to be cyto-protective, allowing for the recycling of dysfunctional and toxic proteins, as 
well as superfluous or damaged organelles into their basic building blocks. These can, in turn, be 
utilized for energy provision or biosynthesis. Autohpagy was first described to occur in the 
hepathocytes of starved rats, in the late 1950s by Clark and Novikoff (44, 188). However, it was 
not until 1963 that this process received its modern name “autophagy”, as coined by the 
visionary Christian de Duve (128). De Duve defined autophagy as vesicles containing material 
that is in various states of disintegration; he was also the first to suggest the involvement of 
lysosomes in this process. In 1974 de Duve received the Nobel Prize in physiology or medicine 
for his discovery of peroxisomes and lysosomes. Interestingly, the most significant 
breakthroughs in autophagy research occurred only in the last 20 years or so. Renewed interest in 
this process surfaced after novel evidence from yeast suggested autophagy can be genetically 
regulated. Indeed, pioneering work from Dr. Yoshinori Ohsumi's group indicated that the 
morphology of autophagy in yeast was similar to that documented in mammals (279). They then 
carried out a genetic screen in yeast to identify the first autophagy-related (Atg) genes (164). It 
was the identification of ATG genes in yeast that was the cornerstone upon which the field of 
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autophagy, as we know it today, was founded. This seminal finding along with major 
advancements in molecular biology and gene sequencing led to an autohpagy renaissance, giving 
rise to deeper molecular analysis of the process in higher eukaryotes. 
Autophagy, is now well recognized as a highly conserved catabolic process responsible 
for the degradation of damaged or dysfunctional cellular components, as well as protein 
aggregates through the lysosomal machinery. A basal level of autophagy is ever-ongoing in all 
eukaryotic cells, and aids in cellular housekeeping, as it is responsible for the homeostatic turn-
over of molecules and organelles (21). Indeed, in long-lived, post-mitotic tissues, such as striated 
muscle and neurons, autophagy presents the sole mechanism for whole-sale organelle removal, 
and degradation of aggregated proteins. Autophagy is of greater importance in these cells, due to 
their inability to dilute undigested materials by cellular division. It has been estimated that in the 
liver approximately 1%–1.5% of cellular proteins are catabolised by autophagy per hour, even 
under basal conditions (256). During metabolic stress, autophagy can be further up-regulated and 
acts as an adaptive response system, essential for cell survival and the maintenance of energetic 
balance (58, 256). Aberrant autophagy contributes to tissue dysfunction, and collapse of cellular 
homeostasis. While excessive autophagy may exacerbate protein catabolism, autophagic 
deficiency during development is often lethal, and if disturbed in adulthood leads to devastating 
cellular abnormalities. Undeniably, the pathogenesis of a myriad of conditions has been 
attributed to defective autophagy including: neurodegenerative disease, muscular dystrophies, 
metabolic disorders, cancer and cardiovascular disease (162, 182, 184, 213). Thus, autophagy is 
a tightly controlled process, the regulation of which is vital for the maintenance of cellular 
homeostasis and function.  
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Generally, three distinct types of autophagy exist, microautophagy; chaperone-mediated 
autophagy (CMA); and macroautophagy (Fig. 2). During microautophagy, the lysosmal 
membrane directly and indiscriminately engulfs cytosolic proteins that are in its vicinity, through 
invagination of the lysosomal membrane (145). During CMA, select cytosolic proteins 
containing a KFERQ motif are shuttled into the lysosome by chaperones, such as heat shock 
cognate protein of 70kDa (hsc70) (120). This substrate protein-chaperone complex then binds to 
lysosome-associated membrane protein type 2A (LAMP-2A) which facilitates the translocation 
of the complex into the lysosomal lumen, where it is rapidly degraded by lysosomal proteases 
(120). Macroautophagy (hereafter referred to as autophagy), is the most well studied of the three, 
and is characterized by the engulfment of materials to be degraded by a double membrane 
vesicle, known as the autophagosome. Autophagosomes, are subsequently delivered to the 
lysosome for hydrolytic degradation. Thus, autophagy is a vital cellular process involved in the 
catabolism and recycling of cytoplamic components by the lysosome.  
2.2.2 Autophagosome formation  
The recipe for making an autophagosome is complex and multi-factorial, and requires the 
tethering together of membranes from donor sources, much like quilting. The exact origin of the 
autophagosomal membranes is the subject of much debate, but mitochondria (78, 80), 
endoplasmic reticulum (67, 302), plasma membrane (217), and even the nuclear envelope (214) 
have all been documented to donate membranes to the growing phagophore, the immature 
precursor to the autophagosome. It is becoming more and more evident that not one size fits all, 
but rather the autophagosome membrane source may vary based on the autophaphagic stimulus 
and the cargo destined for degradation.  
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Autophagy is now recognized to occur in both a selective manner by targeting specific 
flagged proteins and organelles, as well as in a non-selective way, by haphazardly sequestering 
portions of the cytoplasm. A common overall mechanism directed by the core autophagy 
machinery governs both selective and non-selective autophagic degradation. Thus far, 38 
autophagy related genes (Atgs) have been identified in fungi, but many additional proteins have 
been recognized to play a role in autophagy. These factors can be subdivided into categories 
based on the stage at which they are most relevant. The induction of phagophore formation is 
mediated by the unc-51-like kinase 1 (ULK1, the mammalian homologue of yeast Atg1) 
complex (Fig. 3) (164). This induction complex is composed of the core components: ULK1 
which is a serine/threonine protein kinase, Atg13 a phosphoprotein, and focal adhesion kinase 
family–interacting protein of 200 kDa (FIP200; also known as RB1CC1) (84, 93, 94). Typically, 
under steady state conditions, when energetic supply and demand are in equilibrium, the 
metabolic sensors mammalian target of rapamycin (mTOR) and protein kinase A (PKA) 
negatively regulate autophagy through the phosphorylation and inhibition of the induction 
complex (93, 113, 274). When nutrients become scarce, the metabolic stress that ensues is 
recognized by energetic sensors. This leads to the activation of AMP dependant kinase (AMPK), 
and inhibition of mTOR activity, culminating in the induction of the autophagy process (93, 
123). The next stage of autohpagy is the nucleation of the autophagosomal membrane. This 
involves the class III phosphatidylinositol 3-kinase (PI3K) complex, which is composed of PI3K 
vacuolar protein sorting 34 (VPS34), beclin 1, VPS15, activating molecule in BECN1 regulated 
autophagy protein 1 (AMBRA1), and ultraviolet irradiation resistance-associated gene 
(UVRAG). Bcl-2, on the other hand, can antagonise autophagy induction by sequestering beclin 
1 and AMBRA1 (63, 103). This step is followed by vesicle expansion.  
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Phagophore expansion is a poorly defined event, but is thought to involve Atg9–mediated 
membrane recruitment (316). Indeed, Atg9 levels determine the number of autophagosomes. 
Moreover, there are two ubiquitin like (UBL) protein conjugation systems that act to promote the 
formation of the autophagosome precursor, the phagophore (193). These are involved in 
conjugation of Atg12, and ultimately, microtubule-associated protein light chain 3 (LC3) and its 
close relatives GABARAP and GATE16 (99, 117, 134). One pathway involves the covalent 
conjugation of Atg12 to Atg5. This occurs with the help of Atg7 and Atg10, E1- and E2-like 
enzymes, respectively. The Atg12–Atg5 heteromer then interacts with Atg16-like 1 (Atg16L1) 
(217). This complex acts as a de facto E3-like ligase to promote the second conjugation reaction, 
involving LC3. The conjugation of LC3 to phosphatidylethanolamine (PE) is essential for 
phagophore expansion and sealing. LC3 exists in its inactive form free in the cytosol, and must 
first be cleaved by the protease Atg4 giving rise to LC3-I (250). The E1-like enzyme Atg7 and 
the E2-like enzyme Atg3 are then tasked with priming LC3-I for its final conjugation to PE, by 
the E3-like complex of Atg12-Atg5. Lipid conjugation converts LC3-I, to the LC3-II form that is 
attached to either side of the growing phagophore membrane.  
Aside from its role in autophagosome expansion, LC3-II also plays an essential role in 
cargo selection. In selective types of autophagy, cargo recognition occurs during the expansion 
step. During selective autophagy the receptors p62 (also known as Sqstm1) (178), neighbor of 
BRCA1 gene 1 (NBR-1) (125), nuclear dot protein 52 kDa (NDP52) (177), and optineurin (309) 
interact with ubiquitinated proteins on organelles or invading pathogens and recruit the 
autophagosome. These proteins act as unique adaptors, as they are endowed with both ubiquitin 
(Ub) and LC3 interacting regions (LIR). The cargo–receptor complex is then selectively 
encapsulated by the autophagosome through receptor-mediated interaction with LC3-II. 
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Organelle specific autophagy receptors that act independently of Ub have also been identified. 
Mitophagy specific receptors such as BNIP3 and BNIP3-like (BNIP3L; also known as NIX), or 
pexophagy specific receptor Atg36, interact directly with LC3-II on the phagophore (83, 175, 
242).  
Fusion; Once the autophagosome is complete it begins its journey along microtubule 
track to the lysosome. LC3, Rab7 and FYCO1, form an adaptor protein complex that promotes 
microtubule transport of autophagic vesicles. FYCO1, which contains both an LIR and a 
phosphatidylinositol 3-phosphate (PtdIns3P)-binding domain is important for autophagosome 
movement (198).The autophagosome and lysosme then fuse together to form the autolysosome, a 
process which requires the assistance of lysosomal-associated membrane proteins (LAMPs), as 
well as the tethering and fusion components, including Rab proteins, and SNAREs (171). 
However, these proteins are not specific to macroautophagy.  
Degradation and efflux; The autophagosomal contents are subsequently broken down 
within the lysosomal acidic environment by a wide range of hydrolases. The macromolecules 
released can then be recycled to restore cellular energetic balance or be used for biosynthesis. 
Moreover, the amino acids generated from proteolysis within the lysosomal lumen can act in a 
retrograde manner to activate mTOR and inhibit autophay progression, in a negative feedback 
loop.   
2.2.3 Selective autophagy 
Once considered a non-selective, bulk degradation process, autophagy is now well 
recognized for its selectivity.  It is clear that autohpagy is able to discriminate between healthy 
and toxic organelles and proteins as well as invading organisms, with the aid of various receptors 
and signaling components. Although, autophagy induced by severe nutrient depletion may not be 
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overly selective, as the sole goal of bulk autophagy is nutrient liberation. Constitutive autophagy, 
however, is extremely selective and provides a helping-hand during the turnover of cellular 
components. Various types of substrates have already been described for selective autophagy, 
and this number is continuously on the rise. These include: mitochondria (mitophagy), 
endoplasmic reticulum (reticulophagy), peroxisome (pexophagy), nucleus (nucleophagy), 
pathogens (xenophagy), lipids (lipophagy) and many more (219). During selective autophagy, 
dysfunctional or obsolete proteins and organelles are targeted for degradation by various 
receptors, which in turn, entice the arrival of the autophagosome.  
The process of selective autophagy, as mentioned above, relies on core autophagy 
components, but also requires specific selective receptors. The most infamous of them is p62, 
which is ubiquitously expressed and mediates the removal of a wide range of ubiquitinated 
proteins. p62 contains both a ubiquitin binding domain and an LIR, thus assisting with the 
association of cargos with autophagosomes (199). p62 itself is often degraded alongside its 
cargo, as it accompanies the targeted components to their final destination. Indeed, conditions 
that are characterised by defective autophagy often display large accumulations of p62 along 
with ubuiquitinated proteins. Interestingly, in some cases elimination of p62 in autohpagy 
deficient models results in protein aggregate clearance (221), suggesting a role for p62 in the 
coalescing of materials for autophagic degradation. Many other adaptor proteins have been 
described such as NBR1 (125), SMURF1 (194), mitophagy specific FUNDC1, NIX and BNIP3 
(153, 242), xenophagy specific NDP52 (177) and optineurin (309),  and the number of receptors 
continues to grow as more types of selective autophagy are identified .  
The benefits of selective autophagy are vast, as it allows for the surgical removal of 
targeted substrates, without disturbing any other cellular components. For instance, the selective 
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removal of mitochondria during hypoxia, or organelle damage, or even when the organelle 
becomes obsolete such as during erythrocyte maturation, all occur selectively through mitophagy 
(16, 112, 187) (for details see Mitophagy chapter 2.1.4). The ability to specifically target the 
elimination of desired cellular constituents presents great therapeutic potential for the treatment 
of many diseases characterised by the accumulation of toxic materials such as Huntington’s 
disease, Alzheimer’s disease, lysosomal storage diseases and many more.  
2.2.4 The Lysosome 
Lysosomes are acidic membrane-bound organelles, containing hydrolytic enzymes 
required for the degradation of a wide variety of substrates including proteins, lipids, 
carbohydrates, nucleic acids, and more. The long standing dogma depicting lysosomes as mere 
cellular repositories, has recently been dismissed by evidence that lysosomes play a key role in 
cellular homeostasis (261). By controlling both cellular clearance and energy production in 
response to environmental cues, the lysosome has reinvented itself as an essential metabolic 
organelle. Lysosomes act not only as the final degradative organelles but also possess  the ability 
to sense nutrient status and initiate the appropriate long- and short-term signaling cascades 
required to restore equilibrium, if it is disturbed (259, 261, 329). Moreover, lysosomal hydrolytic 
enzyme activity increases during cellular insults, indicating lysosomes are malleable and 
responsive to cellular needs (131, 232, 261). These organelles contain a slew of hydrolases (e.g., 
proteases, nucleases, esterases, polysaccharidases, and glycosidases) capable of degrading a wide 
range of components. As such, lysosomes act as the terminal degradative compartment for 
macromolecules, derived from within the cell or from its surroundings (Fig. 2). Aside from their 
well documented role in autophagy, lysosomes also present a central hub for vesicular 
trafficking. Indeed, vesicles originating from the trans-golgi network (TGN) or the endocytotic 
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network often end up in the lysosome, implicating the involvement of this organelle in receptor 
recycling as well as intra- and extra-cellular communications.  
2.2.4.1 Lysosomal biogenesis 
Lysosmes are not formed de novo, but rather receive input from both the endocytic and 
biosynthetic pathways. In addition, lysosomes exist in all shapes and sizes due to variations in 
their contents and stages of material degradation. This peculiar diversity of lysosomal 
morphology and the existence of various maturation steps resulted in a complex terminology for 
lysosomes.  
The lysosome is mainly composed of two functionally essential classes of proteins, acid 
hydrolases, and integral lysosomal membrane proteins. There are currently over 50 known 
lysosomal hydrolases which function to break down the various substrates and macromolecules. 
These allow the lysosome its potent catabolic abilities. Lysosomal membrane proteins have also 
been documented to be vital for lysosomal function and are active in organelle acidification, and 
import of functional proteins as well as those destined for degradation. The most well-studied 
membrane proteins are the lysosome associated membrane proteins 1 and 2 (LAMP1 and 
LAMP2) and the vacuolar ATPases. Both classes of lysosomal proteins are required for the 
lysosomal biogenesis. 
 Due to its role as a major vesicular trafficking hub, it is often difficult to distinguish 
vesicles targeted to the lysosome for degradation versus those delivering freshly synthesised 
hydrolases for lysosomal biogenesis and expansion. Indeed, proteins destined for the lysosome 
may arrive from either the endocytic or biosynthetic pathways (131, 232). Cargo that is 
endocytosed at the plasma membrane travels through various endosomal intermediates with the 
goal of ending up at its final destination, the lysosome. A large number of endosomal 
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intermediates exist and they vary in everything from morphology, content, makeup, pH and 
more. A multitude of steps involving exchange of membranes and fusion result in the maturation 
of an early endosome into a late endosome and eventually may be even to a fully functional 
lysosome.  
Similarly, the pathway of lysosomal enzyme biosynthesis involves transport of the newly 
synthesized enzymes through multiple endosomal compartments before reaching their final 
destination. This ensures that once reaching the lysosome, these hydrolases are proteolytically 
processed (131). A wide majority of lysosomal hydrolases are manufactured in the endoplasmic 
reticulum and sorted in the trans-Golgi network (TGN). The transport of newly synthesized 
lysosomal enzymes to lysosomes is dependent on their specific recognition by receptors for 
mannose 6-phosphate (MPR) (62).  MPRs bind the mannose 6-phosphate tagged constituents, 
and the receptor-ligand complexes are transported through the TGN to endosomes in clathrin-
coated vesicles. The ligands dissociate from the MPRs once they have reached the acidic pH of 
the endosome. MPR-independent transport can also occur but this process is poorly understood.  
The structural and molecular machinery required for the transport of membrane proteins 
is enigmatic but is known to involve TGN sorting.  
Thus, lysosomes are the final degradative organelles upon which many cellular 
trafficking networks converge.  With this in mind, very little is actually known about the 
biosynthesis of this important organelle, warranting further investigation.   
2.2.5 Transcriptional regulation of the autophagy-lysosome system 
Transcriptional regulation of autophagy is still in its infancy and only a handful of 
transcription factors have been recognized to have a role in the regulation of the autophagy-
lysosome system. However, a growing body of evidence suggests that the autophagic response to 
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stress may be biphasic. Cellular metabolic distress first induces a rapid increase in autophagic 
flux, which occurs within minutes or hours of exposure to stressful stimulus, and is mediated by 
post-translational protein modifications. If prolonged, the initial phase is generally followed by a 
long-term potentiation that relies on the activation of a transcriptional program (206). Stress-
responsive transcription factors including the FoxO family, p53, and TFEB, have all been 
identified to play a major role in the regulation of the secondary autophagic response.  
A recent seminal discovery, by the group of Dr. Andrea Ballabio, of a lysosomal gene 
network — the coordinated lysosomal expression and regulation (CLEAR) network — and of its 
master regulator TFEB has lead to an increased interest in the transcriptional regulation of the 
autophagy-lysosome system (197, 260). TFEB is a basic helix-loop-helix, leucine zipper, 
transcription factor, belonging to the family of microphthalmia-associated transcription factors 
(MITF). TFEB was found to regulate lysosomal biogenesis, and clearance as well as autophagy 
and autophagy-lysosome fusion related proteins (260). These findings placed TFEB at the 
epicentre of cellular degradation pathways. This factor acts by recognizing a 10–base pair 
CLEAR motif, enriched in the promoter regions of numerous genes. Interestingly, TFEB 
transcriptional activity appears to be regulated by mTORC1. When mTORC1 is activated by 
amino acids arising from within the lysosomal lumen, it phosphorylates TFEB on several serine 
and threonine residues, including serine 211 (261). Phosphorylated TFEB is detained in the 
cytosol by the chaperone14-3-3. Additionally, TFEB can also be phosphorylated and negatively 
regulated by ERK. During starvation, TFEB is liberated and can translocate to the nucleus, 
where it stimulates the expression of  autophagy-lysosome genes (261). Interestingly, TFEB also 
translocates into the nucleus during lysosomal stress that is pharmacologically induced by drugs 
that block lysosomal acidification or autophagosome-lysosome fusion (261). Therefore, TFEB 
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provides a coordinated transcriptional regulation of autophagosomes and lysosomes in response 
to cellular and lysosomal stress. A TFEB family member, TFE3, has also been recently 
recognized to have very similar regulation and function to TFEB (160).  This type of redundancy 
further supports the importance of these transcriptional modulators. Similar to TFEB, TFE3 is 
regulated by mTORC1 at the lysosome, and after nutrient deprivation rapidly translocates to the 
nucleus, where it too activates the transcription of genes carrying the CLEAR motif (160). In 
contrast to TFEB and TFE3, ZKSCAN3, is a repressor of autophagy (43). Overexpression of 
ZKSCAN3 results in suppression of autophagy, whereas silencing this repressor promotes 
autophagy. In contrast to TFEB and TFE3, ZKSCAN3 negatively regulates the expression of 
genes involved in autophagy and lysosome biogenesis. ZKSCAN3 also appears to be regulated 
by mTORC1, where nutritional abundance promotes the nuclear localization of ZKSCAN3 in an 
mTOR-dependent manner. Starvation, on the other hand, results in cytoplasmic accumulation of 
this repressor. Thus, TFEB and TFE3 provide a turn-key mechanism for cellular clearance by 
coordinately regulating both autophagosome and lysosme arms involved in this process. These 
transcription factors appear to be antagonized by the transcriptional repressor ZKSCAN3. This 
presents an interesting tug-of-war model, where the regulation of cellular clearance may hang in 
the balance between these antagonists. Indeed, this is an enticing regulatory axis to target 
pharmacologically, for the fine-tuning of cellular clearance. 
Additional transcription factors that have been recognized to regulate the expression of 
autophagy and lysosomal biogenesis include the evolutionarily conserved Forkhead box O 
(FoxO). The function and activity of FoxO proteins are mainly regulated by post translational 
modifications such as phosphorylation and acetylation which effects their cellular localization. 
The FoxO family is negatively regulated by the insulin-Akt axis, which is upstream of mTOR.  
31 
 
Both transcription-dependent and -independent functions have been described for the FoxO 
family in the regulation of autophagy. FoxO3 drives a transcriptional program that enhances the 
expression of numerous autophagy-related genes in various cell types. For instance, FoxO3 
upregulates the transcription of  core autophagy machinery, in response to cellular stress (298, 
324, 325). FoxO1, another family member, also transactivates autophagy genes once in the 
nuclear compartment (86, 327). However, cytosolic FoxO1 can also regulate autophagy, 
independently of its transcriptional activity (326). In summary, these observations indicate that 
the FoxO family regulates autophagy, mainly via transcriptional events (159, 324). Interestingly, 
like TFEB, FoxO3 can also be regulated by ERK. Where ERK directly interacts with and 
phosphorylates FoxO3 rendering it inactive. The ERK-phosphorylated FoxO3 is then degraded 
in an MDM2-mediated ubiquitin-proteasome pathway (317). Therefore, ERK and mTOR 
negatively regulate autophagy-lysosome transcription by blocking nuclear translocation of both 
FoxO3 and TFEB.  
The tumour suppressor p53, often endearingly referred to as “the guardian of the 
genome”, has been documented to regulate an ever increasing number of biological processes. 
Indeed, this jack of all traits has been implicated in the transcriptional regulation of the 
autophagy-lysosome system. p53 activation has been documented to inhibit mTOR activity and 
promote transcriptional upregulation of autophagy (60, 206). Moreover, a global genomic 
profiling of the p53 transcriptome revealed  a large number of autophagy proteins, involved in 
various steps of the process to be direct p53 target genes (121, 158). However, this regulation 
appears to be complex and is highly dependent on the subcellular localization of this protein, as 
cytosolic p53 appears to arrest autohpagy (18, 227, 283). Moreover, the p53 target genes Sesn1 
and Sesn2 have also been documented to regulate autophagy through the modulation of AMPK-
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mTORC1 axis (158). On the contrary, however, cytoplasmic p53 inhibits autophagy in a TIGAR 
dependant mechanism, providing a negative feedback loop for this process (18). 
The transcriptional co-activator PGC-1α has also been recently documented to exert 
transcriptional regulation over autophagy in several cell types (257, 280, 291). TFEB promoter 
activity was enhanced in Huntington disease patient cells that were over-expressing PGC-1α, 
which ultimately resulted in increased clearance of toxic protein aggregates via autophagy (291). 
Interestingly,  the reverse was also documented, where during conditions of overfeeding over-
expression of TFEB enhanced PGC-1α  levels in the liver (259). Moreover, PGC-1α 
overexpression in a mouse model of Pompe disease, a lysosomal storage disease, has been 
attempted as a therapeutic approach, albeit with limited success  (280). Interestingly, cells 
lacking the acetyl transferase GCN5 display an upregulation in both PGC-1α and TFEB. In this 
context manipulation of either TFEB or PGC-1α resulted in the same magnitude change in the 
other, suggesting a potential regulatory loop between the two transcriptional regulators. 
Therefore, against all odds, PGC-1α and TFEB make the unlikeliest of friendships in order to 
transcriptionally co-ordinate the regulation of metabolic homeostasis. 
Altogether, a number of transcriptional regulators of autophagy have emerged and appear 
to potentiate a nuclear-autophagic response to cellular metabolic stress. With this in mind, the 
transcriptional regulation of autophagy and lysosomal components has only recently begun to be 
elucidated, much more work is necessary to establish additional transcriptional regulators of this 
pathway as well as further investigate the physiological circumstances that modulate this 
regulation.  
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2.2.6 Autophagy-lysosome in health and disease 
The importance of the autophagy-lysosome system in cellular health has been 
documented time and again. Countless disorders have been attributed to dysfunctions in various 
stages of this pathway. However, the importance of this mechanism is further highlighted by 
conditions that require enhanced cellular turnover or increased energetic supply such as 
development and aging.  
2.2.6.1 Autophagy in health and disease 
Autopahgy has been documented to play a major role during oocyte fertilization in both, 
the degradation of maternal mRNAs, and the elimination of paternal mitochondria (171, 218, 
249, 290). Moreover, autophagy works to provide nutrients to the developing zygote until 
implantation, and to the neonate during the period of nutrient deprivation that occurs 
immediately after birth (133). Indeed, the importance of autophagy in development is 
recapitulated when essential autophagy genes are deleted early in this process.  Loss of Beclin 1 
(320), AMBRA1 (63), or TFEB (260) is embryonically lethal, whereas mice succumb shortly 
after birth when either Atg3, (270), Atg5 (133), Atg7 (129), Atg9 (233), or Atg16L1 are 
eliminated (234). The generation of conditional tissue-specific knockout models further 
elucidated the importance of autophagy in organogenesis, lineage commitment, and 
differentiation of various cell types. Skeletal muscle from animals with autophagic deficiencies, 
mediated by a conditional deletion of core autophagy proteins, such as Atg5 or Atg7, exhibits 
massive accumulations of dysfunctional mitochondria that are less efficient at energy provision, 
and produce harmful reactive oxygen species as a by-product of improper respiration.  This 
muscle also accrues p62 and ubquitin positive protein aggregates, all of which contributes to 
muscle wasting, weakness and fatigue. (162). Surprisingly, genetic mutations in extracellular 
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matrix proteins such as collagen-VI (col6a1), corresponding to human Bethlem myopathy and 
Ullrich congenital muscular disorder, also result in autophagy mismanagement and accumulation 
of damaged and superfluous proteins and organelles that are toxic to the cellular milieu (75). 
Remarkably, the reactivation of autophagy in a mouse model of col6a1 knockout with a low-
protein diet, rapamycin, or cyclosporin A, results in the clearance of abnormal organelles, which 
ameliorates the dystrophic phenotype. This suggests a potential therapeutic model for the 
treatment of these debilitating genetic diseases. These studies confirm the importance of an 
effective autophagy program to skeletal muscle health.  
2.2.6.2 Lysosomes in health and disease  
Several pathologies, as well as aging have been associated with lysosomal dysfunction. 
This may be due to a decline in cellular clearance and a progressive accumulation of toxic 
intracellular materials. 
Indeed, dysfunctional lysosomal degradation is observed with aging, and likely 
contributes to cellular senesce. Moreover, various genetic abnormalities that impede the 
autophagic process lead to deleterious pleiotropic defects, collectively dubbed lysosomal storage 
diseases (LSDs). LSDs result from rare mutations to essential lysosomal genes. LSDs are 
characterized by the accumulation of undegraded autophagosomes, implicating autophagy in the 
ethiology of these conditions. Over 60 distinct LSDs have been identified (181), and are 
characterized by severe neurodegeneration, mental decline, cognitive problems, behavioural 
abnormalities, myopathies, cardiomyopathies and more. Mutations that impair lysosome-
mediated degradation result in the accumulation of undegraded substrates within the lysosome, 
which ultimately result in a backlog of undegraded materials and in the accumulation of 
autophagosomes as well as toxic protein aggregates and dysfunctional organelles.  This leads to a 
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myriad of symptoms in different cells and tissues. Indeed, acid alpha-glucosidase (GAA) 
deficiency in mice, an animal model of Pompe disease, results in glycogen accumulation, 
lysosomal expansion and rupture as well as autophagosome accumulation all of which lead to 
cardiomyopathy and debilitating muscular myopathy (213). Moreover, evidence implicating 
lysosome and autophagy dysfunction in neurodegenerative diseases such as Parkinson’s, 
Alzheimer’s and Huntington’s continue to accumulate. The currently available therapeutic 
strategy for LSDs is enzyme replacement therapy, aimed at reactivating the defective lysosomal 
enzyme, however, this therapeutic model leaves much to be desired. TFEB over-expression was 
recently successfully used to clear autophagy-lysosome backlog in Pompe mice by mediating 
lysosomal exocytosis (273). 
The autophagy-lysosome system appears to have a pleiotropic role in tissue turnover and 
cellular clearance, which  are compromised during cellular senescence (95, 229). In accordance 
with this, suppression of autophagy causes progressive dysfunction in various organs with age. 
Interestingly, multiple factors currently recognized to be involved in life extension also impinge 
on autophagy. For instance, rapamycin-mediated longevity is mediated by mTOR suppression 
which leads to activation of autophagy. Similarly, resveratrol mediated-sirtuin activation also 
leads to enhanced autophagy. Caloric restriction can inhibit mTOR and activate sirtuins as well 
as AMPK, all signals that converge on autophagy activation. Moreover, spermidine- and coffee- 
mediated life-span extension have been attributed to autophagy activation (56, 207). Exercise 
also mediates many metabolic benefits that could potentiate longevity and these also appear to, at 
least partially, depend on functional autophagy (87). The compilation of these findings indicates 
that autophagy may indeed be an important element of the water flowing down the fountain of 
youth. How autophagy may mediate life extension, is not fully elucidated yet, but an educated 
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guess may be that autophagy facilitates the disposal of noxious proteins and organelles, thus 
preventing their accumulation and promoting cellular rejuvenation. 
2.2.7 Conclusions 
 
Autophagy is important for the maintenance of cellular vigour, health and youth as it 
allows for proper cellular remodelling and organelle turnover. The identification of factors that 
regulate the autophagy-lysosome system, both transcriptionally and post-translationally, 
illuminate attractive pharmacological targets intended for the treatment of diseases in which this 
system is compromised, and maybe even to combat some age-dependant whole body 
derailments. 
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2. 3 Skeletal Muscle 
2.3.1 Introduction 
Skeletal muscle is the largest organ in the human body and can comprise 40-50% of the 
body mass of a lean healthy adult (108). Perhaps the most obvious role of skeletal muscle is 
locomotion. Throughout evolution, muscle allowed our ancestors to escape from whatever may 
have been chasing them and, in turn, hunt and capture pray to survive. However, skeletal muscle 
also serves as a protein and energy reservoir which is indispensible in times of nutritional deficits 
(20, 30, 59). Indeed, skeletal muscle is a highly adaptive tissue molded by its milieu, a property 
known as muscle plasticity (91). Physiological stimuli such as contractile activity, endocrine 
stimulation and nutritional status can all influence muscle homeostasis.  Exercise, proper 
nutrition and growth factors help preserve muscle mass and health. Conversely, muscle disuse, 
loss of innervation, inflammation, nutritional deficit, loss of hormonal stimulation, and an 
underlying morbidity all lead to muscle atrophy (253). Moreover, muscle wasting is now being 
recognized as a co-morbidity accompanying a growing number of pathologies such as 
cardiovascular disease, diabetes, as well as cancer, and importantly, is associated with poor 
prognosis (11, 77, 119, 141, 277). Therefore, delving into the molecular mechanisms responsible 
for the regulation of muscle health will help shed light on potential targets for the treatment of 
debilitating muscle atrophy. Moreover, exercise is able to induce pleiotrophic metabolic benefits, 
as well as delay or even prevent the loss of muscle mass induced by various atrophic conditions 
(54, 223, 322). Indeed, physical activity is the only common remedy for a variety of ailments and 
metabolic abnormalities. Thus, illuminating proficient ways to harvest the benefits of exercise 
will lead to great breakthroughs in the treatment of disease. 
40 
 
Muscle mass, by and large, depends on the balance between protein synthesis and protein 
degradation, tilting the scale in one direction or another will result in muscle hypertrophy or 
atrophy. Interestingly, muscle mass also correlates with metabolic status. As mitochondria 
present the main source of energy in the form of ATP, organelle content and vitality also 
constitute an important avenue of muscle mass regulation. This chapter will focus on molecular 
mechanisms involved in the regulation of muscle mass and plasticity. 
2.3.2 Muscle Atrophy 
Atrophy is defined as a decrease in cellular or tissue size as a result of loss of organelles, 
cytoplasm and proteins. Prolonged muscle disuse, loss of innervation, starvation, diabetes, 
cardiovascular disease, and sarcopenia of aging all result in muscle atrophy. Moreover, various 
pathologies such as cancer, sepsis and AIDS are accompanied by muscle atrophy, known as 
cachexia. Loss of skeletal muscle mass and force generating capacity is debilitating and may lead 
to loss of independence. Thus, the prevention of muscle atrophy is of great importance and 
interest for public health.  
Protein synthesis is largely regulated by the insulin and IGF-1 (Insulin-like Growth 
Factor 1) pathway acting through downstream kinases such as Akt (PKB) and mTOR (23, 47, 
226). Various atrophic conditions perturb this axis, resulting in reduced protein synthesis (69). 
However, although lower protein synthesis contributes to the loss of muscle mass, increased 
protein degradation appears to play a more dominant role in muscle atrophy. In fact, during 
certain atrophic conditions, such as denervation, protein synthesis remains the same or can even 
increase slightly, but the robust induction in protein elimination predominates, resulting in a net 
loss of muscle protein.  
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Several proteolytic systems have been described in skeletal muscle, but not any one of 
those is an island, as these systems often work in concert to result in atrophy (278). The two 
major proteolytic pathways are the ubiquitin-proteasome and autophagy-lysosome systems 
which provide machinery for the degradation of a majority of proteins and organelles. Two 
additional systems, the calcium- dependent (calpain) and the caspase systems are responsible 
only for some restricted proteolysis (278, 287, 304). A small amount of atrophy can also be 
attributed to cell death (apoptosis <1%) although this topic is controversial (29, 192). Moreover, 
due to the dynamic nature of muscle atrophy, continuous transcriptional input is required to fuel 
proteolytic pathways (Fig. 4).  
2.3.2.1 Ubiquitin-Proteasome system in muscle atrophy 
The ubiquitin-proteasome system (UPS) is responsible for the degradation of a large 
number of individual proteins. Interestingly, components of the UPS are amongst the most 
commonly upregulated genes in a number of models of muscle atrophy including diabetes, 
denervation, cancer cachexia, fasting and renal failure (137). To be degraded, proteins must first 
be tagged by the addition of polyubiquitin chains. This allows the targeted protein to dock onto 
the proteasome, a large multisubunit proteolytic complex. The ubiquitination of a target substrate 
requires three distinct components E1, E2 and E3. E1 is a ubiquitin activating enzyme which 
must first prime ubiquitin (Ub) in an ATP-dependent process. The activated ubiquitin is then 
transferred to E2, a conjugating enzyme, and then transferred onto a specific substrate with the 
help of E3, a ubiquitin ligase enzyme. E3 enzymes catalyse the rate-limiting step in Ub 
conjugation and are extremely substrate-specific, providing selectivity to the UPS. Once tagged, 
the protein is delivered to the proteasome for digestion. Two muscle-specific ubiquitin ligases, 
muscle ring finger1 (MuRF1/Trim63)  and muscle atrophy F-box (Atrogin1/MAFbx), are 
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dramatically upregulated in various atrophic models (22, 72, 137). Moreover, mice deficient in 
MuRF1 and MAFbx are partially protected against disuse atrophy (22). However, over 650 E3 
ubiquitin ligases have been identified within the genome and additional E3 ligases involved in 
muscle atrophy continue to be recognized. For example, Trim32 has been recently documented 
to be responsible for the degradation of thin filaments by reducing PI3K-Akt-FoxO signaling in 
normal and atrophying muscle (45, 46). Inhibition or down-regulation of Trim32 during atrophic 
conditions protected against muscle loss (46). TRAF6 is another E3 ligase which acts upstream 
of NF-κB and is upregulated during atrophic conditions (202). TRAF6 is a peculiar ubiquitin 
ligase as it catalyzes the conjugation of ubiquitin to the Lys63 residue of its target proteins. 
Lys63-linked ubiquitination is more commonly associated with autophagic degradation as it is 
recognized by the adaptor protein p62, as compared to Lys48-linked polyubiquitin chains which 
signal proteasome-dependent degradation (126, 199). Mice lacking TRAF6 are protected against 
atrophy induced by denervation, cancer or starvation (202). An additional novel E3 ubiquitin 
ligase downstream of TGF-β /BMP signaling, named muscle ubiquitin ligase of the SCF 
complex in atrophy-1 (MUSA1/ Fbxo30), has only recently emerged and appears to contribute to 
muscle loss, however, its substrates remain to be defined (248). Interestingly, the ubiquitination 
process is reversible and targets can be untagged by de-ubiquitylating enzymes, which remove 
polyubiquitin chains from tagged proteins. This presents an enticing point of regulation however, 
to date, very little is known about these enzymes in skeletal muscle (48). 
Although the UPS greatly contributes to muscle atrophy by degrading a large mass of 
proteins, this system cannot degrade intact myofibrils or organelles, and therefore cannot alone 
account for muscle atrophy (278). This suggests that proteolytic systems work in concert to 
result in muscular atrophy. 
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2.3.2.2 The Autophagy-Lysosomal system in muscle atrophy 
The autophagy-lysosome system allows for the bulk degradation of long-lived organelles 
and protein aggregates. In this process (discussed in detail in chapter 2), tagged portions of the 
cytoplasm, dysfunctional organelles, and protein aggregates are sequestered into double 
membrane vesicles. These vesicles are known as autophagosomes and are delivered to the 
lysosome for proteolysis. Lysosomal involvement in cellular degradation, during nutrient 
depletion and denervation atrophy, was reported in muscle as far back as the 1970s, by the group 
of Dr. Stefano Schiaffino (254). However, the molecular basis for the regulation of this pathway 
remained largely unexamined until recent years. Autophagy was brought back into the limelight 
by the discovery of novel autophagy genes in yeast, and by the development of better tools 
allowing for the proper dissection of this intricate pathway (164, 279). The generation of a 
mouse line expressing green fluorescent protein tagged LC3 (an essential factor responsible for 
autophagosome formation), revealed muscle to have one of highest rates of autophagy during 
nutrient depletion (172). Interestingly, glycolytic type II muscles display a higher content of 
autophagosomes than slow oxidative type I muscles, and indeed autophagy flux is higher in these 
muscles both basally and in response to fasting (172, 173). Moreover, autophagy has been 
documented to contribute to muscle atrophy induced by constitutively active FoxO3, or by 
oxidative stress resulting from a mutation in superoxide dismutase (SOD1G93A). Reducing 
autophagy by LC3 knockdown was protective of muscle mass in both of these atrophic models 
(52). These findings prompted a surge of interest into ways of blocking autophagy in an attempt 
to spare muscle mass during atrophic conditions. However, muscle-specific deficiencies in the 
essential autophagy factors Atg5 or Atg7 resulted in loss of force generating capacity, activation 
of unfolded protein response, accumulation of dysfunctional organelles and damaged proteins 
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culminating in myofiber degeneration (162, 213). These animals also exhibited an exacerbation 
in muscle wasting in response to atrophic stimuli such as starvation and denervation. Moreover, 
deficient autophagy results in a myriad of myopathies and muscular dystrophies (75, 196, 203, 
213, 275) which can be rescued by reactivation of this process (75, 196, 203, 213). Thus, 
autophagy is required for muscle mass maintenance, and is critical for the quality control of 
skeletal muscle organelles, however, over-active autophagy can result in excessive catabolism 
and atrophy.   
Interestingly, evidence implicating aberrant autophagy in aging-induced atrophy are 
beginning to emerge. Indeed, aged rats demonstrate higher expression of autophagy proteins 
basally, however, these are less able to further up-regulate autophagy in response to 
perturbations, indicating reduced plasticity (189). Moreover, the accumulation of undegraded 
cellular materials in the form of lipofuscin is also suggestive of impaired autophagy in aged 
animals (189). Indeed, a recent study demonstrated that the lack of autophagy in Atg7-null 
muscle resulted in the degeneration of the neuromuscular junction, and the loss of force 
generating capacity, leading to a premature aging phenotype. Interestingly, this phenotype is 
partially preventable by antioxidants, indicating the importance of autophagy in the elimination 
of oxidized proteins and dysfunctional mitochondria (37).  Moreover, chronic caloric restriction 
with and without exercise, was found to activate autophagy and improve muscle health with 
aging (310).  
Therefore, aside from its catabolic role in protein breakdown, autophagy is responsible 
for cellular quality control and proper organelle turnover, which is vital for muscle health and 
homeostasis. However, autopahgy must be kept in check, since, if gone rogue, autophagy can 
result in excessive catabolism and muscle wasting.   
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2.3.2.3 Apoptosis in muscle atrophy 
Apoptosis is a type of programmed cell death, and is a rare phenomenon in healthy 
skeletal muscle. However, during cellular injury or prolonged metabolic distress apoptosis can be 
activated. In the context of muscle atrophy, apoptosis has been documented to contribute, albeit 
minimally. Since skeletal muscle is multinucleated, myonuclear decay results in the loss of 
transcriptional machinery in the specific region governed by the lost nucleus. This, in turn, 
results in the shrinkage of that particular domain (7). Increases in the expression of apoptotic 
proteins as well as in DNA fragmentation (3, 26, 61, 190, 264) have been noted under several 
atrophic conditions including denervation, microgravity and prolonged disuse. Interestingly, it is 
the mitochondrially-mediated apoptotic pathway that appears to be most at play during atrophy. 
Indeed, mitochondria isolated from atrophic muscle are more susceptible to permeability 
transition pore opening, and apoptosis (49). Moreover, mice with deletions in the pro-apoptotic 
proteins Bax and Bak, are partially protected from denervation-induced loss in muscle mass, 
further supporting a role for apoptotic cell death in atrophy (192, 265). However, this issue is 
controversial as a time lapse microscopy study of single fibers in vivo revealed no loss of murine 
myonuclei during prolonged muscle atrophy induced by denervation or unloading (29). 
2.3.2.4 Transcriptional regulation of muscle atrophy 
Although the transcriptional regulation of atrophy is complex and largely stimulus-
dependent comparative gene expression profiling of a number of atrophy models resulted in the 
discovery of several genes that are coordinately regulated under the various atrophic conditions 
(22, 137). These genes are now known as atrophy related genes (atrogenes) and include 
molecules involved in both the ubiquitin-proteasome, and the autophagy-lysosome proteolytic 
systems. Interestingly, several cellular signaling pathways have been documented to converge on 
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the transcription of these key atrophic components. Forkhead family of transcription factors 
(FoxO) (159, 244, 324), NF-κB (31, 116) and factors downstream of TGF-β (166, 246, 248) have 
all been demonstrated to impinge on the atrophic transcriptional program, culminating in the 
induction of atrogenes.  
The FoxO family of transcriptional regulators consists of FoxO1, 3, 4 and 6 which are 
involved in a wide range of biological processes including metabolism, cellular proliferation and 
differentiation, apoptosis, longevity and muscle mass regulation (1, 239). In skeletal muscle, 
FoxO1 and FoxO3 have both been documented to induce muscle atrophy in response to disuse 
and metabolic distress by coordinating the expression of factors involved in both of the cells 
major proteolytic systems, the UPS and ALP (137, 159, 244). Overexpression of FoxO3 is 
sufficient to induce muscle atrophy (159, 244, 324) through the up-regulation of atrogin-1 and 
MuRF1(244), as well as the autophagy factors LC3 and BNIP3 (159, 324). Moreover, FoxO3 
knock down, or the expression of dominant negative FoxO3, blocks the induction of atrogin-1 
and MuRF1 under some  atrophic conditions (244, 258, 267). Similar to FoxO3, FoxO1 can also 
induce muscle atrophy by upregulating atrogin-1 and MuRF1 (239, 267). Furthermore, genetic 
deletion of three FoxO isoforms (FoxO1/3/4) induces muscle hypertrophy and prevents 
denervation-induced atrophy (282). FoxO activity is all about location, and these transcription 
factors must be de-phosphorylated before they are allowed entry into the nucleus. During 
atrophy, decreased levels of Akt leave FoxO3 uninhibited and free to enter the nucleus. 
Moreover, AMPK can phosphorylate FoxO3 on numerous residues which positively influences 
its activity (19, 74, 240). The capacity of FoxO3 to be post-translationally modified allows for 
the rapid potentiation of the atrophy program, and it also presents an attractive target for 
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pharmacological manipulation. Interestingly, PGC-1α and β can inhibit FoxO3 activity on the 
promoters of atrogenes, thus rescuing muscle mass during denervation and fasting (27, 243). 
Inflammation often accompanies various models of atrophy and in itself can activate an 
atrophic program under the command of NF-κB. Levels of cytokines such as tumor necrosis 
factor α (TNFα) are increased in the circulation during inflammation. The binding of TNFα to its 
receptor facilitates the translocation of NF-κB to the nucleus where it induces the transcription of 
atrogenes. Blocking NF-κB action through the overexpression of a negative regulator of this 
system (inhibitor of NF-κβalpha, Iκβα) is sufficient to prevent disuse atrophy (116, 176). 
Moreover, the cytokine TNF-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 are 
also up-regulated during muscle disuse (169, 311) and mice lacking TWEAK are resistant to 
denervation. TWEAK-Fn14 regulate TRAF6 action, which coordinates  the degradation of 
proteins and organelles via the UPS and ALP by activating NF-κβ, AMPK and FoxO catabolic 
signaling pathways (202).  
The role of the transforming growth factor beta (TGF-β) family in the regulation of 
muscle mass continues to grow and develop as novel downstream effectors emerge. The TGF-β 
family is composed of numerous secreted proteins which rule a wide variety of cellular 
processes. The TGF-β family can be subdivided into two ligand subfamilies: the TGF-β/activin 
subfamily and the bone morphogenetic protein (BMP) subfamily, which appear to have opposite 
roles in skeletal muscle. Myostatin, which is perhaps the most notorious TGF-β family member, 
is a potent negative regulator of muscle growth (139, 166). Mice, cattle, sheep and even humans 
with mutations in the myostatin gene are hyper muscular (139, 246). Myostatin and its TGF-
β/activin family members negatively regulate muscle mass by activating SMAD2/3 mediated 
atrophic program (247, 284, 289). SMAD 2/3 can inhibit the transcription factor JunB which 
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normally promotes muscle growth and blocks atrophy by blocking FoxO3 (215, 247). On the 
other hand, BMPs act to prevent muscle atrophy by activating SMAD1/5/8 and repressing 
MUSA1, a novel E3 ligase downstream of TGF-β (246, 248). Indeed, RNA interference of 
MUSA1 was protective against denervation-induced atrophy. This pathway appears to be 
particularly promising for pharmacological intervention as blocking TGF-β signaling through 
administration of a soluble receptor (ActRIIB) was able to rescue muscle mass under several 
atrophic models. Even more importantly, blocking the ActRIIB was sufficient not only to reverse 
cancer cachexia, but also to delay mortality independently of tumor progression (328). 
During atrophic conditions, reduced signaling through the IGF-1-Akt-mTOR axis 
contributes to atrophy not only through reduced protein synthesis, but also through increased 
degradation by releasing FoxO inhibition (23, 28, 266). Moreover, reduced mTORC1 activity 
can also result in the activation of autophagy, as mTORC1-mediated phosphorylation inhibits the 
autophagy induction complex composed of Atg13 and ULK1 (23, 93, 123). To add to the 
complexity, during early days of denervation the increase in cellular amino acids released from 
enhanced proteasomal activity can constitutively activate mTOR, resulting in feedback 
suppression of Akt, and thus the activation of FoxO-dependent protein breakdown, counter-
intuitively promoting catabolism (212, 282). However, it is conceivable that mTORC1 is 
activated during denervation in order to support the synthesis of proteins needed for catabolism 
as the cell adapts to a new homeostasis. More research into the role mTOR during atrophy is 
warranted. 
Finally, microRNAs (miRs) have also recently been documented to regulate muscle mass 
during disuse. MiRs are endogenous, noncoding, short (20-22 nucleotides) RNAs that are 
involved in a wide variety of cellular processes. These miRs recognize the 3’-untranslated 
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regions of their target substrates and silence their expression by either inducing transcript 
degradation, or by blocking translation. Atrophic conditions such as denervation, starvation, 
cancer cachexia or aging result in altered miR expression profiles. For instance miR-206 and -21 
are induced with denervation and are both sufficient and required for atrophy (268). miR-182, on 
the other hand, targets FoxO3, thus attenuating atrophy related gene expression (96). Indeed, 
miR-182 levels are reduced in response to some atrophic stimuli. Additional miRs associated 
with muscle disuse include miR-1 and miR-133a, both of which are reduced with bed rest and 
denervation (109, 222).  
Altogether, it is evident that the transcriptional regulation of muscle atrophy depends on 
the interplay between a wide range of pathways which often converge on the transcription of 
common atrophic factors known as atrogenes. 
2.3.2.5 Mitochondrial involvement in atrophy 
Muscle atrophy is also accompanied by alterations in cellular bioenergetics. Reductions 
in mitochondrial content and changes in organelle morphology are common among various types 
of atrophy. Indeed, atrophying muscle is characterised by both reduced mitochondrial biogenesis 
and increased mitochondrial elimination. For instance, 7 days of denervation result in a ~50% 
drop in mitochondrial density which correlates closely with the loss in muscle mass (308). 
Interestingly, the decrease in mitochondrial content precedes atrophy, suggesting that organelle 
loss contributes to the observed decline in muscle mass. However, causality has not been directly 
determined.  
The level of the mitochondrial master regulator PGC-1 plummets under various 
atrophic conditions including diabetes, renal failure, cancer cachexia and denervation, and with it 
so does organelle biogenesis (3, 230, 243, 307). Moreover, levels of another PGC-1 family 
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member, PGC-1β, are also reduced rapidly upon cessation of contractile activity. The decrease in 
both of these coactivators results in diminished mitochondrial synthesis though decreased 
expression of ERR, NRF-1/2 and Tfam. Moreover, transcript levels of mitochondrial electron 
transport chain proteins such as cytochrome c and COXIV also decrease with muscle disuse, 
further indicating diminished biogenesis (3, 25, 118, 230, 299). Overexpression of either PGC-
1 or - is sufficient to block protein degradation and spare muscle mass during denervation (27, 
243). Interestingly, TWEAK was noted to induce atrophy by repressing PGC-1α. In this context 
the overexpression of PGC-1α was sufficient to block TWEAK-induced atrophy, as well as 
decrease the levels Fn14 in denervated skeletal muscle (89).  
Muscle atrophy is also accompanied by alterations in mitochondrial morphology (100, 
189). Indeed, reduced levels of fusion proteins MFN2 and OPA1 with denervation result in 
fragmented mitochondria (100). Small punctate mitochondria are less efficient at ATP 
production, more prone to ROS generation as well as apoptosis, and are therefore predisposed for 
elimination by autophagy, all of which add to atrophy. Interestingly, the overexpression of 
fission protein Fis1 is sufficient to induce muscle atrophy (224), which can be reversed if the 
mitochondrial network is restored (224). Importantly, PGC-1/  regulate the expression of the 
mitochondrial morphology factor MFN2 through interaction with ERR (148, 269). Indeed, 
animals overexpressing PGC-1 in muscle maintain mitochondrial integrity and are protected 
from the loss of muscle mass and function with aging (307).  
2.3.2.6 Contribution of mitophagy to muscle atrophy 
Although historically autophagy was considered to be a non-selective degradation 
pathway, the significance of selective autophagy is becoming increasingly evident. Indeed, 
autophagy can trigger the selective removal of specific organelles, such as mitochondria via 
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mitophagy. The contribution of this process to muscle atrophy is highlighted by models of 
chronic muscle disuse such as denervation. The expression of autophagy factors and the targeting 
of mitochondria for removal increase in muscle in response to disuse and denervation. The 
localization of Parkin, p62 and LC3-II to the mitochondrial subfraction (189, 191, 192) were all 
enhanced with denervation, supporting the role of mitophagy in the robust elimination of  
organelles observed with this condition. Mitochondrial degradation is likely triggered by 
organelle dysfunction and fragmentation. Indeed, mitochondria isolated from denervated muscle 
are smaller, consume less oxygen, produce more ROS, and are more susceptible to apoptosis, 
this is sufficient grounds for elimination by mitophagy (3, 263). ROS produced by dysfunctional 
mitochondria can directly activate autophagy through the induction of AMPK, and ROS 
scavenging decreases autophagic flux (216). Interestingly, mitochondrial morphology and 
dynamics also play a key role in sealing mitochondrial fate, since organelle fission alone is both 
sufficient and required to activate mitophagy (17, 224). Conversely, inhibition of mitochondrial 
fragmentation attenuates autophagy, as well as muscle atrophy (224, 225). Indeed, mitochondrial 
fusion proteins mitofusin1 and 2 are targeted for degradation by the E3 ubiquitin ligases Parkin 
and Mul1 (156, 281, 321) thus halting mitochondrial fusion, and facilitating fission under 
atrophic conditions. Mitochondrial E3 ligases preferentially ubiquitinate proteins on the 
mitochondrial outer membrane, this acts as a signal to entice the arrival of autophagosomes. 
Mice lacking Parkin were partially protected against the loss of organelle density and muscle 
atrophy in denervated slow-twitch muscle (64). Moreover, FoxO1/3 enhance Mul1 expression 
during denervation and Mul1 appears to be necessary for mitophagy in skeletal muscle (156). 
The importance of this process is highlighted by the existence of redundancy, where E3 ligases 
compensate one for the loss of another. For instance Mul1 steps in to help preserve 
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mitochondrial integrity when PINK1/Parkin are lacking (321). Furthermore, the targeting of 
mitochondria for degradation can also be achieved through the display of various receptors on 
the outer membrane of the organelle. BNIP3, and close relative BNIP3-like (BNIP3L) protein, 
also known as NIX, are two such receptors. These factors anchor to the mitochondrial membrane 
and directly signal to LC3 as they both possess an LC3 interacting region.  BNIP3 and NIX are 
sufficient to induce muscle wasting and constitute another avenue of the atrophic program 
regulated by FoxO3 (159).  
Despite its contribution to muscle wasting, mitophagy actually plays a vital role in proper 
organelle turnover and mitigation/ rehabilitation of damaged organelles. The importance of this 
process is particularly evident in myopathies induced by autophagy deficiency. In models of 
lysosomal storage disease, or in mice lacking fundamental autophagy factors Atg5 or Atg7, the 
burden of dysfunctional and swollen mitochondria contributes to, and exacerbates pathogenesis 
(75, 162). Although several mechanisms of mitochondrial quality control exist (discussed in 
chapter 1), mitophagy is the only known mechanism for the wholesale removal of mitochondria 
from post-mitotic tissues, such as skeletal muscle. This process is required for the proper 
progression of the mitochondrial life cycle and is therefore vital for mitochondrial vigor (292). 
Thus, mitochondria are intimately involved in muscle wasting under a variety of atrophic 
conditions. Reduced mitochondrial biogenesis, increased mitochondrial fragmentation and 
mitophagy all contribute to muscle atrophy induced by disuse and denervation. However, a basal 
level of mitophagy is vital for routine mitochondrial turnover and housekeeping, as insufficient 
mitophagy results in mitochondrial dysfunction and oxidative stress which serve to exacerbate 
muscle wasting. However, it is not yet clear if mitochondrial alterations are the cause or 
consequence of muscle atrophy and further research is required in order to unravel this mystery.  
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2.3.3 Muscle metabolic plasticity with exercise 
The numerous merits of regular physical activity on whole body metabolism and general 
health have been known for decades, making the field of exercise physiology busy exploring the 
how, and the why. Regular exercise has been reported to mediate widespread protective benefits 
ranging from glucose homeostasis during metabolic stress, to preservation of muscle mass during 
atrophic stimuli, and even improved mood and cognition with aging. Thus, exercise exerts health 
benefits for the body and the mind. Indeed, regular exercise can attenuate loss of muscle mass, 
health and function with disuse, ageing and cachexia. Exercise was also recently reported to 
reduce depression in stressed mice through a PGC-1α-mediated modulation of kynurenine 
metabolism (5). The molecular mechanisms underlying the merits of exercise have been under 
vigorous investigation, and although significant breakthroughs have been made, we are far from 
fully understanding the vast reaching consequences of exercise. Pioneering studies by Dr. John 
Holloszy and colleagues in the 1960s demonstrated that muscle oxidative capacity is induced 
with aerobic exercise training (90), and the implication of the transcriptional co-activator PGC-
1α in this process by the same group in the early 2000s indicated a true inflection point in 
exercise physiology (10). PGC-1α is strongly induced by an acute bout of exercise and is in itself 
sufficient to induce mitochondrial biogenesis in cells and tissues (10, 208, 251, 315). Although 
the need for PGC-1α in exercise-induced benefits is debated (208, 228, 294), its role in organelle 
biogenesis is a soundly supported conclusion (Fig. 5).  
2.3.3.1 Mitochondrial biogenesis during exercise 
During exercise, molecular messengers induce downstream signaling cascades that 
activate a transcriptional program aimed at increasing oxidative capacity. This transcriptional 
program is largely governed by the master regulator of mitochondrial biogenesis, PGC-1α.  
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Indeed, at times it seems as though all upstream signals impinge on this co-activator. Increased 
energy demands induced by contractile activity result in elevated levels of AMP relative to ATP 
which activates the metabolically sensitive AMP-activated kinase (AMPK) (85). AMPK, in turn, 
phosphorylates and activates PGC-1α (104). AMPK deletion in skeletal muscle results in 
diminished mitochondrial content and impaired performance (114), whereas constitutively active 
AMPK results in mitochondrial enrichment and fatigue resistance in mice (15, 66). Moreover, 
administration of AICAR (5-Aminoimidazole-4-carboxamide ribonucleotide) a synthetic 
activator of AMPK, recapitulates some of the metabolic benefits induced by exercise (180). 
AMPK can also induce an increase in cellular NAD+ which activates the NAD-dependent 
deacetylase sirtuin-1 (SIRT1). SIRT1 can further activate PGC-1α through de-acetylation (36). 
Calcium transients are also typical during muscle contraction, and the temporary increases in 
intracellular calcium signal downstream to calcium/calmodulin phosphatase (Calcineurin) and 
kinase (CaMK) (42).  Both Calcineurin and CaMK can upregulate the transcription of PGC-1α 
via NFAT and MEF-2, respectively (9, 42, 81).  Indeed, deficient calcineurin or its 
pharmacological inhibition attenuates exercise-induced adaptations, whereas over-expression of 
the phosphatase promotes the formation of slow-oxidative muscle fibers (183, 200). Similarly, 
CaMK overepression promotes the formation of slow-oxidative fibers, whereas reduced CaMK 
activity results in lower expression of oxidative genes (132, 312). Increased ROS production as a 
result of higher ETC action and NADPH oxidase activity also impinges on PGC-1α. Indeed, p38 
MAPK is activated by ROS and enhances PGC-1α transcription (6, 209). Genetic deletion of the 
p38γ isoform in muscle has revealed that it is required for endurance exercise-induced 
mitochondrial biogenesis and PGC-1α transcription (209). Finally, some recent data suggest a 
role for p53 in exercise induced-mitochondrial biogenesis. Indeed, PGC-1α protein levels are 
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reduced in muscle from p53 knockout animals (236). Moreover, in the absence of p53, exercise-
induced p38 activation and the translocation of PGC-1α to the nucleus were abolished, as were 
the increases in the transcript levels of its downstream targets COXIV and cytochrome c (237). 
Once PGC-1α is active, it enters the nucleus and enhances the activity of various transcription 
factors such as NRF-1/2 and ERRα, thus augmenting the expression of nuclear genes that encode 
mitochondrial proteins (NUGEMPS) (92). NUGEMPs, in turn, contribute to the growth and 
expansion of the mitochondrial reticulum either by becoming incorporated into the existing 
mitochondrial network, or by enhancing mitochondrial DNA transcription and replication (70, 
231). Exercise-induced increases in the expression of ETC components as well as mitochondrial 
transcription factor A (Tfam) ensure the co-ordinated up regulation of both mitochondrial and 
nuclear encoded genes. Indeed, mitochondrial DNA copy number as well as the protein import 
machinery are all induced with chronic contractile activity (115). Interestingly, proteins involved 
in the regulation of mitochondrial morphology are also induced with contractile activity. Indeed, 
chronic exercise results in more elongated reticular mitochondria and an increase in the fusion 
factors OPA1 and MFN2 (38, 100). This effect could be mediated by PGC-1α, as the coactivator 
induces the expression of both MFN1 and MFN2 through ERRα (38). However, the issue of 
mitochondrial dynamics with exercise warrants further investigation. 
In summary, increases in energetic demands, ROS production and calcium signaling 
during muscle contraction all converge on PGC-1α activation, and thus the stimulation of 
mitochondrial biogenesis.  
2.3.3.2 Autophagy and mitophagy with exercise 
Chronic contractile activity induces a cellular remodeling in an attempt to satisfy newly 
elevated energy requirements. Inefficient, nascent, and dysfunctional organelles, as well as 
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oxidized and damaged proteins must be recycled to allow for the synthesis of new and improved 
machinery. This cellular renovation process results in superior myofiber health and improved 
oxidative capacity, which contributes to whole body metabolic improvements, and is therefore a 
major benefit of chronic exercise. Indeed, autophagy is activated with an acute bout of endurance 
exercise in various organs and tissues including skeletal muscle of humans and rodents (76, 87, 
105, 106, 237). It was first hypothesized that autophagy is required during exercise in order to 
provide energy for contraction, and more chronically to increase turnover of damaged organelles.  
Enhanced lysosomal degradation with strenuous exercise has been observed in liver and 
skeletal muscle as far back as 1980 (235, 238). However, more recently Grumati et al. 
demonstrated that autophagy is induced immediately following an acute bout of exercise, and 
that autophagy is required for proper muscle function during physical activity (76). Indeed, the 
dystrophic phenotype of animals lacking collagen-VI, a model where autophagy is compromised, 
was exacerbated by acute and chronic exercise (75, 76) suggesting that functional autophagy is 
required for a healthy response to exercise. Autophagy has also been shown to be activated with 
an acute bout of low intensity exercise, but this activation was enhanced if combined with 
nutrient deprivation (107). An increase in the expression of autophagy genes as well as induction 
in autophagy proteins has also been noted in humans following ultra-endurance exercise, which 
consisted of 24-28h of treadmill running (105, 106).  
Seminal work by the group of Dr. Beth Levine also demonstrated the induction of 
autophagy with an acute bout of exercise in heart, skeletal muscle, as well as other peripheral 
metabolic tissues such as liver, pancreas, and adipose tissue (87). This study revealed that 
exercise-induced autophagy engages the Bcl-2–beclin1 complex. Bcl-2 is an anti-apoptotic 
protein that can also inhibit autophagy by sequestering beclin1. When autophagy is induced, 
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phosphorylation of Bcl-2 results in the release of beclin1 from its captivity, thus promoting the 
formation of autophagosomes. To study the role of autophagy in exercise-mediated metabolic 
adaptations, Bcl-2 AAA knock-in (Bcl2AAA) mice were generated by mutagenesis of three 
conserved phosphorylation residues of Bcl-2 (Thr 69, Ser 70 and Ser 84). These mice exhibited 
normal basal autophagy, but were deficient in stimulus-induced autophagy. Bcl2AAA had a lower 
maximal endurance capacity, as well as impaired exercise-induced increases in insulin 
sensitivity, which was attributed to the lower activation of AMPK. These findings were further 
confirmed in mice heterozygous for beclin 1 (Beclin1+/- mice), as well as mice hypomorphic for 
Atg16L1, an essential autophagy protein vital for autophagosomal membrane synthesis. This 
study also revealed that autophagy is required for exercise-mediated protection against high fat 
diet (HFD)-induced metabolic derailment. Bcl2AAA mice were more susceptible to HFD-induced 
obesity, and failed to exhibit exercise-training mediated protection against HFD-induced 
impairments in glucose tolerance. These findings point to the involvement of autophagy in 
metabolic renovation chronically (87). However, the perturbations in autophagy described above 
were global and the importance of autophagy in skeletal muscle specifically revealed certain 
differences. Mice deficient in the essential autophagy protein Atg7 (Atg7-/-) specifically in 
skeletal muscle do not indicate alterations in endurance performance. In fact, these mice show an 
improved metabolic profile as well as protection from obesity, all stemming from mitochondrial 
stress and the release of the mitokine FGF21 (124, 157). These contrasting findings bring into 
question the requirement of autophagy as an energy source for muscle contraction. Repeated 
bouts of damaging downhill running exercise, however, revealed a progressive drop in 
performance as well as diminished organelle membrane potential in muscle-specific Atg7-/- 
females, a finding which was not evident in WT exercised animals. This suggests that autophagy 
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is needed for organelle turnover post-exercise. This autophagy activation is, in part, dependent 
on ROS, as treatment with general or mitochondria-specific ROS scavengers attenuated 
autophagy induction in WT mice (157). Moreover, aerobic exercise also enhanced mitochondrial 
LC3II, p62, and ubiquitin content with exercise in mice suggesting the induction of mitophagy 
with exercise (237). These findings indicate autophagy is important for cellular turnover post-
exercise, thus contributing to exercise-induced adaptations. With this in mind, chronic voluntary 
exercise-training results in increased basal autophagy and mitophagy protein expression (152). 
However, this increase is compromised in mice that are heterozygous for beclin1 (beclin1-/+), as 
expected. Beclin1-/+ mice also showed attenuated mitochondrial biogenesis, and angiogenesis in 
skeletal muscle, along with impaired improvement of endurance capacity. These results 
demonstrate that increased basal autophagy is required for exercise training-induced skeletal 
muscle adaptations and improvement of physical performance (152). Due to the involvement of 
the autophagy-lysosome system in exosome release and in vesicular trafficking (12),  it is 
conceivable that deficient autophagy may alter the release of muscle-derived myokines and 
miRs. This could potentially dampen whole body exercise-induced benefits, as these messengers 
play an important role in relaying information from muscle to other metabolic tissues. 
 Long-term exercise training was also demonstrated to restore autophagy flux in skeletal 
muscle of animals treated with the lysosomal inhibitor chloroquine (110). Indeed, lifelong 
exercise, in combination with caloric restriction, was found to improve the decline in autophagy 
with aging, as well as dampen age-related increase in oxidative damage and apoptosis (310). 
This suggests exercise as potential form of therapy for myopathies characterized by deficient 
autophagy. However, exercise should be prescribed with caution, as in certain autophagy 
deficient conditions, such as collegen VI-deficiency, it may be detrimental (76). 
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Although the early events leading to autophagy activation with exercise have not been 
thoroughly examined, several possibilities exist since muscle contraction constitutes a form of 
energetic stress, much like nutrient deprivation due to caloric restriction or fasting. First, the 
increased metabolic demands of contracting muscle and elevated ROS production activate the 
cellular stress responders comprised of AMPK, SIRT1 and p38. These molecules can lead to the 
induction of the autophagic machinery as well as potentiate the autophagic transcription program 
by transcription factors such as p53 and FoxOs.  An acute bout of exercise also leads to reduced 
Akt phosphorylation, which would result in mTOR inhibition and FoxO activation, thus inducing 
the transcription of autophagy  related genes (76, 87). Indeed, FoxO1 and 3 gene expression 
along with certain autophagic and proteasomal markers were all increased following exhaustive 
exercise in humans (105, 106). Exercise-mediated increases in AMPK and SIRT11 also activate 
FoxO1 and 3 through post-translational modifications (36).  
Another possible mechanism at play may be the unfolded protein response (UPR), which 
is activated in response to sarcoplasmic reticulum stress induced by contractile activity (122, 
313). Certain UPR factors have been implicated in the activation of autophagy in various cell 
types (144, 186, 319). Interestingly, PGC-1α was shown to contribute to UPR induction with 
exercise acting through the UPR activating transcription factor 6 (ATF6), and mice lacking 
ATF6 are exercise-intolerant (313) (Fig. 5). 
Therefore, although several studies indicate that autophagy is activated during an acute 
bout of exercise, the mechanisms underlying this activation remain to be elucidated. It is also 
becoming increasingly evident that autophagy is involved in chronic physical activity-induced 
adaptations through increased organelle turnover. It would therefore be interesting to investigate 
the kinetics of autophagy activation during and following an exercise bout. 
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2.3.4 Conclusions 
Given the magnitude and importance of skeletal muscle in whole body metabolism and 
the intrinsic capacity of this tissue to rapidly and effectively adapt to its milieu, it is a prime 
candidate for pharmacological manipulation. Indeed, the molecular mechanisms responsible for 
muscle plasticity are much sought after. When it comes to muscle mass however the mechanism 
is simple, and the old adjunct “use it or lose it”, is definitely applicable. Under conditions of 
disuse, muscle atrophies and is characterised by a decrease in strength and oxidative capacity, 
whereas physical activity increases muscle oxidative capacity and is protective of muscle mass 
and health. Skeletal muscle mass depends on the balance between protein synthesis and protein 
degradation. During atrophy, a rise in the activity of cellular proteolytic pathways, regulated by a 
transcriptional atrophy program leads to muscle wasting. The cellular energetic status dictated by 
mitochondria also plays a key role in cellular destiny. Decreases in mitochondrial biogenesis, 
along with increased organelle fragmentation and elimination by mitophagy, lead to a net loss in 
mitochondrial volume and contribute to cellular shrinkage. On the other hand, restoration of 
mitochondrial health by inducing the expression of PGC-1α co-activators is protective of muscle 
mass. This can be achieved via chronic contractile activity, resulting in enhanced oxidative 
capacity, increased organelle efficiency and overall improved muscle health. This is largely due 
to pathways mediating an increase in organelle density, reticulum formation and the elimination 
of nascent and dysfunctional organelles by mitophagy. Although some studies suggest a role for 
autophagy in exercise-induced adaptations, very few have actually examined mitophagy 
regulation during an acute bout of exercise, and even fewer have evaluated the mechanisms 
involved in this activation. Moreover, the interplay between autophagy and PGC-1α during 
exercise, and its related adaptations, has yet to be evaluated.  
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CHAPTER 3: 
 
PhD Dissertation Objectives and Hypotheses 
 
Based on the review of the literature, it can be concluded that the process of autophagy 
and the activity of the transcriptional co-activator PGC-1α remain two important, but distinct 
entities in the regulation of muscle health and metabolism. Both appear to be involved under 
various metabolic alterations in muscle such as nutrient deprivation, contractile activity, and 
disuse. However, it is not clear if PGC-1α plays a role in the process of autophagy in skeletal 
muscle throughout the continuum of muscle contractile and metabolic states. Due to the inherent 
importance of both autophagy and PGC-1α for muscle and mitochondrial health, we were 
interested in evaluating the role of PGC-1α in the regulation of autophagy under divergent 
muscle metabolic and contractile states, namely exercise, and denervation. To this end, the 
purpose of this dissertation was to examine skeletal muscle mitochondrial remodeling within the 
spectrum of changes in muscle contractility. We investigated the interplay between the master 
regulator of mitochondrial biogenesis PGC-1α and the mitochondrial degradation machinery 
with the hopes of uncovering any potential cross-talk between these two opposing processes. 
Therefore, the objectives of my dissertation were three-fold: 
Objective 1 (Chapter 4): Investigate the role of PGC-1α in autophagic signaling, basally and 
during chronic muscle disuse, utilizing a loss of function model. 
Hypotheses: 
1) We hypothesized that autophagy and mitophagy would be induced with denervation; 
2)  We expected that the lack of PGC-1α would attenuate autophagy/mitophagy induction as 
well as autophagy flux by transcriptionally modulating key autophagy and lysosomal 
genes.  
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Objective 2 (Chapter 4): Elucidate the effect of PGC-1α overexpression on muscle health as 
well as autophagy/mitophagy basally and following denervation. 
Hypotheses: 
1) We posited that PGC-1α gain-of-function would result in enhanced muscle oxidative 
capacity as well as protection of muscle mass and mitochondrial content during 
denervation-induced atrophy; 
2) We anticipated that enhanced PGC-1α levels would result in greater basal and 
denervation-induced autophagy and mitophagy signaling and flux through enhanced 
expression of autophagy and lysosomal genes.  
Objective 3 (Chapter 5): Delineate autophagy and mitophagy activation and flux following an 
acute bout of contractile activity, and establish the involvement of PGC-1α in this process. 
Hypotheses: 
1) We estimated that autophagy and mitophagy would be activated with an acute bout of 
exercise and contribute to mitochondrial turnover; 
2) We speculated that the lack of PGC-1α would dampen mitochondrial biogenesis and 
autophagy/mitophagy in response to exercise, resulting in reduced organelle turnover. 
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Abstract 
Background: Alterations in skeletal muscle contractile activity necessitate an efficient 
remodeling mechanism. In particular, mitochondrial turnover is essential for tissue homeostasis 
during muscle adaptations to chronic use and disuse. While mitochondrial biogenesis appears to 
be largely governed by the transcriptional co-activator PGC-1α, selective mitochondrial 
autophagy (mitophagy) is thought to mediate organelle degradation. However, whether PGC-1α 
plays a direct role in autophagy is currently unclear. 
Methods: To investigate the role of the co-activator in autophagy and mitophagy during skeletal 
muscle remodeling, PGC-1α knockout (KO) and overexpressing (Tg) animals were unilaterally 
denervated, a common model of chronic muscle disuse.  
Results: Animals lacking PGC-1α exhibited diminished mitochondrial density alongside 
myopathic characteristics reminiscent of autophagy-deficient muscle. Denervation promoted an 
induction in autophagy and lysosomal protein expression in wild type (WT) animals, which was 
partially attenuated in KO animals, resulting in reduced autophagy and mitophagy flux. PGC-1α 
overexpression led to an increase in lysosomal capacity as well as indicators of autophagy flux, 
but exhibited reduced localization of LC3II and p62 to mitochondria, compared to WT animals. 
A correlation was observed between the levels of the autophagy-lysosome master regulator 
TFEB and PGC-1α in muscle, supporting their co-ordinated regulation.  
Conclusions: Our investigation has uncovered a regulatory role for PGC-1α in mitochondrial 
turnover, not only through biogenesis, but also via degradation using the autophagy-lysosome 
machinery. This implies a PGC-1α-mediated cross-talk between these two opposing processes, 
working to ensure mitochondrial homeostasis during muscle adaptation to chronic disuse. 
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Background 
Skeletal muscle is the largest organ of the body, and as such is recognized for essential 
roles that extend beyond locomotion. Muscle is an indispensable metabolic center that possesses 
a remarkable capacity to adapt to alterations in its milieu, a property known as muscle plasticity. 
This type of malleability to cues such as contraction, nutrient availability or hormonal stimuli, 
requires efficient cellular remodeling and a rapid shift in metabolic profile. Since mitochondria 
are central to muscle metabolism, these types of alterations require amendments in organelle 
content and its network. Mitochondrial density depends on the intricate balance between 
biogenesis and degradation. Biogenesis is largely regulated transcriptionally through the 
coordinate expression of nuclear and mitochondrial genes, governed by the transcriptional co-
activator peroxisome proliferator gamma coactivator-1α (PGC-1α) [1]. On the other hand, 
mitochondrial degradation is achieved through a selective form of macroautophagy (hereafter 
autophagy)  termed mitophagy [2]. This process is of particular importance for long-lived post-
mitotic tissues such as striated muscle and neurons, as this represents the sole mechanism for 
these cells to rid themselves of dysfunctional organelles. During mitophagy, defective 
mitochondria are first segregated from the network and are then engulfed into double membrane 
vesicles termed autophagosomes [3], which are subsequently delivered to the lysosome for 
proteolytic degradation.  
Mitochondrial health is vital not only for proficient energy provision but also for proper 
cellular signaling and homeostasis, as mitochondria are often found at the fulcrum of cellular 
life-and-death decisions[4]. Thus, it is not surprising that mitochondrial abnormalities have been 
implicated in a plethora of muscle wasting conditions such as the sarcopenia of aging[5], 
pathology-related cachexia[6] and various muscular dystrophies[7–9]. Interestingly, skeletal 
muscle from animals with autophagic deficiencies closely resembles that of sarcopenic and 
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atrophic patients[10]. Thus, the intricacies underlying mitochondrial remodeling in skeletal 
muscle have great therapeutic potential for a myriad of debilitating conditions. While mitophagy 
is important for proper tissue remodelling and organelle turnover, the regulation of this process 
in skeletal muscle remains largely elusive. 
PGC-1α, which is most well recognized for its role in mitochondrial biogenesis, has been 
documented to spare muscle mass and improve endurance in atrophic muscle induced by 
senescence [11], chronic heart failure [12], and a variety of additional muscle wasting conditions 
[13, 14]. More recently, PGC-1α has been implicated in the autophagy-lysosome pathway, and 
its over-expression was demonstrated to induce lysosomal biogenesis, possibly through the 
upregulation of TFEB [15–17], a transcription factor that is a master regulator of the lysosomal 
system. However, the role of PGC-1α in mitochondrial removal and autophagy in skeletal 
muscle has not been thoroughly examined. To this end, the purpose of this study was to examine 
the possibility of a co-ordinated regulation of mitochondrial remodeling by the metabolic master 
regulator PGC-1α in skeletal muscle. Here we investigate the involvement of PGC-1α in basal 
and denervation-induced autophagy using both gain- and loss-of-function approaches. Our 
results implicate PGC-1α in the regulation of the mitochondrial network, not only via biogenesis, 
but also through degradation.  
Methods 
Animal generation, procedures and treatment 
The generation and characterization of PGC-1α KO and PGC-1α Tg mice have been described in 
detail elsewhere[13, 18–20]. PGC-1α whole body KO animals were generated by Lin J wt al as 
described previously[18]. For PGC-1α Tg mice, the transgene was expressed specifically in 
muscle under the control of muscle creatine kinase (MCK) promoter. All mice were housed in a 
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12:12-h light-to-dark cycle, and given food and water ad libitum. Where indicated, animals were 
unilaterally denervated by severing the sciatic nerve as previously described [21], while the 
contralateral limb served as an internal control.  To assess autophagy flux, animals were treated 
with either colchicine or an equal volume of vehicle (water) through an intraperitoneal injection 
every 24 hours at a dose of 0.4mg/kg/day [22] for the last 4 days of denervation, with the final 
injection taking place 24h prior to sacrifice. Following 7 days of denervation, the muscles were 
harvested and either immediately frozen for histology, protein, and gene expression analysis, or 
used for cellular fractionation. EDL muscles were fixed for single fiber analysis or electron 
microscopy. All procedures involving PGC-1α KO and corresponding WT animals were 
approved by and conducted in accordance with the regulations of the York University Animal 
Care Committee in compliance with the guidelines set forth by the Canadian Council on Animal 
Care. All PGC-1α Tg and corresponding WT procedures were approved and authorized by the 
Italian Ministry of Health.  
Histology and cross sectional area 
Cytochrome oxidase (COX) and succinate dehydrogenase (SDH) staining was performed on 10-
μm cross sections of digitorum longus (EDL) and tibialis anterior (TA) muscles as previously 
described [23]. Fiber cross-sectional area (CSA) of individual muscle fibers was determined 
using Image J software (NIH, Bethesda, MD, USA) by a blinded investigator. Fiber sizes were 
expressed in micrometers squared. 
COX activity 
Cytochrome c oxidase (COX) enzyme activity was measured as previously detailed [24] by 
determining the maximal rate of oxidation of fully reduced cytochrome c, evaluated as a change 
in absorbance at 550 nm using a microplate reader (Bio-Tek Synergy HT).  
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Electron microscopy  
Tissue preparation for electron microscopy (EM) was performed as previously described [25]. 
Briefly, sections of EDL muscles from WT and KO animals were fixed for 1h in 3.0% 
glutaraldehyde followed by a 1h fixation in 1% osmium tetroxide diluted in 0.1 M sodium 
cacodylate at room temperature. Muscle sections were dehydrated and embedded in Epon resin, 
sliced into Ultrathin (60-nm) sections and stained with uranyl acetate and lead citrate. Electron 
micrographs were obtained using a Philips EM201 electron microscope. 
Gene expression analysis 
Quantitative real-time PCR was performed to determine mRNA expression levels. Total RNA 
was isolated using TRIzol reagent (Invitrogen, 15596-026). RNA was reverse transcribed into 
cDNA using a Superscript III first strand synthesis kit (Invitrogen, 18080-044) according to 
manufacturer instructions. The primers used for gene expression analysis are listed in Table S1 
and were designed based on sequences available in GenBank 
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi). Analyses were performed with SYBR® Green 
chemistry (PerfeCTa SYBR® Green Supermix, ROX, Quanta BioSciences, 95055-500) in a 
StepOnePlusTM Real-Time PCR System (Applied Biosystems Inc., Foster City, CA, USA). 
Gapdh and Actb were used in combination as housekeeping genes. 
Immunoblotting 
Protein extracts from frozen TA cryosections[26], isolated mitochondria, or nuclear extracts 
were separated by SDS-PAGE and transferred to nitrocellulose membranes, which were blocked 
with 5% skim milk or 5% BSA solution. Membranes were incubated overnight at 4°C with the 
appropriate concentration of primary antibody (see Table S2 for a full list of antibodies). 
Membranes were subsequently washed and incubated with the suitable HRP-conjugated 
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secondary antibody for 1h at room temperature, and visualized with enhanced 
chemiluminescence. Quantification was performed with Image J Software (NIH, Bethesda, MD, 
USA) and values were normalized to the appropriate loading control.  
Autophagy and Mitophagy flux calculation 
Autophagy flux was calculated by the Δ change in LC3II and p62 protein levels in whole muscle 
extracts, between colchicine treated and untreated animals of the same condition and genotype. 
Where Δ change = (colchicine treated-Vehicle treated)/Vehicle treated.  
Mitophagy flux was calculated by the Δ change in LC3II and p62 protein levels in isolated 
mitochondria, between colchicine treated and untreated animals of the same condition and 
genotype. 
Single fiber Immunofluorescence 
Immunofluorescence staining was performed on isolated fixed EDL fibers [27] and imaged using 
a confocal microscope. Briefly, freshly excised EDL muscles were anchored at both ends, and 
fixed with 2% paraformaldehyde in phosphate buffer for 1h at room temperature. Muscles were 
then washed with PBS, kept in 50% glycerol at 4˚C overnight, and were subsequently transferred 
to -20˚C and stored until further use. Muscles were gradually transitioned through diminishing 
concentrations of glycerol and individual fibers were then mechanically teased apart in a puddle 
of 0.04% saponin. Fibers were mounted onto glass slides and permeabilized with 0.2% Triton X-
100 in 10% goat serum in PBS blocking solution. Fibers were then co-incubated overnight at 4 
°C with the appropriate primary antibodies (Table S2) diluted in blocking solution. Fibers were 
washed with PBS and then co-incubated with the suitable fluorescent secondary antibodies for 2 
h at room temperature. Fibers were subsequently washed three times with PBS and DAPI was 
added to the first wash at a 0.5 μg/ml concentration in order to visualize the myonuclei. Glass 
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cover slips were mounted onto the slides with DPX Mountant for histology (Fluka, 44581) and 
sealed. Images were acquired with an Olympus Fluoview confocal microscope equipped with a 
60x objective (Olympus Corporation, Shinjuku, Tokyo, Japan).  
Cellular Fractionation 
 Enriched mitochondrial and nuclear cellular subfractions were isolated by differential 
centrifugation, as previously described[24]. Briefly, muscles were minced on ice and 
homogenized using a Teflon pestle and mortar, and suspended in mitochondrial isolation buffer 
(MIB; 250 mM Sucrose, 20 mM HEPES, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM 
EGTA) supplemented with protease (Complete, Roche, 1169749801) and phosphatase inhibitor 
cocktails (Cocktail 2 and 3, Sigma, P5726 and P0044). The homogenates were then centrifuged 
at 1,000 g for 10 min at 4 °C to pellet the nuclei while mitochondrial and cytosolic fractions were 
contained within the supernate. The supernate fraction was re-centrifuged at 16,000 g for 20 min 
at 4 °C to pellet the mitochondria. The mitochondrial pellet was washed twice and resuspended 
in a one-fold dilution of MIB. Mitochondria were subsequently sonicated 3x3sec to yield the 
enriched mitochondrial fraction. Pellets containing nuclei were re-suspended in nuclear lysis 
buffer (1.5 mM MgCl2, 0.2 mM EDTA, 20mM HEPES, 0.5M NaCl, 20% glycerol, 1% Triton-X-
100), incubated on ice for 30min, and then sonicated 3x10 sec followed by a final centrifugation 
step of 15min at 16,000g. The supernate was collected to obtain the enriched nuclear fraction. 
Protein concentrations within the samples were determined using the Bradford method. Fraction 
purity was determined by western blot analysis (Fig. S3) 
Statistics 
Comparisons between WT and KO or TG, Con and Den animals were evaluated using two-way 
analyses of variance (ANOVA) on each of the treatment conditions. Bonferroni post-tests were 
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performed when applicable. All values represent the mean ± S.E. Data were considered 
statistically different if P < 0.05. 
Results 
Lack of PGC-1α results in diminished mitochondrial content, reduced muscle mass, and a 
myopathic phenotype.  In order to ascertain the role of PGC-1α in skeletal muscle autophagy, 8 
month old whole body PGC-1α knockout (KO) and wild type (WT) animals were unilaterally 
denervated for 7 days by severing the sciatic nerve of one hindlimb, with the contralateral limb 
serving as an internal control (Con).  Denervation resulted in similar reductions in muscle mass 
in both WT and KO animals (Fig. 1A).  When corrected for body weight, muscle mass of KO 
animals was greater than that of WT littermates, however this was a result of their reduced body 
weight and not due to muscle hypertrophy, as fiber cross-sectional areas were smaller in mice 
lacking PGC-1α (Supp Fig.1A-C). Basal mitochondrial content was significantly diminished in 
KO animals, as evident from the reduced intensity of COX and SDH staining, as well as a lower 
COX activity measured biochemically (Fig. 1B-D). Denervation resulted in 33% and 42% 
decrease in mitochondrial content in WT and KO mice, respectively (Fig.1B). Electron 
microscopy images revealed myopathic features in PGC-1α KO mice, evident from the 
accumulation of multivesicular bodies, aberrant mitochondria as well as tubular aggregates (Fig. 
1E). These features are suggestive of autophagic deficiency in animals lacking PGC-1α.   
Attenuated autophagic signaling, lower lysosomal abundance and decreased denervation-
induced autophagy flux in mice lacking PGC-1α. We next set out to assess the role of the co-
activator in the transcriptional regulation of key autophagy genes and in autophagy signaling, 
both basally and in response to denervation. Denervation resulted in increased expression of 
various genes that are involved in a variety of aspects of autophagy and mitophagy. Significant 
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increases in Park2, Sqstm1, Maplc3b, Atg7, Lamp2 and Ctsd mRNA expression in response to 
denervation (Fig.2A) were observed. We did not find a significant difference in the mRNA 
expression of autophagic factors between WT and KO animals, other than an attenuated 
denervation-induced increase in Atg7. We also assessed autophagy signaling using western blot 
analysis. In accordance with our mRNA data, we found significant increases in autophagy 
proteins in response to denervation (Fig.2B). Beclin1, Atg7, Cathepsin D and Lamp-2 all 
increased, while parkin tended to increase in WT animals (Fig.2B-G).  Although there was no 
significant difference in the content of autophagy proteins between WT and KO animals basally, 
the denervation-induced increases in Beclin1 and Lamp-2 levels were significantly attenuated in 
KO muscle, while Cathepsin D induction tended to be lower in KO animals.  
In order to ascertain the influence of PGC-1α on autophagy flux, we treated the animals 
with the microtubule de-stabilizing drug colchicine, previously reported to effectively block 
autophagic degradation [22] (Fig.3). Denervation resulted in increased accumulation of LC3B-II, 
p62 and Nix (Bnip3l) proteins in WT muscle. Colchicine treatment resulted in further 
accumulations of LC3B-II and p62 in denervated WT muscle, indicating a successful block in 
autophagic degradation with the drug (Fig.3A-C). In contrast, PGC-1α KO animals exhibited an 
attenuated LC3B-lipidation and expression of the mitophagy specific receptor Nix both basally 
and in response to denervation (Fig.3 A-B, D). No significant difference in p62 expression was 
observed basally between the genotypes, and p62 levels did not change in KO animals with 
either Den or Col treatment (Fig.3C).  Importantly, both basal and denervation-induced p62 and 
LC3B-II flux were lower in KO animals, as evident by a smaller accumulation of LC3BII and 
p62 in KO animals treated with colchicine (Fig. 3E-F). We further examined lysosomal 
abundance and autophagy flux in KO and WT animals using confocal microscopy (Fig.3G). We 
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did this by isolating single fibers from fixed EDL muscles and co-immunostaining them for 
LC3B and Lamp-2. KO animals had lower lysosomal abundance, as indicated by a diminished 
intensity and frequency of red fluorescence, and this was especially evident following 
denervation (Fig.3G and Fig.S2). We also noted an increase in the colocalization (yellow) of 
autophagosomes and lysosomes and their aggregation in the perinuclear region of denervated 
WT muscles (Fig.3G Merge). This was not as evident in denervated KO muscle, as indicated by 
decreased yellow flourescence. Taken together, these results indicate that the lack of PGC-1α 
results in lower lysosomal abundance and reduced autophagy flux in response to denervation.    
Mitophagy is attenuated in PGC-1α-deficient muscle. Since PGC-1α is a major metabolic 
regulator that plays a key role in mitochondrial homeostasis, we were interested in elucidating 
the role of this co-activator in mitochondrial removal by mitophagy. During denervation, the 
mitochondrial pool within skeletal muscle undergoes a substantial reduction (33-42% Fig.1B). 
To determine the involvement of PGC-1α in mitophagy, we isolated mitochondria from both 
denervated and control gastrocnemius muscle of WT and KO animals that were treated with 
either vehicle or colchicine (Fig.4). Denervation resulted in an increase in the localization of 
LC3BII, p62 and parkin to the mitochondria, as well as an elevated overall ubiquitination of 
mitochondrial substrates (Fig.4A-E), culminating in increased mitophagy flux (Fig.4H). These 
findings indicate that mitophagy is involved in the removal of mitochondria from muscle basally, 
and during denervation. This response was reduced in the KO animals (Fig 4G-I). Muscle from 
KO animals exhibited similar basal localization of autophagic proteins to the mitochondria (Fig. 
4A-F), but had an attenuated increase in mitochondrial localization of these proteins with 
denervation. Importantly, KO animals exhibited lower basal and denervation-induced mitophagy 
flux (Fig.4G-H).  To further investigate mitophagy flux, we co-stained isolated single EDL fibers 
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with mitochondrial cytochrome c (Cyto C; green) as well as with Lamp-2 (red) and assessed 
their co-localization (Merge; yellow) using confocal microscopy (Fig. 4I). The images suggest a 
decrease in the co-localization of mitochondria with lysosomes in denervated KO animals 
compared to WT animals, further supporting a decrease in mitophagy flux in the KO animals in 
response to denervation. 
TFEB protein levels are induced with denervation and may mediate PGC-1α action on 
autophagy. To examine the role of PGC-1α in the expression of autophagy genes we examined 
TFEB, the master transcriptional regulator of the autophagy-lysosome system, as several recent 
studies have indicated an interplay between these two factors[16, 17, 28, 29]. TFEB protein 
levels were increased with denervation in WT animals (Fig. 5A-C), and this tended to impact the 
levels of TFEB in the nucleus. In the KO animals, TFEB levels and nuclear localization were 
lower under basal conditions (p<0.05), and did not change in response to denervation (Fig. 5A-
C).  
Overexpression of PGC-1α results in increased mitochondrial content and protection from 
denervation-induced mitochondrial loss and muscle atrophy. Since our results indicate a 
potential role for PGC-1α in regulating autophagy flux in response to denervation, we 
investigated whether PGC-1α alone was sufficient to induce autophagy. Thus, we compared WT 
to muscle-specific PGC-1α overexpressing animals (Tg). TA muscle from Tg animals displayed 
a much more oxidative phenotype (Fig. 6C-D) and they were protected from denervation-
induced muscle atrophy (Fig.6A). We confirmed PGC-1α over-expression in Tg animals by 
immunoblotting for PGC-1α (Fig. 6B) and COXIV (Fig.6C), a downstream target of the co-
activator, as well as with histochemical staining for SDH (Fig. 6D). TA muscles of Tg animals 
were significantly richer in mitochondria and exhibited a reduced loss of mitochondrial content 
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in response to denervation, as indicated by greater COXIV protein (Fig. 6C) and darker SDH 
staining (Fig. 6D), compared to WT controls. 
PGC-1α overexpression increases lysosomal and mitophagy receptor expression. We 
examined the effect of PGC-1α overexpression on the levels of autophagy genes and proteins 
basally, and in response to denervation. Real-time PCR analyses confirmed that 7 days of 
denervation resulted in increased expression of various autophagy and mitophagy genes, such as 
Park2, Sqstm1, Maplc3b, Atg7, and Ctsd (Fig.7A) consistent with our earlier results (Fig. 2A). 
We found a decrease (p<0.05) in the basal expression of Sqstm1, Bnip3l and Atg7 in Tg animals. 
In addition, we also observed attenuated denervation-induced increases in Sqstm1, Maplc3b, and 
Atg7. We also assessed autophagy signaling by western blot analysis. Parkin, Beclin1 and Atg7 
protein levels were similar in WT and Tg animals, both basally and in response to denervation 
(Fig. 7B-E). However, the levels of the lysosomal proteins Cathepsin D and Lamp-2 were 
significantly higher in Tg as compared to WT animals, and these were markedly increased in 
denervated Tg muscle (Fig. 7F-G). Tg animals also displayed significantly higher levels of both 
LC3I and II than WT controls, and these were augmented to a greater extent by denervation 
compared to WT animals (Fig.8A-C). Similarly, Nix protein content was higher in Tg, as 
compared to WT animals, both basally and in response to denervation (Fig, 8D), while p62 levels 
were similar in both genotypes (Fig. 8E). Taken together, these data suggest that PGC-1α 
selectively induces the expression of specific autophagy and lysosomal proteins. 
PGC-1α overexpression resulted in reduced autophagy markers in the mitochondrial 
subfraction. Since we found a protective effect of PGC-1α overexpression on mitochondria 
following denervation (Fig. 6) we wanted to investigate whether mitophagy was affected. Our 
results indicate that PGC-1α overexpression leads to a decreased localization of LC3BII and p62 
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to the mitochondrial fraction in Tg muscle, both basally and in response to denervation (Fig. 9 A-
C). 
TFEB is induced with denervation and may mediate PGC-1α action on autophagy. Since 
we found a decrease in TFEB protein levels in animals lacking PGC-1α (Fig. 5), we further 
investigated the effects of PGC-1α over-expression on this transcription factor. TFEB protein 
levels were significantly higher in PGC-1α Tg animals (Fig. 10A-B). Similar to our earlier 
findings, TFEB increased with denervation in WT animals, to a level that was similar to the 
higher basal level evident in Tg animals (Fig. 10A-B). TFEB protein was not further induced by 
denervation in Tg animals.  
Discussion 
Metabolic plasticity is a unique property which permits the fine tuning of energy 
production to meet energy demands in skeletal muscle, allowing for adaptations in response to 
alterations in nutrient availability, hormonal stimuli and contractile activity. This property makes 
muscle a pillar of whole body homeostasis, in particular during energetic distress. Interestingly, 
both the autophagy-lysosome system and the transcriptional co-activator PGC-1α have been 
separately documented to contribute to whole body metabolic homeostasis, as well as to muscle 
plasticity, in response to alterations in nutrient availability and contractile activity[10, 15, 29–
34]. However, the role of PGC-1α in autophagy and mitophagy has not been dissected thus far. 
In this study, we illuminate a role for PGC-1α in autophagy and mitophagy in skeletal muscle in 
response to chronic muscle disuse. Moreover, we identify the transcription factor TFEB to be a 
potential target of PGC-1α in the regulation of autophagy in this tissue.  
Our results have confirmed the myopathic phenotype evident in muscles of animals 
lacking PGC-1α. Muscle of KO animals was characterized by a diminished mitochondrial 
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content, smaller cross-sectional area, and an accumulation of damaged organelles and 
multivesicular bodies as evident by the appearance of abnormal structures in EM images. Some 
of the myopathic features of PGC-1α KO muscle are reminiscent of those found in autophagy-
deficient animals which also exhibit deficient mitochondria and increased apoptosis [10, 35, 36].  
We did not note a basal difference between WT and KO animals in the mRNA or protein 
expression of various autophagy markers. However, it is possible that an earlier time point 
following the onset of denervation, when autophagy gene expression may have peaked, could 
have revealed some endogenous expression differences between the two genotypes in response 
to this muscle atrophy stimulus. Importantly, we did observe an attenuated induction in LC3B 
lipidation and protein expression of lysosomal factor Lamp-2 with denervation in KO animals. A 
lack of PGC-1α also resulted in reduced basal as well as denervation-induced autophagy flux, 
suggesting that the presence of PGC-1α has a significant impact on the maintenance of 
autophagy in muscle. 
In contrast to the mitochondrial phenotype observed in KO animals, over-expression of 
the co-activator resulted in a highly oxidative muscle that was protected from denervation-
induced loss of mitochondria and muscle mass. This was evident from the much darker SDH 
staining, as well as the increased COXIV protein expression in Tg animals that did not decrease 
with denervation. This protection has been previously documented to be a result of improved 
mitochondrial function [37], cellular oxidative status [38], and suppression of FoxO3-mediated 
catabolism [13]. Similar to our observations with KO animals, overexpression of the coactivator 
did not result in dramatic alterations in autophagy protein expression. However, levels of the 
lysosomal marker Lamp-2, and the protease cathepsin D were significantly induced in Tg 
animals, and were further increased with denervation. Moreover, LC3B protein levels, as well as 
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LC3B lipidation were both enhanced in the Tg animals, suggesting an increased autophagy flux 
mediated by PGC-1α. In another study involving the use of fasting as an inducer of autophagy, 
we have confirmed the increase in autophagy flux in Tg animals (Fig. S4) 
To investigate the role of PGC-1α in mitophagy, we examined the expression of the 
mitophagy receptor Nix (Bnip3L) as well as the localization of autophagy factors to isolated 
mitochondria. The expression of Nix was significantly reduced in KO, and strongly induced in 
Tg, when compared to WT animals, indicating that Nix may be under the control of PGC-1α.  
This could be mediated by the PGC-1α-HIF-1α axis, as Nix was found to be under HIF-1α 
control during hypoxia [39], and HIF-1α was documented to be stabilized by PGC-1α in muscle 
cells [40]. However, further research is required to confirm this interaction in muscle. We also 
noted an enhanced localization of LC3B-II, p62, parkin as well as ubiquitin to isolated 
mitochondria with denervation in WT animals, but this effect was attenuated in KO animals. 
Indeed, both basal and denervation-induced mitophagy flux were reduced, indicating impaired 
mitophagy in the absence of PGC-1α. We have previously documented oxygen consumption 
deficits and enhanced susceptibility to apoptosis in mitochondria of PGC-1α KO muscle [18]. 
These findings can now likely be attributed to deficient mitochondrial turnover, resulting from a 
combination of an impairment in mitochondrial biogenesis [1, 19, 41] as well as mitophagy in 
the absence of PGC-1α.  
Interestingly, we also noted reduced localization of autophagic markers p62 and LC3B-II 
to the mitochondrial fraction of Tg animals, both basally and in response to denervation. This 
corresponded to the enhanced protection of mitochondrial content during denervation in these 
animals, and it occurred despite increases in LC3B and the mitophagy receptor Nix in whole 
muscle extracts. We also confirmed reduced mitophagy flux under fasting conditions in PGC-1α 
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Tg animals compared to WT littermates (Fig. S5). These data suggest that PGC-1α mediates a 
reduced targeting of mitochondria for mitophagy when mitochondrial function and content are 
high. Based on our data, we contend that physiological levels of PGC-1α are required for the 
proper propagation of mitophagy in muscle, as a lack of PGC-1α results in reduced 
mitochondrial turnover, culminating in the accumulation of defective mitochondria, increased 
susceptibility to cell death [18] and overall muscle atrophy. In contrast, PGC-1α overexpression 
is protective of mitochondrial mass via several mechanisms (Fig. 11A and B). First, PGC-1α has 
been shown to improve mitochondrial function [42, 43] and enhance cellular antioxidant 
capability [38] which can result in reduced mitochondrial targeting for degradation. Second, 
mitochondrial fragmentation is required for mitophagy to occur, and PGC-1α augments the 
expression of factors involved in mitochondrial fusion such as mitofusin1 and 2[44], resulting in 
a more reticular mitochondrial phenotype that can better evade mitophagy. Third, PGC-1α 
overexpression has been documented to block FoxO3-mediated transcriptional activity [13], and 
since FoxO3 drives the expression of multiple mitophagy factors such as Mul1 and Bnip3 [45, 
46], repression of FoxO3activity may be sufficient to protect mitochondria from elimination. 
The involvement of autophagy during denervation has recently been brought into 
question. Some evidence has indicated a block in autophagy early in denervation [47, 48], while 
other data point to the contrary at later time points [10, 21, 22, 46, 49–51]. Here we demonstrate 
that autophagy and mitophagy flux were both elevated at 7 days of denervation, with mitophagy 
contributing to mitochondrial loss during disuse. Indeed, localization of LC3B-II, p62 and parkin 
to the mitochondria were all induced during denervation resulting in enhanced mitophagy flux in 
WT animals. 
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 Our study has also revealed key evidence supporting a role for PGC-1α in lysosomal 
biogenesis. Lack of PGC-1α resulted in reduced denervation-induced lysosomal protein 
expression and overall lysosomal abundance, while PGC-1α overexpression provoked an 
increase in basal and denervation-induced levels of the lysosomal proteins Lamp-2 and cathepsin 
D. Furthermore, we found a correlation (Pearson r=0.84; data not shown) between levels of 
PGC-1α and the lysosomal master regulator TFEB. This further supports findings by Scott et al 
[17] on the co-ordinated regulation of PGC-1α and TFEB, which works to ensure the proper 
matching between mitochondrial removal and biogenesis. Thus, we highlight a role for PGC-1α 
in lysosomal biogenesis which could be mediated, at least in part, by TFEB.  
Conclusions 
Our results suggest a role for the transcriptional co-activator PGC-1α in the regulation of 
autophagy-lysosomal machinery and mitophagy in skeletal muscle. A lack of PGC-1α results in 
reduced disuse-induced autophagy and mitophagy signaling and flux, whereas PGC-1α 
overexpression increased lysosomal abundance and bulk autophagy flux while suppressing 
mitophagy (Fig. 11B) Therefore, our findings elucidate a previously unidentified role for PGC-
1α in the fine tuning of autophagy and mitophagy in skeletal muscle, and the identification of 
pharmacological targets along the PGC-1α-autophagy axis could be of therapeutic benefit to 
those suffering from metabolic or muscle wasting myopathies. 
 
List of Abbreviations: 
Atg7, autophagy related 7; Con, control; COX, cytochrome oxidase; Den, denervated; EDL, 
extensor digitorum longus; FOXO3, Forkhead box O3; KO, Knockout; Lamp-2, lysosome 
associated membrane protein 2; LC3/Maplc3, microtubule-associated protein 1 light chain 3; 
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MCK, muscle creatine kinase; Nix/Bnip3l, Bcl-2/adenovirusE1B 19kDa interacting protein 3-
like; p62/Sqstm1, sequestosome 1; Parkin/park2, RBR E3 ubiquitin protein ligase; PGC-1α, 
Peroxisome Proliferator co-activator 1 alpha; ROS, reactive oxygen species; SDH, succinate 
dehydrogenase; TA, tibialis anterior; TFEB, Transcription factor EB; Tg, transgenic; WT, wild 
type. 
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Figure Legends 
Fig.1 PGC-1α KO animals have lower mitochondrial content and display myopathic 
features. A. TA muscle mass corrected for body weight B. Cytochrome C oxidase activity. C. 
Representative images of COX staining of EDL muscle from Con and Den WT and KO animals. 
D. Representative images of SDH staining of EDL muscle from Con and Den WT and KO 
animals. E. EM images of control WT (top left panel) and PGC-1α KO muscle (top right and 
bottom two panels). PGC-1α KO animals display a myopathic phenotype characterised by the 
accumulation of multivesicular bodies (top right), aberrant mitochondria (bottom left) as well as 
tubular aggregates (bottom right). *P<0.05, significant effect of denervation. †P<0.05, 
significant effect of genotype (n=4-8 for all groups).   
Fig.2 Lack of PGC-1α results in attenuation of autophagic signaling induced by 
denervation. A. Autophagy gene expression measured by real time PCR.  mRNA fold change 
between wild type (WT) and PGC-1α KO (KO) control (Con) and denervated (Den). All groups 
were compared to WT Con, and Gapdh and Actb were used as housekeeping genes.  B-G; Blots 
and quantification of autophagic proteins in TA muscle of control (C; Con), denervated (D; Den) 
WT and KO animals. B. Representative blots. Quantification of C. Parkin; D. Beclin 1; E. Atg7; 
F. Cathepsin D; G. Lamp-2. *P<0.05 significant difference between Con and Den. GAPDH was 
used as a loading control (n=4-8 for all groups).  
Fig.3 Lack of PGC-1α results in reduced lysososmal abundance and denervation-induced 
autophagy flux. A-C. Blots and quantification of autophagic proteins in TA muscle of control 
(Con), denervated (Den) WT and PGC-1α KO (KO) animals; treated with vehicle (water) or 
0.4mg/kg/day colchicine (col) for 4 days. A. Representative blots. Quantification of B. LC3BII; 
C. p62; D. Representative blot and quantification of  Nix; E. Basal autophagy flux; F. 
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Denervation-induced autophagy flux; G. Confocal images of fixed single fibers immuno-stained 
for LC3 (green) and lysosomal Lamp-2 (red) and colocalization is shown in yellow (Merge) and 
represents autophagosomes within lysosomes. Nuclei are in blue (DAPI). *P<0.05 significant 
difference between Con and Den. †P<0.05 significant effect of genotype. GAPDH was used as a 
loading control (n=3-5 for all groups). 
Fig.4 Lack of PGC-1α results in attenuated mitophagy flux.  A-D. Blots and quantification of 
autophagic proteins in isolated mitochondrial fractions in control (Con), denervated (Den) WT 
and PGC-1α KO (KO) animals  treated with vehicle (water) or colchicine (col) 0.4mg/kg/day for 
4 days. A. Representative blots. Quantification of B. LC3BII; C. p62; D. Representative blots. 
Quantification of mitochondrial E. Ubiquitin; F. Parkin. G. Basal mitophagy flux. H. 
Denervation-induced mitophagy flux. I. Confocal images of fixed single fibers immuno-stained 
for cytochrome c (a mitochondrial marker, green) and lysosomal Lamp-2 (red), their 
colocalization (yellow) represents mitochondria within lysosomes. *P<0.05 significant difference 
between Con and Den. †P<0.05 significant effect of genotype. VDAC was used as loading 
control. (n=3-5 for all groups).  
Fig.5 Lack of PGC-1α results in lower TFEB protein levels and nuclear localization. A-C 
Blots and quantification TFEB protein levels between wild type (WT) and PGC-1α KO (KO) 
control (Con) and denervated (Den). A. Representative blots. Quantification of B. whole muscle 
TFEB protein; C. Nuclear localization of TFEB in TA muscle*P<0.05 significant difference 
between Con and Den. †P<0.05 significant effect of genotype. GAPDH was used as loading 
control and Histone 2 B (H2B) was used as nuclear loading control (n=4-8 for all groups).  
Fig.6 PGC-1α over-expressing animals have higher mitochondrial content and are 
protected from denervation-induced muscle atrophy A. TA muscle mass corrected for body 
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weight. B. PGC-1α blot confirming overexpression in TA muscle C. Representative blot and 
quantification of COXIV as a mitochondrial content marker. D. Representative images of SDH 
staining of TA muscle from Con and Den WT and Tg animals. *P<0.05, significant effect of 
denervation .†P<0.05, significant effect of genotype (n=3-5 for all groups)  . 
Fig.7 Over-expression of PGC-1α results in enhanced lysosomal protein expression induced 
by denervation. A. Autophagy gene expression. mRNA fold changes between wild type (WT)  
and PGC-1α Tg (Tg) control (Con) and denervated (Den). All groups are compared to WT con, 
Gapdh and Actb were used as housekeeping genes. B-G Blots and quantification of autophagic 
proteins in Con, Den WT and Tg animals. B. Representative blots. Quantification of C. Parkin; 
D. Beclin 1; E. Atg7; F. Cathepsin D; G. Lamp-2. *P<0.05 significant difference between Con 
and Den. †P<0.05, significant effect of genotype. GAPDH was used as a loading control. (n=3-5 
for all groups). 
Fig.8 Elevated PGC-1α results in greater basal and denervation-induced autophagy protein 
expression. A-E. Blots and quantification of autophagic proteins in control (Con), denervated 
(Den) WT and PGC-1α Tg (Tg) animals. A. Representative blots. Quantification of B. LC3BI; C. 
LC3BII; D. Nix; E. p62; *P<0.05 significant difference between Con and Den. †P<0.05 
significant effect of genotype. GAPDH was used as a loading control. (n=3-5 for all groups) 
Fig.9 PGC-1α Tg animals demonstrate lower presence of autophagy markers in isolated 
mitochondria. A-C. Blots and quantification of autophagic proteins on isolated mitochondria in 
control (Con), denervated (Den) WT and PGC-1α Tg (Tg). A. Representative blots. 
Quantification of B. LC3BII; and  C.p62. †P<0.05 significant effect of genotype. VDAC was 
used as loading control. (n=3 for all groups). 
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Fig.10 Elevated PGC-1α results in increased TFEB protein levels. A-B. Blots and 
quantification TFEB protein level in TA muscle and in nuclear fraction of wild type (WT) and 
PGC-1α Tg (Tg) control (Con) and denervated (Den). A. representative blots. B. Quantification 
of TFEB protein in TA muscle. *P<0.05 significant difference between Con and Den. †P<0.05 
significant effect of genotype. GAPDH was used as loading control for whole muscle and 
Histone 2 B (H2B) was used as nuclear loading control (n=3-5 for all groups).  
Fig.11 Proposed relationship between PGC-1α expression, mitochondrial function and 
mitophagy during cellular stress. A-B Upon cellular metabolic stress such as denervation or 
nutrient deprivation lack of PGC-1α results in diminished mitochondrial function, biogenesis and 
impaired autophagy and mitophagy, whereas its overexpression results in superior mitochondrial 
function and biogenesis as well as enhanced autophagy, but reduced mitophagy. A. Hypothetical 
graphical representation of the relationship between levels of PGC-1α, mitochondrial function 
and mitophagy. B. Schematic outlining mitochondrial turnover during denervation-induced 
metabolic stress in muscle in light of variations in PGC-1α expression. Steady state 
mitochondrial content is represented in the center of each panel. In the presence of endogenous 
PGC-1α levels (middle panel), biogenesis is active at a low level during denervation, but both 
mitophagy and autophagy flux are enhanced leading to a reduced steady state mitochondrial 
content. When the expression of PGC-1α is abolished (upper panel), biogenesis is further 
reduced during denervation, as are autophagy and mitophagy flux, leading to a smaller, 
dysfunctional pool of mitochondria. When PGC-1α levels are elevated (lower panel), biogenesis 
is higher while mitophagy is lower than normal during denervation, leading to a maintained 
organelle content. Arrow thickness provides an indication of the magnitude of the pathway.  
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Fig.S1 PGC-1αKO animals have lower muscle cross-sectional area . A-C. TA muscle fiber cross 
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Average size of oxidative fibers. B. Average size of  glycolytic fibers. C. Fiber size distribution . 
*P<0.05, significant effect of denervation .† P<0.05, significant effect of genotype (n=4 for all groups).  
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Table S1. Primer sequences based on gene transcripts available in GenBank.
Gene Forward primer (5’ → 3’) Reverse primer (5’ → 3’)
Coxiv CTCCAACGAATGGAAGACAG TGACAACCTTCTTAGGGAAC
Mul1 GCCTTGCTGATGTAGTTGTCTG CAGGCCCAGCTTATGATAGAA
Bnip3l GGAAAGCGGCACAGAGAA GAATGACGCCAGTGCTGAT
Park2 GTCTGCAATTTGGTTTGGAGTA GCATCATGGGATTGTCTCTTAAA
Sqstm1 TGTGGTGGGAACTCGCTATAA CAGCGGCTATGAGAGAAGCTAT
Maplc3b GCTTGCAGCTCAATGCTAAC CCTGCGAGGCATAAACCATGTA
Atg7 TTTCTGTCACGGTTCGATAATG TGAATCCTTCTCGCTCGTACT
Lamp2 GCTGAACAACAGCCAAATTA CTGAGCCATTAGCCAAATACAT
Catsd TTTGCCAATGCTGTCGTACT AGCGAGTGTGACTATGTGTGAG
Foxo3 ATGGACGACCTGCTGGATAAC GGAGCTCTTGGCGGTATATG
Actb TGTGACGTTGACATCCGTAA GCTAGGAGCCAGAGCAGTAA
Gapdh AACACTGAGCATCTCCCTCA GTGGGTGCAGCGAACTTTAT
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Antibody Manufacturer Product number
Goat anti-Rat Alexa Flour® 647 Life Technologies A-21247
Goat anti-Rabbit Alexa Fluor® 488 Life Technologies A-11034
Atg7 Sigma-Aldrich A2856
Beclin1 Cell Signaling Technology 3738
Cathepsin D Santa Cruz Biotechnology Sc6486
COXIV Abcam Ab14744
GAPDH Abcam Ab8245
Histone-2B/H2B Cell Signaling Technology 2934
Lamp-2 Abcam Ab13524
LC3B/Maplc3b Cell Signaling Technology 2775
NIX/Bnip3l Abcam Ab109414
p62/Sqstm1 Sigma-Aldrich P0067
Parkin Cell Signaling Technology 4211
PGC-1α/Ppargc1a Millipore Corporation AB3242
T-eIF2α Cell Signaling Technoogy 9722
TFEB MyBioSource Inc MBS120432
Ubiquitin (Ub) Enzo Life Sciences ADI-SPA-203
VDAC/Porin Abcam 14734
Table S2. Antibodies list
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Fig. S8: Mitochondrial Function and cell death. A. State III and state IV respiration measured in
mitochondria isolated from WT and KO animals. B. State III and state IV ROS productions in
mitochondria isolated from WT and KO animals. C Mitochondrial membrane potential measured by
flow cytometry, State IV and state III in WT and KO animals. D. Apoptotic cell death as measured by
DNA fragmentation using a cell death ELISA in Con and Den WT and KO animals. *P<0.05
significant difference between Con and Den. †P<0.05 significant effect of genotype. (n=4-8 for all
groups).
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CHAPTER 5: 
 
The role of PGC-1α during acute exercise-induced autophagy and mitophagy in skeletal 
muscle 
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AMPK, AMP-activated knase; Atg7, autophagy related 7; Con, control; COX, cytochrome 
oxidase; COXIV, cytochrome oxidase subunit IV; EDL, extensor digitorum longus; Ex, exercise; 
Ex+R, exercise and recovery; FOXO3, Forkhead box O3; KO, Knockout; Lamp-2, lysosome 
associated membrane protein 2; LC3/Maplc3, microtubule-associated protein 1 light chain 3; 
Nix/Bnip3l, Bcl-2/adenovirusE1B 19kDa interacting protein 3-like; NPC1, Niemann-Pick C1; 
p38 MAPK, p38 mitogen activated protein kianse; p62/Sqstm1, sequestosome 1; Parkin/park2, 
RBR E3 ubiquitin protein ligase; PGC-1α, Peroxisome Proliferator co-activator 1 alpha; ROS, 
reactive oxygen species; SDH, succinate dehydrogenase; TA, tibialis anterior; Tfam, 
mitochondrial transcription factor A; TFEB, Transcription factor EB; Tg, transgenic; WT, wild 
type. 
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Abstract 
Regular exercise leads to systemic metabolic benefits which require the remodeling of energy 
resources in skeletal muscle. During acute exercise the increase in energy demands initiate 
mitochondrial biogenesis, orchestrated by the transcriptional co-activator PGC-1α. Much less is 
known about the degradation of mitochondria following exercise, although new evidence 
implicates a cellular recycling mechanism, autophagy/mitophagy, in exercise-induced 
adaptations. How mitophagy is activated, and what role PGC-1α plays in this process during 
exercise, has yet to be evaluated. Thus, we investigated autophagy/mitophagy in muscle 
immediately following an acute bout of exercise (Ex), or 90 min following exercise (Ex+R) in 
wild type (WT) and in PGC-1α knockout animals (KO). Deletion of PGC-1α resulted in a 40% 
decrease in mitochondrial content, as well as a 25% decline in running performance which was 
accompanied by severe acidosis in KO animals, indicating metabolic distress. Ex induced 
significant increases in gene transcripts of various mitochondrial (e.g COXIV, Tfam) and 
autophagy-related genes (e.g. p62, LC3) only in WT, but not in KO animals. Exercise also 
resulted in enhanced targeting of mitochondria for mitophagy, as well as increased autophagy 
and mitophagy flux in WT animals. This effect was attenuated in the absence of PGC-1α. We 
also identified NPC1, a transmembrane protein involved in lysosomal lipid trafficking, as a 
target of PGC-1α that is induced with exercise. These results suggest that mitochondrial turnover 
is increased following exercise, and that this effect is at least in part co-ordinated by PGC-1α. 
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Introduction 
The merits of physical activity are numerous and well documented. Regular exercise leads to 
improved cardiovascular health, cognition, metabolism, oxidative capacity, and fatigue 
resistance, among many other beneficial consequences. Moreover, increased contractile activity 
is also protective of muscle mass and function under a myriad of pathologies. Although 
alterations in skeletal muscle metabolism, as well as its secretome, have been documented to 
contribute to the pleiotropic benefits of regular exercise, the molecular mechanism underpinning 
these adaptations remain unclear.  
Skeletal muscle possesses a remarkable capacity to adapt to alterations in contractile 
activity, a property referred to as muscle plasticity. This type of cellular remodeling often 
requires a shift in metabolic profile, with amendments to the structure of the mitochondrial 
network, as well as changes in mitochondrial content. Organelle density is determined by the 
balance between its synthesis and degradation. Mitochondrial biogenesis is regulated 
transcriptionally through the coordinated expression of nuclear and mitochondrial genes, 
orchestrated largely by the transcriptional co-activator peroxisome proliferator gamma 
coactivator-1α (PGC-1α) (18, 41). Conversely, organelle degradation is mediated by a selective 
form of macroautophagy known as mitophagy (13, 15). During mitophagy, dysfunctional 
mitochondria are first segregated from the healthy network by fission and are then tagged for 
elimination (14, 37). Mitochondrial targeting can occur either via mitophagy-specific receptors 
such as Nix and Bnip3 (14, 26, 30), or by the ubiquitination of mitochondrial outer membrane 
proteins by E3 ligases such as Parkin and Mul1 (4, 21, 25). Tagged mitochondria are then 
recognized by, and engulfed into, double membrane vesicles termed autophagasomes. 
Autophagosomes are subsequently delivered to the lysosome for proteolytic degradation.  
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Several recent studies have indicated that autophagy is activated following an acute bout 
of endurance exercise (5, 6, 8–10, 20, 22) and this may contribute to chronic exercise-induced 
improvements in muscle health and oxidative capacity. Indeed, deficient autophagy results in 
lack of exercise-mediated metabolic benefits, as well as progressive degeneration in 
mitochondrial function and performance (6, 20, 22). Coincidentally, PGC-1α levels have also 
been demonstrated to increase following an acute bout of endurance exercise (2), and PGC-1α is 
localized to the nucleus during the post exercise recovery period. The significance of this is that 
absence of PGC-1α also results in diminished exercise-induced metabolic benefits (2, 16). 
However, it is currently unknown whether PGC-1α plays a role in acute exercise-induced 
autophagy, or in the regulation of mitophagy flux. Thus, we set out to investigate the function of 
PGC-1α in mediating autophagy and mitophagy induction in skeletal muscle following an acute 
bout of exercise. Our results should shed light on how the mitochondrial biogenesis and 
degradation pathways may interact to ensure proper mitochondrial remodeling, and thus 
contribute to muscle plasticity as a result of exercise. 
Materials and Methods 
Animal generation, treatment and exercise 
PGC-1α whole body KO animals and C57BL/6 wild-type (WT) were housed in a 12:12-h light-
to-dark cycle, and given food and water ad libitum. The generation and characterization of PGC-
1α KO mice have been previously described (1, 19). To evaluate autophagy flux, animals were 
treated with either colchicine or an equal volume of vehicle (water) through an intraperitoneal 
injection every 24 hours at a dose of 0.4mg/kg/day (12) for 2 days prior to the day of exercise/ 
sacrifice, with the final injection taking place 24h prior to sacrifice. After two days of habituation 
to the treadmill and colchicine or vehicle injections (water; Veh), the EX and Ex+R groups were 
run to failure on a treadmill (Fig. 1C). The exercise bout was terminated when the animals could 
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not continue running after 3 consecutive shocks. Animals were sacrificed either immediately 
(Ex) or 90 min post exercise (Ex+R). Muscle was then excised, and either immediately frozen in 
liquid nitrogen for later use in protein or gene expression analysis, or used fresh for cellular 
fractionation. All procedures involving animals were approved and conducted in accordance with 
the regulations of the York University Animal Care Committee in compliance with the 
guidelines set forth by the Canadian Council on Animal Care.  
Blood Lactate 
Blood lactate was measured prior to, immediately post-exercise, and following 90 min of 
recovery. A 0.2μL blood sample was obtained by tail nick and immediately analyzed using the 
Lactate Scout+ analyser (EKF-diagnostic GmbH, Magdeburg, Germany).  
Histology 
Cytochrome oxidase (COX) and succinate dehydrogenase (SDH) staining was performed on 10-
μm cross sections of digitorum longus (EDL) muscles as previously described (24). Briefly, 
frozen muscle sections adhered to glass slides were dried and subsequently incubated with either 
COX or SDH reaction solutions for 30 min in the dark at 30 °C. Each slide contained sections 
from all conditions, in order to ensure equal staining across the groups. After washing with PBS, 
glass cover slips were mounted onto the slides with DPX Mountant for histology (Fluka, 44581) 
and sealed. Images of stained muscle sections were captured with a Nikon 90i eclipse upright 
microscope using a ×20 objective. 
COX activity 
Cytochrome c oxidase (COX) enzyme activity was measured as previously detailed (38) by 
determining the rate of oxidation of fully reduced cytochrome c by isolated enzymatic extract, 
evaluated as a change in absorbance at 550 nm using a microplate reader (Bio-Tek Synergy HT).  
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Gene expression analysis 
Quantitative real-time PCR was performed to determine mRNA expression levels. Total RNA 
was isolated using TRIzol reagent (Invitrogen, 15596-026). RNA was reverse transcribed into 
cDNA using a Superscript III first strand synthesis kit (Invitrogen, 18080-044) according to 
manufacturer instructions. The primers used for gene expression analysis are listed in Table 1 
and were designed based on sequences available in GenBank 
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi). Analyses were performed with SYBR® Green 
chemistry (PerfeCTa SYBR® Green Supermix, ROX, Quanta BioSciences, 95055-500) in a 
StepOnePlusTM Real-Time PCR System (Applied Biosystems Inc., Foster City, CA, USA). 
Gapdh and Actb were used in combination as housekeeping genes. 
mRNA array 
The gene expression of 84 key autophagic genes were profiled by RT2 Profiler Autophagy PCR 
Arrays (SABioscience, PAMM-084) as recommended by the manufacturer. RT-PCRs were 
performed in 96-well plate format using StepOnePlusTM Real-Time PCR System. Fold changes 
in autophagic gene expression from KO samples relative to WT control samples were calculated 
using the ΔΔCt method with the integrated software package for PCR Array Systems provided 
by the manufacturer (RT2 Profiler PCR Array Data Analysis Template v3.3). ΔΔCt values from 
each sample were normalized by three housekeeping genes that did not change across the 
conditions. 
Immunoblotting 
Protein extracts from frozen TA cryosections (22), isolated mitochondria, or nuclear extracts 
were separated by SDS-PAGE and transferred to nitrocellulose membranes, which were blocked 
with 5% skim milk or 5% BSA solution. Membranes were incubated overnight at 4°C with the 
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appropriate concentration of primary antibody. The following antibodies were used: P-AMPK 
(Thr 172), T-AMPK, P-p38 (Thr 180/Tyr 182), T-p38, LC3, and Parkin (Cells Signaling 
Technology), GAPDH, VDAC and NPC1 (Abcam), DRP-1 (BD Transduction Laboratories), p62 
(Sigma-Aldrich), PGC-1α (Millipore Corporation), and Ubiquitin (Enzo Life Sciences). 
Membranes were subsequently washed and incubated with the suitable HRP-conjugated 
secondary antibody for 1h at room temperature, and visualized with enhanced 
chemiluminescence. Quantification was performed with Image J Software (NIH, Bethesda, MD, 
USA) and values were normalized to the appropriate loading control. 
Autophagy and Mitophagy flux calculation 
Autophagy flux was calculated by the Δ change in LC3II and p62 protein levels in whole muscle 
extracts, between colchicine treated and untreated animals of the same condition and genotype. 
Where Δ change = (colchicine treated-Vehicle treated)/Vehicle treated.  
Mitophagy flux was calculated by the Δ change in LC3II and p62 protein levels in isolated 
mitochondria, between colchicine treated and untreated animals of the same condition and 
genotype. 
Cellular Fractionation 
 Enriched mitochondrial and nuclear cellular subfractions were isolated by differential 
centrifugation, as previously described (38). Briefly, muscles were minced on ice and 
homogenized using a Teflon pestle and mortar, and suspended in mitochondrial isolation buffer 
(MIB; 250 mM Sucrose, 20 mM HEPES, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM 
EGTA) supplemented with protease (Complete, Roche, 1169749801) and phosphatase inhibitor 
cocktails (Cocktail 2 and 3, Sigma, P5726 and P0044). The homogenates were centrifuged at 
1,000 g for 10 min at 4 °C to pellet the nuclei while mitochondrial and cytosolic fractions were 
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contained within the supernate. The supernate fraction was re-centrifuged at 16,000 g for 20 min 
at 4 °C to pellet the mitochondria. The mitochondrial pellet was washed twice and resuspended 
in a one-fold dilution of MIB. Mitochondria were subsequently sonicated 3x3sec to yield the 
enriched mitochondrial fraction. Pellets containing nuclei were re-suspended in nuclear lysis 
buffer (1.5 mM MgCl2, 0.2 mM EDTA, 20mM HEPES, 0.5M NaCl, 20% glycerol, 1% Triton-X-
100), incubated on ice for 30min, and then sonicated 3x10 sec followed by a final centrifugation 
step of 15min at 16,000g. The supernate was collected to obtain the enriched nuclear fraction. 
Protein concentrations within the samples were determined using the Bradford method. Fraction 
purity was determined by Western blot analysis of each fraction for the loading controls of all 
fractions (Fig.S3). 
Statistics 
Comparisons between WT and KO, Con, Ex and Ex+R animals were evaluated using two-way 
analyses of variance (ANOVA) on each of the treatment conditions. Bonferroni post-tests were 
performed when applicable. All values represent the mean ± S.E. Data were considered 
statistically different if P < 0.05. 
Results 
PGC-1α KO animals exhibit diminished mitochondrial content, reduced endurance 
capacity and metabolic stress with exercise. Deletion of PGC-1α resulted in significantly 
lower mitochondrial content in skeletal muscle, as demonstrated by reduced succinate 
dehydrogenase (SDH) as well as cytochrome oxidase (COX) staining, and a ~40% decrease in 
COX activity (Fig.1 A-B). To examine the involvement of PGC-1α in exercise-induced 
autophagy, 3 month old PGC-1α knockout (KO) and wild type (WT) animals were subjected to 
an acute bout of incremental treadmill running (Fig.1C-E). The lack of PGC-1α resulted in 
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diminished endurance performance, as the KO animals ran significantly less when compared to 
their WT counterparts (Fig. 1D). Moreover, KO animals exhibited a ~40% higher blood lactate 
basally, which increased by 3.8-fold with exercise, compared to a 2.8-fold increase in WT 
animals (Fig.1E). We also noted that the blood lactate of KO animals did not return back to 
baseline as effectively as that of WT animals during the 90 min recovery period. This indicates 
increased metabolic stress and a greater reliance on glycolysis in the KO animals. Confirmation 
of metabolic stress was evident from the changes in the phosphorylation of the metabolically 
sensitive p38 and AMPK kinases. Exercise resulted in a ~2.5-fold increase in the 
phosphorylation of AMPK in WT animals, while KO animals exhibited a ~4-fold induction (Fig 
2A-B). Phosphorylation of p38 MAPK was elevated by ~50%, with exercise, in both WT and 
KO animals. However, KO animals expressed higher levels of phosphorylated p38 overall, 
which did not return to baseline during recovery (Fig. 2A, C). 
PGC-1α localization to the nucleus and gene expression are elevated in response to exercise 
resulting in the induction of mitochondrial biogenesis in WT animals. Exercise induced the 
localization of PGC-1α to the nucleus (Fig. 3A) which was accompanied by an 8.5-fold increase 
in PGC-1α mRNA (Ppargc1a) expression following recovery (Fig. 3B). The increase in PGC-1α 
with exercise resulted in ~60% and ~50% inductions in the expression of the downstream targets 
cytochrome oxidase subunit IV (COXIV) and mitochondrial transcription factor A (Tfam), which 
were not evident in the KO animals (Fig. 3C-D).  Thus, an acute bout of exercise was sufficient 
to induce the onset of mitochondrial biogenesis, in a PGC-1α-dependent manner, an effect that 
was not observed in KO animals. 
Acute exercise results in the induction of autophagy, and this process is differentially 
regulated in PGC-1α KO animals. During autophagy, p62 and LC3 are consumed within the 
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lysosome while accompanying their respective organelle targets. A continuous transcriptional 
contribution is, therefore, required in order to avoid exhaustion of these important autophagy 
factors. We observed ~80% and ~94% inductions of Maplc3b (LC3) and sqstm1 (p62) transcript 
levels with exercise, respectively. However, this effect was abolished in KO animals (Fig 4A and 
B). In contrast, the transcript levels of additional autophagy (Atg7, Becn1) and lysosomal (CtsD, 
Lamp2) markers were not different between WT and KO animals, and did not change with 
exercise or recovery (data not shown). Our acute exercise protocol was sufficient to induce LC3 
lipidation in the muscle of WT animals, however we did not observe this increase in the KO 
mice until after the recovery period, indicating a delayed response to exercise in KO animals 
(Fig. 4C-D). The levels of p62 did not change immediately following exercise in WT animals, 
but increased with recovery (Fig. 4C, E). Conversely, p62 levels were elevated both immediately 
after exercise and following recovery in KO animals (Fig.4 C, E). This is indicative of impaired 
autophagosome degradation of p62 in KO animals.  
One major difficulty in evaluating autophagic flux is the extremely dynamic and transient 
nature of autophagosomes, since the average half-life of this organelle is about 10 min (20). 
Therefore, we evaluated autophagy flux by measuring the percent change in LC3II and p62 
protein in vivo with interperitoneal administration of the microtubule destabilizing drug 
colchicine, as previously described (12). Colchicine blocks autophagosome degradation by 
destabilizing the microtubule tracks on which they travel to the lysosome for degradation, 
resulting in the accumulation of autophagosomes, and thus in a back-log of LC3II and p62. 
Interestingly, LC3II flux tended to increase immediately following exercise and after recovery in 
WT animals, but was lower overall and did not follow a similar trend in KO animals (Fig. 4F). 
We also observed a trend for an increase in p62 flux with exercise in both WT and KO animals 
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(Fig. 4G), however this tendency was attenuated in the KO animals. Taken together, these results 
indicate an induction of autophagy with exercise in WT animals that is impaired in mice lacking 
PGC-1α. 
Mitochondrial targeting for degradation is enhanced following an acute bout of exercise, 
but this signaling is attenuated in mice lacking PGC-1α.  In order to investigate mitophagy 
induction and the role of PGC-1α in this process, we measured the presence of autophagy 
markers in isolated mitochondrial subfractions. Exercise induced a ~5.2-fold increase in the 
localization of LC3II to the mitochondria in WT animals, which decreased with recovery (Fig. 
5A-B). Although mitochondrial localization of LC3II tended to increase with recovery in KO 
animals, this did not reach statistical significance. Moreover, LC3II flux was significantly 
elevated with exercise (~4.4-fold, Fig. 5C) in WT animals only, and this increase was completely 
abolished by the lack of PGC-1α. The localization of p62 to the mitochondria did not change 
with exercise or recovery, in either WT or KO animals (Fig. 5A, D). However, p62 flux was 
increased following recovery by 65% and 56% in WT and KO animals, respectively (Fig. 5E).  
In order to elucidate the mechanisms behind mitochondrial targeting with exercise we 
examined the mitochondrial E3 ubiquitin ligase Parkin, which has been well documented to be 
intimately involved in mitophagy (25). Interestingly, Parkin mRNA levels were elevated ~3-fold, 
while mitochondrial localization of the protein was induced ~3.5-fold following exercise, which 
remained elevated during the recovery period in WT animals (Fig. 6 A-C). Parkin mRNA tended 
to increase with exercise in KO animals, but this increase was not statistically significant (Fig. 
6A). Importantly, parkin localization to the mitochondria was both delayed, and attenuated in the 
KO animals, increasing by 2.6-fold only after recovery (Fig. 6B-C). Elevated Parkin in WT 
animals translated to a ~60% increase in the ubiquitination of mitochondrial proteins following 
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exercise, and this effect was absent in KO animals (Fig. 6B, D). Since an important prerequisite 
for mitochondrial degradation by autophagy is organelle fragmentation (37), we also examined 
mitochondrially-localized Drp-1, a fission protein that translocates to mitochondria and 
facilitates their fragmentation. We found a ~2.2-fold increase in the localization of Drp-1 to the 
mitochondrial subfraction following exercise, which returned to baseline during recovery in WT 
animals (Fig. 6B, E). No change in mitochondrial Drp-1 levels was observed in KO animals. 
Thus, these results indicate an increased targeting of mitochondria for mitophagy post-exercise 
which is, at least in part, dependent on PGC-1α. 
Exercise-mediated alterations in transcriptional regulators of autophagy are not different 
between WT and KO animals. The transcriptional regulation of autophagy with exercise has 
not been thoroughly examined. Therefore, we investigated FoxO3 and TFEB, two well known 
transcriptional regulators of the autophagy-lysosome system. Foxo3 expression was induced 2.8-
fold with exercise in WT animals, and was consistently higher in KO animals across all 
conditions (Fig. 7A). Tfeb mRNA expression was not altered during exercise in either WT or KO 
animals, but tended to increase after recovery in WT animals only (Fig. 7B). Thus, both TFEB 
and FoxO3 may play a role in the transcriptional regulation of autophagy, but neither appears to 
be regulated by PGC-1α in this context.  
NPC1 is a novel autophagy factor regulated by PGC-1α. 
In order to identify additional autophagy factors that may be under the control of PGC-1α, we 
performed an unbiased PCR-based mRNA array and compared the expression of 84 autophagy 
related genes (for complete list of genes see table S1) in WT and PGC-1α KO animals. Several 
genes were dramatically down-regulated in KO as compared to WT animals (Fig. 8A), including 
mTOR, Nfkb1, Pik3cg, and NPC1. We chose to further investigate NPC1, a novel transmembrane 
protein responsible for cholesterol trafficking in late endosomes and lysosomes. Mutations in 
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NPC1 result in Niemann-Pick disease type C, an autosomal recessive neurovisceral lipid storage 
disorder, which is accompanied by impaired autophagy (17, 33). We first confirmed our array 
findings with real time PCR and found that NPC1 expression was indeed diminished by the lack 
of PGC-1α (Fig. 8B). NPC1 expression was induced by ~80% with exercise, and returned to 
basal levels during recovery in WT animals. The exercise-mediated increase in NPC1 was 
abolished in KO animals.  We also found that NPC1 protein levels were significantly lower in 
KO animals as compared to their WT counterparts (Fig. 8C). We, therefore, have identified 
NPC1 as a novel autophagy factor that is induced with exercise, and this induction appears to be 
PGC-1α-dependent.  
Discussion 
Skeletal muscle is a malleable tissue that rapidly adapts to its metabolic environment. Much 
research has focused on establishing the mechanism responsible for this remarkable plasticity, as 
it holds within great therapeutic potential for a vast array of muscle and metabolic pathologies. 
The energy demands stemming from muscle contraction are known to initiate signaling cascades 
which lead to increased mitochondrial biogenesis in order to enhance the energetic potential of 
muscle. This exercise signaling largely converges on PGC-1α, a transcriptional co-activator 
responsible for orchestrating the mitochondrial biosynthesis program. However, it is not known 
how mitochondrial degradation is regulated during exercise, and the role of PGC-1α in this 
process has not been conclusively determined. The purpose of this study was to examine the 
activation of autophagy and mitophagy during an acute bout of exercise, and to evaluate the 
involvement of PGC-1α in this process.  
PGC-1α has been documented time and again to drive mitochondrial biogenesis and 
expression of oxidative genes  (2, 18, 28, 29). It is no surprise then that KO animals are 
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profoundly deficient in mitochondria, as observed biochemically by more pale SDH and COX 
staining, as well as diminished COX activity. This reduction in mitochondrial content translated 
to a functional deterioration in endurance performance. PGC-1α KO mice exhibited metabolic 
distress during exercise, evident by elevated lactic acid levels that did not effectively resolve 
with a 90 min recovery period. This was accompanied by reduced endurance performance 
compared to WT animals. KO animals also exhibited greater increases in the activation of the 
metabolic sensor AMPK and cellular stress sensor p38, further supporting metabolic distress in 
these animals. WT animals displayed normal elevations in the activation of these kinases with 
exercise, which returned back to basal levels during the recovery period. Our results confirm that 
the process of mitochondrial biogenesis is initiated with the first bout of exercise, and that PGC-
1α is instrumental in this process (2, 28). PGC-1α has been documented to localize to the nucleus 
shortly after the commencement of exercise (7, 31). We noted an increase in nuclear PGC-1α in 
WT animals immediately following exercise which was followed by a strong induction in the 
transcript levels of the co-activator, particularly following the recovery period. These increases 
in PGC-1α transcript and nuclear localization were accompanied by the induction of 
mitochondrial genes encoded by the nuclear genome. This increase was abolished in animals 
lacking PGC-1α. These findings add further substantive support for the importance of PGC-1α in 
mediating adaptations in oxidative capacity within muscle as a result of exercise.  
Several studies have documented the induction of autophagy following an acute bout of 
exercise (5, 6, 8, 9). Here we demonstrate for the first time that the transcript levels of autophagy 
factors LC3B and p62 are induced immediately following an acute bout of exercise, and that this 
increase is mediated by PGC-1α.We did not detect any alterations in the transcript levels of these 
factors in KO animals 90 min post exercise. We also noted an increase in LC3 lipidation with 
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exercise in WT animals. This response was delayed in KO animals and did not occur until after 
the recovery period, when LC3II levels returned to baseline in WT mice. Interestingly, we did 
not note a decrease in p62 levels in WT animals with exercise, as has been previously described 
(6, 22). This could be a result of differences in the exercise protocol employed between the 
studies, and perhaps due to the increases in p62 mRNA that we noted with exercise. In KO 
animals we observed the opposite effect, where p62 levels were elevated following exercise. 
Because of the lack of increase in p62 mRNA levels in KO animals, we conclude that the 
increase in p62 protein with exercise is likely due to impaired degradation by autophagy in these 
animals. We did not note any basal differences in LC3 or p62 levels between the genotypes, 
indicating that this is an exercise-mediated effect. Moreover, we also observed a trend for 
increases in LC3II and p62 flux in WT animals as determined with colchicine treatment 
experiments, but this trend was not found in KO mice. Indeed, LC3II flux was lower in KO 
animals. These results indicate that autophagy induction, gene expression and flux are all 
induced by exercise, and that this induction is compromised in mice lacking PGC-1α.  Thus, 
PGC-1α appears to play a role in the regulation of exercise-induced autophagy. 
Activation of mitophagy with exercise has only recently been documented, and was deemed 
to be required for the removal of dysfunctional mitochondria following damaging downhill 
running exercise (22). However, the regulation of mitophagy in exercising muscle has not been 
thoroughly examined. Our findings demonstrate that mitophagy signaling, as well as flux, are 
induced with an acute bout of exercise, and that this effect is diminished in animals deficient in 
PGC-1α. In our hands, exercise-induced mitochondrial localization and flux of LC3II was 
abolished in KO animals. Interestingly, no alterations in p62 localization to the mitochondria 
were observed with exercise in either genotype, and p62 flux was similarly elevated in WT and 
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KO animals following recovery only. We also noted that parkin plays a role in exercise-induced 
mitophagy, as there was an increase in the localization of this E3 ligase to the mitochondria. 
Enhanced abundance of ubiquitinated proteins within the mitochondrial subfraction with exercise 
was also observed in the WT animals. In contrast, parkin localization to mitochondria was 
delayed in PGC-1α KO animals, occurring following recovery, and no increase in mitochondrial 
protein ubiquitination was observed. It is interesting to note that, the parkin-PGC-1α axis 
presents a potential point of communication between mitochondrial biogenesis and degradation 
following exercise. Parkin has been documented to target the transcriptional repressor Paris 
(ZNF746) for degradation, thus releasing the Paris-mediated repression of PGC-1α transcription 
(36). This would act to enhance mitochondrial biogenesis to compensate for increased 
mitochondrial degradation.  
The impairment in mitophagy that we observed in KO animals could also be due, in part, to 
altered organelle dynamics. Fission is a prerequisite for mitophagy (37), and in our model the 
localization of the fission protein Drp-1 to the mitochondria was increased after exercise in WT, 
but not in KO animals. This further supports our findings that mitophagy is activated with 
exercise, and that PGC-1α is involved in this process. 
Although several factors have been identified to participate in the transcriptional regulation 
of autophagy (3, 23, 35, 42), little is known about this process in skeletal muscle, and the 
regulation of this process with exercise has not been investigated. Therefore, we examined the 
expression of FoxO3 and TFEB, two transcriptional regulators that have been well documented 
to induce autophagic gene expression in different cells and tissues. FoxO3 transcript levels were 
induced with exercise suggesting a role for this protein in mediating the increased expression of 
autophagy genes with exercise. However, we also noted an overall higher expression of FoxO3 
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in KO animals, indicating that FoxO3 is not likely to mediate PGC-1α-induced autophagy. This 
is in line with previous evidence implicating PGC-1α in the suppression of FoxO3 under atrophic 
conditions (32). We also investigated TFEB, a master transcriptional regulator of the autophagy-
lysosome system (27, 35), previously documented to play a role in the induction of PGC-1α 
expression in the liver during nutrient deprivation (34). We noted a trend for increased TFEB 
transcript levels during recovery only in WT animals. The lack of this trend in KO animals 
suggests a potential role for TFEB in PGC-1α-mediated autophagic induction. Indeed, we have 
previously observed reduced TFEB protein levels in KO animals when compared to their WT 
controls (unpublished observations) under basal conditions. It is possible that PGC-1α may bind 
and co-activate TFEB on the promoter of autophagy-related genes, however, this warrants 
further investigation.  
In an attempt to further characterise the endogenous role of PGC-1α in autophagy regulation 
we performed an unbiased mRNA array to examine 84 genes involved in various aspects of 
autophagy. Our array data reveal that multiple genes that were down-regulated in KO animals. 
We further focused on Niemann-Pick C1 (NPC1), a novel transmembrane protein involved in the 
regulation of cholesterol trafficking from late endosomes and lysosomes. NPC1 protein and 
mRNA were both strongly down regulated in PGC-1α KO animals, but were induced with 
exercise in WT animals, suggesting a role for this protein in exercise-induced adaptations. NPC1 
has not been previously studied in this context, but mutations in NPC1 result in Neimann-Pick 
disease, a devastating lysosomal storage disease characterized by defective autophagy and 
increased cholesterol load (39). Moreover, polymorphisms or haploinsufficiency in the NPC1 
gene have been correlated with obesity and type 2 diabetes (11, 40). Very little is currently 
known about NPC1 and its role in skeletal muscle. 
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Taken together, our findings indicate that exercise-induced metabolic adaptations involve 
augmented mitochondrial turnover that engages concomitant increases in both degradation and 
biogenesis. Our results also demonstrate that the transcriptional co-activator PGC-1α coordinates 
mitochondrial biogenesis and mitophagy immediately following exercise, and that both of these 
processes are compromised in the absence of the co-activator. This study sheds light on the 
mechanisms underpinning mitochondrial turnover induced by exercise, implicating PGC-1α in 
orchestrating this process. 
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Figure Legends 
Fig.1 Lack of PGC-1α results in diminished mitochondrial content and reduced exercise 
performance. A. Representative images of COX and SDH staining of EDL muscle from Con 
WT and KO animals. B. COX activity as a surrogate measure of mitochondrial content in WT 
and KO animals (scale bar: 100μm). C. After 2 days of habituation to the treadmill animals were 
run to until failure utilizing an incremental exercise protocol on a 0% incline. Animals began 
with a warm up period of 5min at 5m/min and 10min at 10m/min followed by a period of 
endurance running for 45min at 15m/min. Finally, running speed was increased by 1m/min every 
2 min until animals refused to continue. D. Running performance in WT and KO animals treated 
with vehicle (water, veh) or 0.4mg/kg colchicine (col), measured by total distance ran. E. Blood 
lactate levels measured in WT and KO animals prior to exercise (Con), immediately following 
exercise (Ex) and following 90 min of recovery (Ex+R). *P<0.05, significant effect of exercise. 
†P<0.05, significant effect of genotype (n=4-12 for all groups).   
Fig.2 Signaling kinases are activated with exercise. A-C. Blots and quantification of signaling 
kinases in control (Con), exercise (Ex),and exercise with recovery (Ex+R) in WT and KO 
animals. A. Representative blots. Quantification of B. P-AMPK; C. P-p38. *P<0.05 significant 
effect of exercise. †P<0.05, significant effect of genotype. Total protein and GAPDH were used 
as a loading controls (n=5-9) 
Fig.3 Exercise induces increased nuclear localization and expression of PGC-1α, and 
mitochondrial biogenesis. A. Blot and quantification of PGC-1α levels in the nuclear 
subfraction of WT animals under basal conditions (con), after exercise (Ex) and following 
recovery (Ex+R). B. PGC-1α gene expression, mRNA fold change immediately following 
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exercise and with recovery in WT animals, all groups are compared to Con, Gapdh and Actb 
were used as housekeeping genes. C-D. Gene expression analysis of mitochondrial factors, 
mRNA fold change with exercise with and without recovery in WT and KO animals, all groups 
were compared to WT Con, Gapdh and Actb were used as housekeeping genes; C. COXIV; D. 
Tfam. *P<0.05 significant effect of exercise. †P<0.05 significant effect of genotype (n=4-9). 
Fig.4 Expression of autophagy genes and induction of autophagy with exercise are 
differentially regulated in PGC-1α KO animals. A-B. Gene expression of autophagy factors, 
mRNA fold change in WT and KO animals either in Con, Ex or Ex+R, all groups were 
compared to WT Con, Gapdh and Actb were used as housekeeping genes; A. LC3; B. p62. C-E. 
Blots and quantification of autophagic protein in whole muscle extracts in control (Con), 
exercise (Ex) and exercise with recovery (Ex+R) in WT and KO animals  treated with vehicle 
(water) or colchicine (col) 0.4mg/kg/day for 2 days. C. Representative blots. Quantification of D. 
LC3BII; E. p62; F-G. Autophagy flux as determined by percent change in protein content from 
Col treated and Veh treated WT and KO animals in Con, Ex and Ex+R groups; F. LC3II; G.p62. 
*P<0.05 significant effect of exercise. †P<0.05 significant effect of genotype. GAPDH was used 
as a loading control (n=5-9). 
Fig.5 Exercise-induced mitophagy signaling and flux are attenuated in PGC-1α KO 
animals. A-E. Blots and quantification of autophagic proteins and flux in isolated mitochondrial 
fractions in control (Con), exercise (Ex), and exercise and recovery (Ex+R) in WT and PGC-1α 
KO (KO) animals,  treated with vehicle (water) or colchicine (col) 0.4mg/kg/day for 2 days. A. 
Representative blots. Quantification of B. LC3BII protein; C. LC3II flux; D. p62 protein; C. p62 
flux. *P<0.05 significant effect of exercise. †P<0.05 significant effect of genotype. VDAC was 
used as loading control (n=7-9). 
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Fig.6 Lack of PGC-1α results in attenuated exercise-mediated mitophagy signaling. A. 
Parkin gene expression, mRNA fold change in WT and KO, Con, Ex, and Ex+R animals, all 
groups were compared to WT Con, Gapdh and Actb were used as housekeeping genes. B-E. 
Blots and quantification of proteins in isolated mitochondrial subfractions. B. Representative 
blots. Quantification of C. Parkin; D. ubiquitin; E. Drp-1. *P<0.05 significant effect of exercise. 
†P<0.05 significant effect of genotype. VDAC was used as loading control. (n=4-9). 
Fig.7 Transcriptional regulators of autophagy with exercise. A-B. Gene expression of 
transcriptional regulators of autophagy, mRNA fold change in Con,  Ex and Ex+R in WT and 
KO animals all groups were compared to WT Con, Gapdh and Actb were used as housekeeping 
genes; A. FoxO3; B. TFEB. *P<0.05 significant effect of exercise. †P<0.05 significant effect of 
genotype (n=4-9). 
Fig.8 Identification of NPC1 as a PGC-1α-regulated autophagy factor, through PCR-array 
analysis. A. Heat map comparing the expression of 84 autophagy related genes between WT and 
KO animals using mRNA-array. Green indicates reduction while red indicates increase in gene 
expression, the brighter the colour the greater the change in gene expression. For the full list of 
fold changes and statistical significance see table S1. B. Gene expression of NPC1, expressed as 
mRNA fold change in Con, Ex, and Ex+R groups in WT and KO animals, all groups were 
compared to WT Con, Gapdh and Actb were used as housekeeping genes. C. Representative blot 
and quantification of NPC1 in TA muscle extracts. *P<0.05 significant effect of exercise. 
†P<0.05 significant effect of genotype. GAPDH was used as loading control. (n=3-4). 
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Table 1 Primer sequences based on gene transcripts available in GenBank.
Gene Forward primer (5’ → 3’) Reverse primer (5’ → 3’)
Coxiv CTCCAACGAATGGAAGACAG TGACAACCTTCTTAGGGAAC
Tfam GAAGGGAATGGGAAAGGTAGA AACAGGACATGGAAAGCAGAT
Bnip3l GGAAAGCGGCACAGAGAA GAATGACGCCAGTGCTGAT
Park2 GTCTGCAATTTGGTTTGGAGTA GCATCATGGGATTGTCTCTTAAA
Sqstm1 TGTGGTGGGAACTCGCTATAA CAGCGGCTATGAGAGAAGCTAT
Maplc3b GCTTGCAGCTCAATGCTAAC CCTGCGAGGCATAAACCATGTA
Atg7 TTTCTGTCACGGTTCGATAATG TGAATCCTTCTCGCTCGTACT
Lamp2 GCTGAACAACAGCCAAATTA CTGAGCCATTAGCCAAATACAT
Catsd TTTGCCAATGCTGTCGTACT AGCGAGTGTGACTATGTGTGAG
TFEB AGCTCCAACCCGAGAAAGAGTTTG CGTTCAGGTGGCTGCTAGAC
Foxo3 ATGGACGACCTGCTGGATAAC GGAGCTCTTGGCGGTATATG
Beclin1 AGGCTGAGGCGGAGAGATT TCCACACTCTTGAGTTCGTCAT
NPC1 AGCATCACCGCATCTTACAA GCATGGCTGTTCTGGAAGTAA
Actb TGTGACGTTGACATCCGTAA GCTAGGAGCCAGAGCAGTAA
Gapdh AACACTGAGCATCTCCCTCA GTGGGTGCAGCGAACTTTAT
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Gene 
Symbol p value Fold change
Akt1 0.76 -2.67
Ambra1 0.61 -1.83
App 0.73 -2.49
Atg10 0.70 -2.39
Atg12 0.76 -1.71
Atg16l1 0.63 -2.16
Atg16l2 0.64 -2.12
Atg3 0.59 -1.43
Atg4a 0.60 -1.47
Atg4b 0.65 -1.99
Atg4c 0.60 -1.67
Atg4d 0.68 -2.61
Atg5 0.62 -1.87
Atg7 0.67 -2.13
Atg9a 0.65 -1.96
Atg9b 0.54 -2.82
Bad 0.76 -2.25
Bak1 0.62 -2
Bax 0.62 -2.15
Bcl2 0.51 -1.39
Bcl2l1 0.48 -1.2
Becn1 0.60 -1.73
Bid 0.68 -2.16
Bnip3 0.68 -1.93
Casp3 0.81 -3.15
Casp8 0.75 -2.35
Cdkn1b 0.66 -2.19
Cdkn2a 0.44 1.55
Cln3 0.65 -2.27
Ctsb 0.74 -2.6
Ctsd 0.68 -2.31
Ctss 0.83 -2.73
Cxcr4 0.97 -3.15
Dapk1 0.70 -2.32
Dram1 0.68 -2
Dram2 0.65 -1.56
Gene 
Symbol p value Fold change
Eif2ak3 0.75 -2.08
Eif4g1 0.67 -2.11
Esr1 0.58 -1.96
Fadd 0.75 -2.67
Fas 0.58 -1.61
Gaa 0.65 -2.26
Gabarap 0.67 -2.02
Gabarapl1 0.61 -1.78
Gabarapl2 0.74 -2.01
Hdac1 0.70 -2.4
Hdac6 0.62 -2.1
Hgs 0.61 -1.95
Hsp90aa1 0.58 -1.39
Hspa8 0.59 -1.64
Htt 0.70 -2.29
Ifng 0.29 -1.43
Igf1 0.77 -2.45
Ins2 0.52 -1.1
Irgm1 0.96 -2.9
Lamp1 0.62 -1.87
Map1lc3a 0.67 -2.36
Map1lc3b 0.76 -2.27
Mapk14 0.64 -2.02
Mapk8 0.63 -1.79
Mtor 0.03 -22.44
Nfkb1 0.05 -20.36
Npc1 0.05 -22.12
Pik3c3 0.73 -1.89
Pik3cg 0.05 -10.45
Pik3r4 0.59 -3.07
Prkaa1 0.60 -1.76
Pten 0.20 -2.94
Rab24 0.66 -2.06
Rb1 0.97 -2.23
Rgs19 0.51 -3.22
Rps6kb1 0.61 -1.59
Table S1 mRNA array data
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Snca 0.72 1.13
Sqstm1 0.67 -1.84
Tgfb1 0.68 -2.55
Tgm2 0.57 -1.5
Tmem74 0.29 -1.04
Tnf 0.00 -6.3
Tnfsf10 0.04 -18.34
Trp53 0.74 -1.94
Ulk1 0.47 -3.06
Ulk2 0.28 -2.59
Uvrag 0.54 -1.52
Wipi1 0.74 -2.25
Table S1 
Continued
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Fig. S3: mRNA expression of autophagy and lysosomal markers. A-D Gene expression as
measured by real time PCR. mRNA fold change between wild type (WT) and PGC-1α KO, Con, Ex
and Ex+R. All groups were compared to WT Con, and Gapdh and Actb were used as housekeeping
genes (n=4-9)
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CHAPTER 6: 
 
Summary and Conclusions 
 
PGC-1α is a transcriptional co-activator that is a bona fide regulator of oxidative 
metabolism in many tissues and organs. This co-activator and its family members co-ordinate 
mitochondrial biogenesis, and have also been documented to contribute to overall organelle and 
tissue health. Indeed, PGC-1α is cytoprotective under a plethora of perturbations. In skeletal 
muscle, enhanced expression of the co-activator is sufficient to protect against loss of muscle 
mass and function with aging, heart failure, denervation and starvation. To date, the focus of 
PGC-1α research has been centered around mitochondrial biogenesis, and its role in 
mitochondrial degradation has been largely ignored.  
Autophagy is a highly conserved proteolytic pathway responsible for the degradation of 
dysfunctional organelles as well as protein aggregates through the lysosomal machinery. The 
selective removal of mitochondria through autophagy has been dubbed mitophagy. Mitophagy, 
like autophagy, occurs basally in all tissues, and aids in cellular housekeeping by mediating the 
turnover of long-lived molecules and organelles. Under conditions of metabolic stress, 
autophagy/mitophagy can be upregulated and act as an adaptive response system, essential for 
cell survival and the maintenance of energetic balance. Aberrant autophagy contributes to 
cellular dysfunction, and can exacerbate muscle wasting during atrophic condtions. Autophagy is 
also activated with exercise, and it mediates some of the metabolic benefits incurred by physical 
activity. The transcriptional regulation of autophagy is not well understood, and governors of this 
process have only recently begun to emerge. Moreover, how mitochondrial turnover is 
coordinated during alterations in muscle contractile activity has not been thoroughly examined as 
of yet. The purpose of my dissertation was to investigate the role of PGC-1α in the regulation of 
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autophagy/mitophagy under the spectrum of muscle contractility. Using denervation and exercise 
as models of muscle use and disuse, we hoped to uncover the cross-talk between mitochondrial 
biogenesis and degradation machinery during these divergent metabolic stresses.  
Objective 1: We first investigated the role of PGC-1α in denervation-induced autophagy and 
mitophagy using a loss of function model. Wildtype (WT) and PGC-1α knockout (KO) animals 
were unilaterally denervated for 7 days. KO animals were mitochondria-deficient, and presented 
signs of myopagthy. Denervation enhanced the expression of autophagy genes as well as 
proteins, and the lack of PGC-1α resulted in diminished autophagy flux both basally and in 
response to denervation. This was assessed by the percent change in LC3 and p62 in animals 
treated with the microtubule destabilizing drug colchicine. Moreover, deletion of the co-activator 
abolished denervation-induced increases in the lysosomal marker, Lamp-2. We also determined 
that enhanced mitophagy participates in the rapid loss of mitochondrial content observed with 
disuse, and that PGC-1α is required for this activation, as KO animals exhibited diminished basal 
and denervation-induced mitophagy flux. Moreover, mice lacking PGC-1α expressed 
significantly lower levels of the mitophagy receptor Nix, both under steady state conditions and 
in response to denervation. In search of a mechanism for PGC-1α action, we measured protein 
expression and nuclear localization of TFEB, a transcriptional regulator of autophagy and 
lysosomal genes. We found that KO animals had reduced levels of TFEB, thus suggesting an 
interaction between the two transcriptional regulators. Thus, PGC-1α plays a role in autophagy 
and mitophagy flux both basally and in response to denervation, and this effect may involve an 
interaction with TFEB. 
Objective 2: In order to further establish the effect of PGC-1α on autophagy during denervation, 
we used a gain-of-function model, where wildtype (WT) and PGC-1α overexpressing (Tg) 
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animals were denervated for 7 days. Overexpression of PGC-1α resulted in a more oxidative 
muscle phenotype which was protected against the denervation-induced loss of muscle mass, and 
mitochondrial content. Interestingly, we observed enhanced expression of the essential 
autophagy protein LC3, lysosomal representatives Lamp-2 and Cathepsin D, as well as the 
mitophagy receptor Nix in Tg animals compared to WT. We also noted a significant increase in 
TFEB protein levels with PGC-1α overexpression. Despite these findings, mitochondrial 
targeting for degradation in Tg animals was reduced both basally and with denervation. These 
results are in contrast with our hypothesis, but are consistent with the protective role of PGC-1α 
on mitochondrial content and function, as well as muscle mass with denervation. Thus, PGC-1α 
plays a role in the regulation of some autophagy and lysosomal proteins during denervation, but 
enhanced expression of the co-activator appears to protect mitochondria from degradation during 
denervation. 
Objective 3: Autophagy induction has been documented to occur with exercise. Therefore, we 
wanted to confirm these findings and further investigate the activation of mitophagy following 
an acute bout of exercise, as well as to determine the role of PGC-1α in this process. To this end, 
we subjected WT and KO animal to an exhaustive bout of acute exercise (Ex) and a subset of 
animals was allowed to recover for 90 min (Ex+R). First we confirmed the importance of the co-
activator in the induction of mitochondrial biogenesis following exercise, and noted a lack of 
increase in COXIV and Tfam post exercise in animals deficient in PGC-1α. We also illustrated 
that an acute bout of exhaustive exercise was sufficient to induce both autophagy and mitophagy, 
and that this activation was dependent on PGC-1α, as lack of the co-activator abolished exercise-
mediated induction of these processes. Moreover, we observed that mitophagy induced with 
exercise appears to involve the E3 ubiquitin ligase parkin as well as ubiquitination of 
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mitochondrial substrates, and this too was mediated by PGC-1α. Thus, PGC-1α orchestrates 
mitochondrial turnover after exercise by enhancing both mitochondrial biogenesis and 
degradation. 
Taken together, these studies confirm the fundamental role of PGC-1α in the regulation 
of mitochondrial content and health in skeletal muscle. We also indicate that PGC-1α plays a 
regulatory role in stress-induced autophagy/mitophagy in skeletal muscle in a stimulus- 
dependent manner, with the ultimate goal of maintaining metabolic homeostasis, thus 
contributing to muscle plasticity. 
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CHAPTER 7: 
 
Future Directions 
 
Based on the findings from the three studies outlined in this dissertation it is evident that 
PGC-1α is intimately involved in the regulation of autophagy and mitophagy during alterations 
in muscle contractile activity. It is also clear that autophagy/mitophagy and PGC-1α play a major 
role in muscle plasticity. However, several questions remain unanswered and could form the 
basis for future studies. A few of these are outlined below. 
1) How does PGC-1α regulate autophagy in skeletal muscle? 
 
Although our studies demonstrate a role for PGC-1α in the regulation of 
autophagy/mitophagy especially following exercise, the mechanisms by which PGC-1α operates 
remain unclear. Several viable culprits of PGC-1α may be responsible for its action, including 
transcription factors known to be co-activated by PGC-1α, such as PPARα and HIF-1α or other 
transcription factors not yet validated, such as TFEB and FoxOs, or others that remain to be 
identified. In our current studies we utilized animal models where the co-activator was 
chronically deleted in the whole body, or overexpressed in skeletal muscle. These can lead to 
complex cellular adaptations to the chronic alterations in PGC-1α. It would, therefore, be of 
interest to study the effects of acute deletion and overexpresion of PGC-1α in an isolated system 
using a cell culture model. Acute deletion of PGC-1α using siRNA or shRNA, would constitute a 
useful model to study the effects of lack of PGC-1α on the expression and flux of 
autophagy/mitophagy. Moreover, tandem-tagged probes that can be targeted to LC3 or the 
mitochondria exist, and could be useful for the dissection of autophagy and mitophagy 
progression in cellular models where PGC-1α levels are manipulated basally, and in response to 
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metabolic stress such as serum starvation. To try and tease out mechanism, and to confirm that 
the effects we observed on autophagy in our animal models were indeed directly mediated by 
PGC-1α, it would be useful to examine whether re-introduction of PGC-1α to cells lacking the 
co-activator would rescue autophagy/mitophagy. Moreover, to confirm interactors of PGC-1α, 
we could immuno-precipitate the co-activator and examine by immunoblot whether any of our 
predicted factors (i.e TFEB) co-precipitate.  
2) What role does NPC1 play in skeletal muscle?  
 
Using our array analysis we uncovered NPC1 to be under the control of PGC-1α. The role of 
this protein in skeletal muscle is completely unknown. Neimann-Pick C1 is a transmembrane 
protein responsible for the trafficking of lipids and cholesterol. Mutations in this protein results 
in Neimann-Pick type C1 disease, a devastating neurovisceral disease characterized by increased 
lipid and cholesterol load. However, a majority of studies examining the etiology of this disease 
have focused on neuronal cells. Since patients with the disease were found to be hypotonic, it 
would be of interest to investigate if this is a by-product of the neurodegeneration occurring in 
these patients, or if this effect is mediated by altered skeletal muscle metabolism and signaling. 
Since this protein has never been examined in the context of muscle health, we could start by 
investigating the expression of NPC1 in various atrophic conditions such as denervation or 
aging. However, to really delve into the role of this protein in skeletal muscle we could obtain 
NPC1 knockout animals that are commercially available (Jasckson labs). To determine the 
functional role of NPC1 in skeletal muscle, we would first have to characterise the muscle of 
these animal by measuring muscle mass and cross sectional area, as well as make functional 
measurements such as force generating capacity and fatigability. Then, to assess muscle 
morphology, we could use electron microscopy and histochemical stains such as hematoxylin 
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and eosin, as well as succinate dehydrogenase in order to get a crude estimate of mitochondrial 
mass. To see any abnormalities in lipid load we could use oil red O staining. Based on our 
findings, we could then further look at mitochondrial function and content in these animals as 
well as assess autophagy protein expression and flux. Since NPC1 has never been examined in 
the context of skeletal muscle, the options here are truly endless.  
3) Does exercise induce autophagy and mitophagy in the heart? 
Autophagy and mitophagy play an important role not only in skeletal muscle but also in 
cardiac tissue.  Indeed, deficient autophagy/mitophagy in cardiomyocytes is detrimental and 
results in apoptotic cell death. Moreover, mitophagy is required for cardioprotection induced by 
pre-conditioning. During cardiac infarction autophagy/mitophagy are protective of cardiac tissue, 
and rescue cardiomyocytes from imminent cell death. Indeed, we have some preliminary data 
that autophagy is a highly active process in the heart, and that it is further activated during 
exercise. But the role of PGC-1α in cardiac autophagy/mitophagy has never been documented. It 
would therefore be of interest to investigate autophagy and mitophagy activation in the heart 
following acute exercise, and to determine the role of PGC-1α in these processes. Since 
cardiovascular disease is currently the second leading cause of death in Canada (Statistics 
Canada) this could have vast implications for public health. 
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The role of PGC-1α in the unfolded protein response  
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Rationale 
                 In chapters 4 and 5 we established a regulatory role for PGC-1α in autophagy and mitophagy 
during varying muscle contractile states. However, the mechanism by which PGC-1α regulates autophagy 
has not been elucidated. The unfolded protein response (UPR) is a cellular stress response system that is 
activated when unfolded or misfolded proteins accumulate in the lumen of the endoplasmic reticulum 
(ER). The ultimate goal of this mechanism is to restore cellular homeostasis by reducing protein 
translation, increasing protein degradation and boosting ER folding capacity. However, if these efforts fail 
to restore steady state, the UPR can trigger apoptosis. Indeed, various UPR factors have been documented 
to enhance autophagy in response to cellular distress in order to avoid cellular demise (1–3, 5). Moreover, 
PGC-1α has been documented to modulate UPR in response to exercise via co-activation of the 
transcription factor ATF6α (4). The PGC-1α-UPR axis has also been deemed important for mediating 
exercise-induced adaptations. However, it is not clear what role PGC-1α plays in the UPR under altering 
muscle contractile states and if this interaction contributes to autophagy induction. Therefore, in this study 
we investigate the role of PGC-1α in the regulation of UPR protein expression in skeletal muscle utilising 
both loss and gain of function models under basal conditions, and in response to denervation, and acute 
exercise. 
Results 
Unfolded protein response is enhanced in PGC-1α Tg animals. In order to investigate the role of PGC-
1α on the basal expression of proteins involved in the UPR we utilised wild type (WT), PGC-1α KO (KO) 
as well as PGC-1α Tg (Tg) animals. Western blot analysis revealed that despite a trend there was no 
significant difference in the expression of the ER chaperone Bip (Fig. 1B) or the transcription factors 
CHOP (Fig. 1C) and ATF6 (Fig. 1F) between WT animals and KO or Tg animals. However, we did find 
a significant ~5.5-fold difference in Bip expression between KO and Tg animals. We also observed 2.4- 
and 2.5-fold higher CHOP and ATF6 expression in Tg compared to KO animals. Protein levels of p-eif2α 
were similar between WT and KO animals, but were significantly induced in Tg animals (Fig. 1D). 
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Unfolded protein response is induced by denervation.  To assess the involvement of PGC-1α in UPR 
during denervation WT, KO and Tg animals were unilaterally denervated by severing the sciatic nerve, 
while the contralateral limb served as an internal control. Denervation resulted in a 2-fold decrease in Bip 
protein levels in WT animals, while lack of PGC-1α resulted in a 10-fold lower overall Bip protein 
expression with no further changes following denervation (Fig 2B). CHOP protein levels were induced 
3.5- and 2.5-fold with denervation in WT and KO animals, respectively (Fig 2C). Phosphorylation of 
eif2α was similarly induced by ~3-fold in both WT and KO animals (Fig 2D).  
PGC-1α overexpression resulted in greater basal levels of Bip protein, which were not further 
altered by denervation in the Tg animals (Fig. 3B). CHOP and p-eif2α protein levels were basally higher 
in Tg animals when compared to their WT counterparts and Tg animals were also better able to up-
regulate these proteins in response to denervation (Fig. 2C-D). This resulted in additive, 17- and 2-fold 
inductions in CHOP and p-eif2α, respectively, in denevated Tg animals when compared to WT controls.  
Unfolded protein response in WT and PGC-1α KO animals in response to an acute bout of 
exhaustive exercise. PGC-1α has been previously documented to upregulate the UPR in response to an 
acute bout of exercise. We, therefore, investigated the expression of UPR genes and proteins in WT and 
PGC-1α KO animals immediately following an acute bout of exhaustive exercise and after a 90min 
recovery period. Bip mRNA was induced by 2.8-fold immediately following exercise in WT animals 
only, and this exercise-induced increase was abolished by the lack of PGC-1α (Fig. 4A). Moreover, Bip 
protein levels progressively declined following exercise in WT animals only (Fig. 4C). Bip protein levels 
were overall lower in KO animals and were not further altered by exercise. CHOP levels were 
significantly induced immediately following exercise in WT animals only, while KO animals expressed 
overall lower CHOP levels which were not further altered with exercise (Fig. 4D). We did not find any 
variations in the levels of p-eif2α following exercise in either WT or KO animals (Fig. 4F). 
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Conclusions 
The unfolded protein response is a major cellular quality control mechanism that is activated 
when the ER is overwhelmed by damaged proteins. Our results indicate that the UPR is activated in 
skeletal muscle during alterations in metabolic demands and PGC-1α appears to be involved in this 
process. Interestingly, two seemingly opposing stimuli: muscle disuse, such as denervation and increased 
contractility such as exercise, both resulted in enhanced activation of the UPR. Moreover, although it 
appears that overall activation of the UPR is perturbed when PGC-1α is lacking and enhanced when the 
co-activator is overexpressed, the relationship between PGC-1α and the UPR appears complex and 
stimulus as well as factor specific. Under basal conditions differences in UPR protein expression could 
only be detected when PGC-1α levels were vastly different, i.e between KO and Tg animals and not WT 
animals. Moreover, PGC-1α overexpression, enhanced the UPR during denervation. However, the lack of 
PGC-1α appeared to attenuate UPR only following exercise with little effect on UPR induction during 
denervation, with the exception of Bip. Indeed, PGC-1α has been previously documented to regulate Bip 
expression though ATF6α (4). Therefore, PGC-1α appears to play a complex role in the regulation of the 
UPR, which provides further insight into the many ways by which this co-activator contributes to skeletal 
muscle metabolic plasticity. 
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Protein Extracts from muscle sections 
Reagents: 
 
1. Lysis buffer: (Make stock and aliquot, store at -20)  
  50mM Tris pH 7.5 
  150mM NaCl 
   10mM MgCl2 
  0.5mM DTT 
  1mM EDTA 
  10% Glycerol 
2. 20% SDS stock 
3. 10% Triton x-100 stock 
4. Protease and Phosphatase inhibitors: Complete 50x stock (from tablet Roche) , phosphatase 
inhibitor cocktail 2 (sigma #P5726) and phosphatase cocktail 3 (sigma #P0044) (both cocktails 
come as 100x stock) 
 
Procedure: 
 
1. Cut muscle frozen in liquid N2 
 20 sections 20um for Gastrocnemius (can also domore i.e 40 sections) 
 40 sections 20um for Tibialis A nterior 
 EDL: *pulverize with mortar 
          *re suspend in 200ul of lysis buffer 
          * Homogenize with pestle 
Place eppendorf with cut sections into Liq. N2 immediately when finished cutting to avoid thawing. 
 
2. Make working stock of lysis buffer with final concentrations of 2% SDS, 1% Triton x-100 
detergents and 1x protease/phosphatase inhibitors. (100ul of stock per sample) .  
 
i.e: For 1ml of lysis buffer add  
100ul of 20% SDS 
100ul of 10% Triton x-100 
20ul of complete 
10 ul phosphatase inhibitor cocktail 2 
 10ul phosphatase inhibitor cocktail 3 
 
3. Take eppendofs with cut sections out of Liq. N2 and place on ice with open lids (to avoid 
explosion), be careful not to spill any sections that are on the lid or the sides.  Add 100ul of 
working lysis buffer stock to each sample. If some sections are stuck on the side or in the lid, 
briefly centrifuge. 
4. Thermomix for 10 min at 70ºC at 700rpm in thermomixer 
5. Centrifuge for 10 min at 4ºC at 13,000rpm 
6. Collect supernate into a newly labelled eppendorfs 
7. Quantify protein concentration with BCA/ Bradford, freeze leftover lysis buffer to use as blank 
for [protein]. 
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Single fiber fixation isolation and Immunofluorescence 
Immunofluorescence staining of isolated fixed EDL fibers for imaging using a confocal 
microscope. (Adapted from Raben N, Shea L, Hill V, Plotz P. Monitoring autophagy in 
lysosomal storage disorders. Methods Enzymol 453:417-49, 2009.) 
Materials and Reagents: 
 
1. 2% Paraformaldehyde in 0.1 M sodium phosphate buffer: 
a)  Make by mixing equal volumes of : 
b)  4% paraformaldehyde and 
c)  0.2M phosphate buffer, pH 7.2. For 100ml: Add 1.93g Na2HPO4 and 0.75g NaH2PO4 
volume up to 100 with H2O. 
5. PBS 
6. 6 well plate with silicone in the wells and pins 
7. Glass slides and cover slips 
8. 50% glycerol in PBS 
9. 0.04% saponin 
10. Blocking solution 10% goat serum in PBS 
11. 0.2% Triton X-100 in a 10% goat serum blocking solution in PBS. 
12. Primary Ab in 10% goat serum in PBS 
13. 0.5ug/ml of Dapi in PBS 
14. Fluorescent secondary Ab in 10% goat serum in PBS 
15. Mounting medium 
 
 Muscle fixation, and fiber isolation procedure: 
1. Carefully isolate and excise EDL muscle, anochor the muscle onto the silicon covered 6 
well dish with pins and submerge in 2% paraformaldehyde in phosphate buffer for at 
least 1h at room temperature.  
2. Wash muscle with PBS and either dissociate immediately or place in 50% glycerol at 4˚C 
overnight, then store in -20 until further use.  
3. After long term storage gradually transition muscle through diminishing concentrations 
of glycerol and mechanically tease apart in a puddle of 0.04% saponin using fine forceps. 
4. Mount single fibers onto glass slide 
 
Fiber immunostaining Procedure: 
1. Permeabilize isolated fibers with 0.2% Triton X-100 in a 10% goat serum blocking 
solution.  
2. Incubate fibers with the appropriate primary antibody diluted in blocking solution 
overnight at 4 °C.  
3. Carefully wash fibers with PBS 3x5min 
4. Incubate for 2 h at room temperature with the suitable fluorescent secondary antibody. 
(From here on make sure to protect fibers from light)  
5.  Carefully wash fibers with PBS 3x5min, add Dapi at a 0.5 μg/ml concentration to the 
first wash (in order to visualize the myonuclei).  
6. Mount glass cover slip and dry thoroughly. Keep refrigerated and protected from light 
until imaging. 
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